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ABSTRACT 
Background 
The changes in cognition, brain structure, and neurological soft signs which are 
characteristic of schizophrenia appear to have been present before the onset of the 
phenotype. They therefore find relevance as potential vulnerability markers of the disease. 
Neurological soft signs are of particular interest because they can be elicited quickly, 
reliably and cheaply. They have also been touted as markers of certain characteristics of 
schizophrenia. The most convincing evidence for these assertions come from prospective 
longitudinal studies of first episode, medication naive patients with schizophrenia. Most of 
these studies have been based on wholly Caucasian or mixed samples of Caucasians and 
other races. The present study provides important reference data on the nature of 
neurological soft signs in indigenous African subjects and clarifies the trait or state 
marking signs in this population.  
Method 
A total of 84 patients with first episode, schizophrenia, schizo-affective disorder, or 
schizophreniform disorder meeting criteria in the fourth edition of the Diagnostic and 
Statistical Manual for Mental Disorders were consecutively recruited. Information on 
demographic characteristics, personal medical and psychiatric history, as well as family 
history was obtained at baseline. Neurological assessment was based on the 26 item 
Neurological Evaluation Scale. An exploratory factor analysis of the items in the scale was 
conducted using the baseline measurements. The derived sub-sets of neurological soft 
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signs were then followed up longitudinally and in parallel with the ‘functional categories’ 
of the signs. The study describes the profile of neurological soft signs across the one year 
course of schizophrenia, as well as their relationship with a wide range of clinical and 
outcome variables. The severity of the baseline psychopathology was evaluated by 
administering the Positive and Negative Syndrome Scale. The overall clinical status was 
assessed using Clinical Global Impression. Additional assessments included the Calvary 
Depression Scale for Schizophrenia, Birchwood Insight Scale, Social and Occupational 
Functioning Assessment Scale, and the World Health Organisation Quality of Life Scale 
(WHO QoL-BREF). Pre-morbid adjustment was assessed using the Pre morbid 
Adjustment Scale, while extra-pyramidal effect of antipsychotics was assessed using the 
Extra-pyramidal Symptoms Rating Scale. Assessments were repeated at three monthly 
intervals for the full 12 months.  
Results 
Neurological soft signs were present in 96.4% of the sample at baseline. The signs loaded 
into a four factor structure: perceptual and motor sequencing (audio-visual integration, 
fist-edge palm, rhythm tapping, extinction, and right-left confusion), eye movements 
(synkinesis, convergence, and gaze impersistence), motor co-ordination and 
graphaesthesia (tandem walk, adventitious flow, and graphaesthesia), as well as 
stegreognosis. The scores for the perceptual and motor sequencing factor, as well as those 
for the sequencing of complex motor acts ‘functional category’ were stable across three 
measurements over 12 months (F=1.26, p=0.287, and F=1.87, p=0.158 respectively). The 
sequencing of complex motor act signs was not significantly correlated with the clinical 
and outcome characteristics of schizophrenia. However, other signs, as well as the NES 
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total score were significantly correlated with more severe negative and disorganized 
psychopathology, as well as poorer outcome in terms of functioning and quality of life. 
Conclusion 
Neurological soft signs were present at a high frequency at baseline. A preponderance of 
the signs was associated with a more severe negative and disorganization 
psychopathology, as well as a poorer functional outcome and quality of life. Abnormal 
sequencing of complex motor act signs, and signs of abnormal cognitive processing of 
perceptual stimuli where resistant to changes in psychopathology, and thus may represent 
viable trait markers for schizophrenia in this cohort. 
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CHAPTER ONE 
 
INTRODUCTION 
Schizophrenia is a disease found in all societies and geographical areas around the world. 
Its incidence has often been quoted as roughly equal worldwide. This notion was 
established by early influential large scaled epidemiological studies funded by the World 
Health Organization (WHO), and also documented in the Diagnostic and Statistical 
Manual (DSM IV) (American Psychiatric Association, 1994). More recent reports 
estimate the prevalence of schizophrenia as 4.6/1000 for point prevalence, 3.3 per 1000 
for period prevalence and 4.0 per 1000 for life time prevalence. The prevalence of 
schizophrenia may be higher in immigrant groups and lower in developing countries (Saha 
et al, 2005).  
 
Schizophrenia commonly presents with impairments in perception, structure of thought, 
concept of self, cognitive functions, volition, and emotions, and in many cases evolves 
into a chronic disorder with deterioration in personal functioning. Abnormalities of 
cognition, brain structure, as well as neurological signs appear to have been present before 
onset of schizophrenia and have been recognized as part of the expression of the disease 
(Chen et al,2005., Chan and Gottesman, 2008., Serene et al, 2007).  
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Neurological abnormalities have often been conceptualized as ‘soft or hard’. Hard signs 
are gross signs elicited by the traditional neurological examination. They often indicate a 
demonstrable lesion in the nervous system. They include signs such as visual field defects 
or hypotonia which can often be traced to specific malfunctioning of the brain, whereas 
Neurological Soft Signs (NSS) feature in individuals with no obvious neuropathology. No 
observable compromise in neurological functioning is identifiable in such individuals. 
Most of the signs suggest a decrement of the individual's performance abilities in motor or 
sensory tests of a neurological examination and are thought to offer little usefulness in 
localising any gross lesion (Gureje, 1988., Compton et al, 2006., Sewell et al, 2010). 
 
The relevance of NSS in schizophrenia has been a subject of repeated research in the past 
40 years. The prevalence of these abnormalities has been a central issue in most of these 
studies, and have been estimated to be between 50% and 65% (Heinrich and Buchanan, 
1988., Shibre et al, 2002., Bombin et al, 2005). This prevalence appears to be particularly 
high in first episode schizophrenia subjects, reaching up to 97.1% (Browne et al, 2000) 
and 100% (Scheffer et al, 2004),  depending on the definition of NSS in the relevant 
studies. This high prevalence among first episode, treatment naïve patients provides 
evidence for the presence of underlying brain disorder in schizophrenia prior to the onset 
of frank psychosis (Zhao et al, 2013., Gay et al, 2012), and supports a neuro-
developmental model for the disorder (Peralta et al, 2011) Studies have also consistently 
shown a higher frequency of NSS in patients with schizophrenia than in other psychiatric 
subjects, and normal comparison groups ( Boks et al, 2004., Chan et al, 2009.,Ellison-
Wright and Bullmore, 2010., Peng et al, 2012), with relatives of patients with 
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schizophrenia showing rates that are somewhere in between those of the patients and 
normal comparison subjects (Gourion et al, 2003., Neelam et al, 2011). This pattern of 
similarity between patients and their relatives may indicate genetic or shared 
environmental factors or both (Sanders et al, 2006). 
 
Thus, NSS have been considered by many as an indicator of vulnerability to schizophrenia 
and as correlates of both clinical and functional outcome. This is because they are 
represented to a large extent in patients with schizophrenia, and may be enduring through 
remission (Prikryl et al, 2012., Piccioni and Dazzan, 2009., Boks et al, 2006., Emsley et al, 
2005., Bachman et al, 2005., Chen et al, 2005., Scheffer, 2004). They also occur in first 
degree relatives of the patients with schizophrenia as well as some schizophrenia spectrum 
disorders (Mechri et al,2010., Chan and Gottesman, 2008., Shubert and McNeil., 2005., 
Prasad et al, 2009., Sanders et al, 2006., Keshavan et al, 2008., Kaczorowski et al, 2009, 
Chan et al, 2010a and b).  
 
Despite this compelling level of evidence, the true nature and prevalence of NSS in 
schizophrenia are still not fully understood, owing in part to a number of methodological 
issues such as the wide variation in neurological assessment procedures across studies, the 
inconsistencies in the criteria for defining normality and abnormality, the unresolved and 
sometimes ambiguous concept of 'soft' and 'hard' neurological signs, as well as the 
unresolved issues of the possible lateralization of neurological abnormalities in 
schizophrenia (Ismail et al, 1998., Gay et al, 2012., Kong et al, 2012). Furthermore, the 
Stellenbosch University  http://scholar.sun.ac.za
  
18 
 
nature of the underlying neuropathology, as well as the aetiology of neurological 
abnormalities in schizophrenia remains unclear, as basic sensory and motor mechanisms 
are not particularly disturbed in schizophrenia (Heinrich and Buchanan 1989).  
 
Studies on NSS in schizophrenia from the African population are few and far between. 
Out of a total of five African studies reporting on the nature of NSS in Schizophrenia 
(Gureje et al, 1988., Mubarak et al, 1999., Shibre et al, 2002., Emsley et al, 2005, and 
Smit et al, 2012), only one was based on a first episode sample (Emsley et al, 2005). That 
study, which is also the only prospective longitudinal study of NSS in the African 
continent, was based on a predominantly mixed sample of Caucasians and other races. Yet, 
prospective longitudinal clinical studies of NSS in first episode schizophrenia subjects 
have provided useful information in the last two decades on the nature of this clinically 
complex and aetiologically heterogeneous condition that affects about 1% of the general 
population.  
 
This study describes the profile of NSS across the one year course of schizophrenia, as 
well as their relationship with illness specific and outcome variables in a group of first 
episode, largely medication-naïve Yoruba Nigerians with the disease. This is in the 
background of some reports suggesting that race and ethnicity affects the profile of NSS in 
schizophrenia (Chen et al, 2003., Keshavan et al, 2003.,  Bombin et al, 2005., Mechri et al, 
2009). The study is expected to provide important reference data on the nature of NSS in 
indigenous African subjects and energize the pursuit of candidate genes in the causal 
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pathway of schizophrenia.  This is with the hope that such a discovery will make it 
possible to develop better diagnostic procedures, treatments and preventive interventions 
targeted at the underlying illness process. 
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CHAPTER TWO 
 
 
LITERATURE REVIEW 
 
A search of the literature for relevant articles on neurological soft signs (NSS) in 
schizophrenia was conducted using the libraries of Stellenbosch University, University of 
Ibadan, and the Institute of Psychiatry, Kings College London. An English language 
search of PUBMED, MEDLINE, PsychINFO, and the World Health Organization (WHO) 
HINARI databases for literatures published between 1969 and 2011 was carried out. This 
was later updated to 2013. Search terms used were in accordance with the Medical Subject 
Headings (MeSH). They include: Neurological AND Soft AND Signs AND Schizophrenia 
OR Psychosis. A narrower search included the following terms: First AND Episode AND 
Schizophrenia OR Psychosis. All abstracts were screened, and articles that might have 
contained relevant information were read in full. The references of key articles were also 
searched to retrieve linked articles. The searches identified a total of 1,828 articles from 
which a total of 47 full texts relevant to the objectives of this dissertation were critically 
reviewed. These materials were of considerable clinical, methodological and statistical 
heterogeneity. The investigator also constantly interacted with three experts in the field of 
NSS and schizophrenia to identify grey literature; Oye Gureje (University of Ibadan), 
Robin Emsley (Stellenbosch University), and Paola Dazzan (Institute of Psychiatry, 
London).  
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2.0. WHAT IS SCHIZOPHRENIA? 
Schizophrenia is a severe psychotic syndrome with a common onset in early adolescence, 
but with evidence of difficulties with psycho-social adjustment in early or late childhood 
in many cases. It is characterized by delusions which may be bizarre, auditory 
hallucinations, thought disorders, strange behaviour and progressive deterioration of 
personal, social and occupational functioning. These features characteristically occur in 
clear consciousness. They represent abnormalities in multiple functional domains, creating 
a complex mixture of psychological and physical signs and symptoms. Thus, there have 
been several attempts to simplify this heterogeneous group of symptoms into clinically 
meaningful sub-divisions. 
 
The concept of ‘positive and negative’ symptoms was first described by Hughling Jackson 
using his experience in the treatment of patients with epilepsy. The fundamentals of 
Jackson’s description were adopted by Andreasen and Olson to sub-divide patients with 
schizophrenia into positive: representing those with an increase in normal function or the 
presence of abnormal function, and negative: representing patients with a reduction or 
absence of normal function (Andreasen and Olson, 1982). Positive symptoms of 
schizophrenia are now known to include hallucinations, delusions, bizarre behaviour, 
formal thought disorders and inappropriate affect while symptoms such as flattened affect, 
alogia, avolition, anhedonia and inattention are generally classified as negative symptoms. 
This subdivision has considerable clinical utility. Positive symptoms respond better to 
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available antipsychotic medications, whereas negative symptoms respond less to both 
conventional and second generation antipsychotics. This categorical approach to 
schizophrenia psychopathology has influenced several subsequent attempt to simplify 
these symptoms such as those of Crows types one (predominantly positive) and two 
(predominantly negative) (Crow, 1985), and the deficit/ non-deficit sub-typification 
(Carpenter, 1988). Dimensional approaches to schizophrenia psychopathology have 
employed factor analyses to group symptoms that aggregate together statistically as 
forming independent syndromes. The three dimensions solution which include reality 
distortion, psychomotor poverty, and disorganization syndromes was proposed in the 
reports of some early factor analyses (Andreasen and Grove, 1986., Kay et al, 1987), 
while more recent factor analyses of the Positive and Negative Syndrome Scale (PANSS) 
has generated up to five or more dimensions of schizophrenia psychopathology (Wolthaus 
et al, 2000., Emsley et al, 2003., Serreti and Olgiatti, 2004., van de Gaag et al, 2006). 
 
2.1. EPIDEMIOLOGY OF SCHIZOPHRENIA 
Schizophrenia is found in all societies and geographical areas around the world. Its 
incidence has often been quoted as roughly equal worldwide, a notion that is now a central 
tenet in the epidemiology of schizophrenia. This notion became very popular after the 
publication of the findings in 1986 of the World Health Organisation (WHO) determinant 
of outcome study (Sartorius et al, 1986), an influential transnational study covering 12 
sites in 10 different countries. However, some recent data are now challenging the similar 
incidence notion. For instance a systematic review of the incidence rate of schizophrenia 
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from 33 countries found a five-/fold variation in the incidence of schizophrenia between 
sites (McGrath et al, 2004).  
 
Individuals who are born or raised in an urban location are known to have at least a two-
fold increase in the risk of developing schizophrenia compared with those born or raised 
in rural areas (Kirkbride et al, 2006). In fact, urban birth has been shown to account for 
about 30% of the population attributable risks of schizophrenia (Mortensen and Pedersen, 
2001). The difference in incidence between urban and rural locations has previously been 
attributed to social drift, where affected or vulnerable individuals lose their means of 
livelihood and drift to poorer inner city areas. Other reports also suggest that an artefact 
during selective migration may be responsible for rural/urban differences (Mortensen, 
2000). However, more recent evidence suggests that the increased incidence of 
schizophrenia in urban centres is related to the degree of urbanization (Pedersen and 
Mortensen, 2006).  Fluctuations in schizophrenia incidence have also been reported over 
many decades. For instance, Boydell et al. (Boydell et al, 2003) reported a large increase 
in Camberwell between 1965 and 1997 using case record analysis. The changing structure 
of the population may however account for some of the changes seen in the incidence 
rates over time. There is also a 3-5 fold increase in the incidence of schizophrenia among 
some migrant populations compared to the general population (Cantor-Grae and Selten, 
2005). The magnitude of this risk has been found to be significantly greater among the 
second generation of these migrant groups (Selten et al, 2007).  Some authors have 
aggregated evidence for a 'country of origin' hypothesis, which suggest immigrants carry 
an excess risk of schizophrenia from their countries of origin. However, this has been 
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challenged by findings that the incidence rates of schizophrenia in Caribbean countries is 
similar to those found among indigenous United Kingdom population (Hickling and 
Rogers-Johnson, 1995). Similarly, there is no consistent evidence for selective 
immigration as part of a pre-psychotic segregation (Selten et al, 2001). Immigrant 
population certainly experience considerable social disadvantages, discrimination, and 
other difficulties related to the ongoing process of acculturation (Veling et al, 2007). This 
chronic process may find relevance within the stress- diathesis model of the aetiology of 
psychosis. A small relative risk of schizophrenia during winter or spring birth has often 
been reported since the 1920s (Davies et al, 2003). This risk remains even in the southern 
hemisphere where winter is between June and July, although most birth are also known to 
occur during these seasons (Boyd et al, 1986).  The male to female incidence of 
schizophrenia is now estimated to be about 1.4:1, with more males being diagnosed with 
the disease (Mcgrath et al, 2004). 
 
 
A systematic review of the prevalence of schizophrenia by Saha et al (Saha et al, 2005), 
based on 136 prevalence estimates derived from 85 studies  found a four to seven fold 
variation in the prevalence of schizophrenia between sites. The median prevalence is 
estimated 4.6/1000 for point prevalence, 3.3 per 1000 for period prevalence and 4.0 per 
1000 for lifetime prevalence (Saha et al 2005). This is slightly different from the 1.0% 
quoted in many influential studies, as well as the DSM IV diagnostic manual (American 
Psychiatric Association, 1994). Saha et al, (Saha et al, 2005) also reported that the 
prevalence of schizophrenia was significantly higher in developed nations compared to 
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developing nations. This finding appears to be a corollary of the 'favourable outcome 
hypothesis', which holds that the outcome of schizophrenia is more favourable in poorer, 
developing nations in contrast to richer, developed nations (Jablenski et al, 1992., WHO, 
1972).  
 
2.2.0. NEUROBIOLOGY OF SCHIZOPHRENIA 
The biological processes that are causal in the pathway to the expression of schizophrenia 
are presently not known. However, evidence for the involvement of biological 
mechanisms in the onset and progression of the disease presently exists and are quite 
robust. Specifically, information from genetic studies and other evidence for pre-morbid 
abnormalities such as obstetric complications, minor physical anomalies, non-progressive 
structural brain defects, as well as measurable neurological and neuropsychological 
abnormalities have allowed for an understanding of schizophrenia as disorder of brain 
development and plasticity. 
 
Genetic factors appear to be important in making an individual vulnerable to 
schizophrenia. Evidence for this is derived from family, twin and adoption studies. 
Genetic factors are now known to account for a majority of the liability to schizophrenia, 
and heritability estimates above 50% have been reported in many studies (Ross et al, 
2006). Results from rigorous family studies that employ a narrow criterion in defining 
schizophrenia such as those of Kendler et al. (Kendler et al, 1993) have shown strong 
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evidence for familial aggregation of schizophrenia. This is especially so in early onset 
schizophrenia, which has been shown to have aetiological continuity with late onset 
schizophrenia (Strandburg et al, 1999). The evidence of familial aggregation of 
schizophrenia is further supported by twin studies which have shown that the risk of 
schizophrenia in the co-twins of a schizophrenia proband is much higher in monozygotic 
than dizygotic twins (Cannon et al, 1998). Twin studies are based on the assumption that 
monozygotic and dizygotic twins share approximately the same environment, but while 
monozygotic twins share similar genetic properties, dizygotic twins share only about half 
of their genetic materials. Furthermore, some adoption studies done to exclude the 
influence of environmental factors in the heritability of schizophrenia have also reported 
that about 10% of the off-springs of schizophrenia patients who are adopted by non 
schizophrenia parents develop the disease, whereas there is no increase in schizophrenia 
among the off-springs of the healthy individuals adopted by schizophrenia parents (Kety et 
al, 1994). However, the pattern of the risk for the transmission of schizophrenia in the 
different types of family studies suggests that the inheritance of schizophrenia cannot be 
explained exclusively by a single gene effect. Inheritance of the disease is more likely the 
result of the combined effect of several genes interacting with each other. Consistent with 
this view is the reports of several studies that have identified significant linkages of 
schizophrenia inheritance to different chromosomal regions, especially 6p24-22 (HLA 
locus), 8p12-21 (neuregulin gene), as well as the gene deletion on 22q responsible for the 
Velocardiofacial syndrome which is associated with schizophrenia in 30% of subjects 
(Waterwort et al, 2002., Ross et al, 2006). It is noteworthy that none of the identified 
chromosomal regions have been replicated consistently in the different studies and none 
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have also been able to completely explain the contribution of these linkage regions to the 
biology of schizophrenia. Similarly, a recent genome wide study investigating the role of 
genetic variation in schizophrenia through mega-analysis of 17 separate large scale studies 
found significant associations with 7 loci, only 2 of which represented replications of 
previously identified loci (Ripke et al, 2011). There are good reasons to believe that some 
rare de novo mutations with protein altering potentials may have important roles in the 
pathogenesis of schizophrenia. This is because a large percentage of schizophrenia 
patients have no family history of the disease (Lichtenstein et al, 2009). Moreover, de 
novo mutations in several genes including the mutation in the DGCR2 gene located on 
22q region have been identified (Xu et al, 2011). 
 
Biochemical systems are important in the normal physiology of the brain as they are for 
other organ systems in the human body. This has naturally led to the conceptualization of 
schizophrenia as a disorder resulting from disruptions in the biochemistry of the human 
brain. Many different biochemical theories have been proposed in the effort to unravel the 
aetiology and processes of schizophrenia. However, the most popular, and probably the 
most plausible of the biochemical theories is the dopamine theory. It suggests that 
schizophrenia is due to a functional increase of dopamine at the post-synaptic receptors in 
the meso-limbic and cortical brain regions. This theory emerges from the observation that 
drugs such as amphetamines, cocaine or levodopa which are known to increase activities 
in the dopamine systems are also able to induce schizophrenia-like symptoms, whereas 
drugs that are capable of blocking post synaptic dopamine receptors reduce many 
symptoms of the disease (Lierberman et al, 1987). Additional evidence for the dopamine 
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theory is derived from functional neuro-imaging findings of increased dopamine receptors 
and binding in antipsychotic naïve patients (Breier et al, 1997), as well as post-mortem 
evidence of increased concentration of dopamine receptors in the brain tissues of 
schizophrenia subjects (Mackey et al, 1982., Roberts et al, 1996). The body of evidence on 
which this theory relied on appeared compelling in the early days of its development. 
However, it only partly explains the schizophrenia process, especially the 
psychopathology and treatment of positive symptoms (Kirkpatric et al, 2001). The validity 
of the dopamine theory in its original form has been challenged by the presence of 
evidence from contemporary genetic, epigenetic and neuro-imaging studies.  Some further 
revisions of the dopamine hypothesis propose that positive symptoms emerge as a result of 
sub-cortical hyper-dopaminergia, while negative symptoms occur as a result of hypo-
dopaminergia in the frontal lobes (Davies et al, 1991). The most recent evidence on the 
involvement of dopamine in the process of schizophrenia suggests that dopamine 
dysregulation has an indirect relationship with the disease. In this proposition, dopamine 
dysregulation results in psychosis in general, and a diagnosis of schizophrenia emerges 
from a combination of the dysregulation and other biological and psycho-social factors 
(Howes and Kapur, 2009).  Other neurotransmitters that are thought to be involved in the 
neurobiology of schizophrenia include serotonin, acetylcholine, and Gamma amino-
butyric acid (GABA). 
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Some of the supportive arguments for the contribution of neural mechanisms in the 
process of schizophrenia come from evidence of structural abnormalities in several areas 
of the brain of patients with the disease. It has been argued that the structural 
abnormalities also affect the functioning of neuronal circuits and therefore the balance of 
the neurotransmitters associated with such systems. Patients with schizophrenia exhibit 
widespread volumetric reduction and underlying cyto-architectural abnormalities in the 
cortical grey matter, as well as several sub-cortical structures involved in cortico-limbic, 
cortico-basal and integrative functions of the brain (Flaun et al,1995., Sedval, 1990., Sun 
et al, 2009). A process sometimes referred to as ‘cognitive dysmetria’ (Andreasen et al, 
1998., Shroder and Heuser, 2008).  Schizophrenia patients  also have an increased 
frequency of cranio-facial and dermatoglyphic minor physical anomalies (Mellor,1992., 
Gabalda and Compton, 2010) 
 
These abnormalities are present pre-morbidly and appear to be stable and non-progressive 
(James et al, 2002., Serene et al, 2007). Subtle neuro-cognitive impairments are also 
known to be present in schizophrenia patients before the onset of florid psychotic 
symptoms (Frommann et al, 2011). Rates of similar cognitive changes have been 
demonstrated to be higher than expected in family members of patients than in the general 
population (Montag et al, 2012). Furthermore, non-specific neurological soft signs (NSS) 
have been demonstrated in over 50% of patients with schizophrenia (Heinrich and 
Buchanan, 1989., Browne et al, 2000., Shibre et al, 2002., Scheffer et al, 2005., Bombin et 
al, 2005). The fact of the presence of these abnormalities pre-morbidly (Chen et al, 2005., 
Serene et al, 2007., Chan and Gottessman, 2008), their relative stability over the course of 
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schizophrenia (Prikryl et al, 2012., Piccioni and Dazzan, 2009., Boks et al, 2006., Emsley 
et al, 2005., Bachman et al, 2005., Scheffer, 2004), as well as their presence in excess in 
non-affected but vulnerable individuals (such as family members of patients) (Gourion et 
al, 2003., Neelam et al, 2011) or other high risk groups (Keshavan et al, 2008., 
Kaczorowski et al, 2009, Chan et al, 2010), has led to the supposition that these 
abnormalities may represent an intermediate phenotypic marker for schizophrenia 
(Gottesman and Gould, 2003). 
 
2.2.1. ENDOPHENOTYPES OF SCHIZOPHRENIA  
The term endophenotypes was coined by Gottesman and Shields in 1973, to represent an 
unseen but measurable phenomenon that is present in the distal genotype to a disease 
pathway (Gottesman and Shields, 1973). They are now more clearly defined as trait-
markers that are present independent of the manifestation of the relevant disease, or 
otherwise, represent a phenotype in the patient below the level of overt clinical symptoms. 
Endophenotypes may be in the form of biochemical, neuro-imaging, electrophysiological, 
pathological, neuro-psychological, or socio-functional markers. Gottesman and Goulds 
(Gottesman and Goulds, 2003) suggested that certain criteria are required to be satisfied 
by an identified disease marker to be described as an endophenotype. These criteria are: 1) 
Association with a candidate gene or region, 2) presence in relatives of patients with a 
high relative risk, thus co-segregating with actual illness, 3) the association with the 
disease should be biologically plausible, 4) expression of the parameter should be 
independent of  the disease, and hence a trait marker rather than a state marker, 5) 
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inheritability of the parameter, and 6) the marker is present in relatives of patients more 
than the general population (Gottesman and Gould, 2003).  
 
Endophenotypes have been shown to be more closely related to the underlying gene 
expression in mental disorders than is psychopathology (Meyer-Lindenberg and 
Weinberger, 2006).They therefore find relevance in the study of the genetics of 
schizophrenia. It is anticipated that the genetics of a heterogeneous and inherently 
complex condition like schizophrenia can be studied easily if it is broken down into its 
constituent endophenotypes. Working memory deficits, information processing defects 
such as pre-pulse inhibition, smooth pursuit eye movement defects, glial cell changes and 
other specific putative neuro-cognitive markers are recognized endophenotypes of 
schizophrenia.  
 
There is an increasing interest in the status of Neurological Soft Signs (NSS) of 
schizophrenia as potential endophenotype of the disease. This is because NSS are more 
common in patients than in healthy controls and have been shown to occur independently 
of the overt clinical or psychopathological manifestation of schizophrenia (Chan and 
Gottesman, 2008). They also predate its onset (Chen et al, 2005). Furthermore, there is 
evidence to suggest that NSS are neuro-developmental in origin (Zabala et al, 2006., 
Peralta et al, 2011) and demonstrate significant heritability (Sanders et al, 2006). 
Neurological soft signs thus meet a minimum of two of the criteria spelt out by Gottesman 
and Shield for categorization as endophenotypes. 
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2.3.0.   THE CONCEPT OF NEUROLOGICAL SOFT SIGNS (NSS) 
Neurological Soft Signs (NSS) are subtle but observable neurological abnormalities that 
are not localized to specific areas of the brain or characteristic of any specific neurological 
condition. They include impairments in motor function, sensory integration, and 
persistence of primitive reflexes. These signs are documented to be in excess in 
schizophrenia patients at various stages of the disease (Heinrich and Buchanan, 1989., 
Browne et al, 2000., Shibre et al, 2002., Scheffer et al, 2005., Bombin et al, 2005), and 
especially among first episode antipsychotic naive schizophrenia patients (Browne et al, 
2000., Shibre et al, 2002., Scheffer et al, 2004) and their unaffected first degree relatives 
(Gourion et al, 2003., Neelam et al, 2011).  
 
The term ‘soft signs’ was first used by Bender in 1947 while describing physical 
examination findings which were thought to represent evidence for a non-specific 
neurological disease (Bender, 1947). It emerges from the inability of clinicians in those 
early days to locate the neuro-pathological underpinnings and the specific clinical 
relevance of such neurological examination abnormalities. Traditional neurological 
examination aims to elicit gross signs that often indicate a demonstrable lesion in the 
nervous system. Such signs as visual field defects or hypotonia can often be traced to 
specific malfunctioning of the brain. These signs are thus conceptualized as hard signs in 
view of their specificity in identifying neuropathology. Neurological soft signs on the 
other hand feature in individuals with no obvious neuropathology. No observable 
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compromise in neurological functioning is identifiable in such individuals. Most of the 
signs suggests a decrement of the individual's performance abilities in motor or sensory 
tests of a neurological examination and offer little usefulness in localising any gross 
lesion. They have been thought of by some researchers as indicators of diffuse brain 
damage (Gureje, 1988).  
 
Categorisation of neurological signs as hard or soft may not always be straightforward 
because some of the so called ‘soft signs’ are also seen in specific brain pathology while 
some of the ‘hard signs’ do not always have localising value on their own. For example, 
signs such as fist-edge palm or the fist-ring require integration of the sensory and motor 
systems, and are therefore soft, but are also present in frontal lobe damage where it 
becomes a specific sign of this pathology. Similarly, tandem walk or finger to nose tests 
reflect impaired sensory and motor integration, but also represent specific signs of focal 
cerebellar damage. 
 
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
  
34 
 
 
Table 1. Some Hard and Soft Signs on Neurological Assessment Batteries 
Hard Signs Soft Signs 
Gait deviation 
Whole body clumsiness 
Dysarthria 
Unilateral reflex hyperactivity 
Unilateral facial weakness 
Unilateral sensory loss  
Unilateral cogwheel rigidity 
Spastic rigidity 
Hypotonia 
Pes cavus 
Babinski reflex 
Involuntary movements 
Intention tremor 
Postural tremor 
Resting tremor 
Choreiform movements 
Athetotiform movements 
Blink reflex 
Gaze impersistence 
Ocular vergence 
Gaze nystagmus 
Suck reflex 
Snout reflex 
Oral apraxia 
Palmomental test 
Grasp reflex 
Stereognosis 
Graphaesthesia 
Diadochokinesia 
Tactile extinction 
Complex motor acts 
Rythm tapping 
Motor perseveration 
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2.3.1. HISTORICAL PERSPECTIVES OF NSS 
Historically, the 1896 re-conceptualization of Augustin Morel's demence preacose into 
what is now known as schizophrenia provided an understanding of the disorder as one 
with an early onset and a deteriorating course, which differentiated schizophrenia from the 
more episodic and better outcome characteristic of manic depressive disorder. This 
development also provided the earliest insight into the biological underpinnings of the 
disease. Emil Kraepelin described how partial damage or destruction of cells in the 
cerebral cortex may be compensated for, but 'mostly led to a permanent impairment in the 
inner life of patients with dementia praecox' (Kraepelin, 1899). Thus his classic 
description of dementia praecox included such neurological examination findings as 
headaches, pupillary disorders, abnormal tendon reflexes, muscular movements, seizures, 
grimacing and aphasia. The exact relationship of these findings to dementia preacox was 
neither known to Kreapelin nor his contemporaries (Kraepelin, 1919). This may have 
contributed to the decline in interest in neurological examination abnormalities in 
psychiatric disorders witnessed in the better part of the 20th century. However, the concept 
of woodteriness (clumsiness) described in child and adolescent psychiatry reawakened 
interest into the phenomenon of neurological examination abnormalities in schizophrenia. 
Thus studies in adult psychiatry emerged (Rochford et al, 1970., Mosher et al 1971) and 
have increased in volume in the last 40 years.  
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2.3.2. EVOLUTION OF PSYCHIATRIC RESEARCH INTO NSS 
In the 1980s, research interest in adult NSS grew significantly after associations were 
noted with both clinical outcome and neuropsychological correlates in schizophrenia 
(Liddle, 1987., Manshreck et al, 1982., Torey, 1980). Further research findings suggested 
that the prevalence of NSS in relatives of patients with schizophrenia was increased 
(Woods et al, 1986., Kinney et al, 1986). This discovery led to a surge in interest in NSS 
and it was hoped they would provide a trait marker for schizophrenia. As research into 
NSS flourished, the quality of these studies also improved greatly and more systematic 
and better validated means of assessment were introduced (Buchanan and Heinrichs, 
1989., Chen et al, 1995).  
 
The extensive studies of NSS also demonstrated the presence of these signs in numerous 
other conditions such as alcoholism, substance abuse, mood disorders, obscessive- 
compulsive disorder, neuroticism and personality disorders. Although this was to a lesser 
degree compared to schizophrenia. Also the body of research into the prevalence of NSS 
in these other neuropsychiatric conditions is much smaller, and limited by small sample 
sizes. It became apparent that a majority of the schizophrenia studies did not find a 
correlation between NSS and clinical outcome, and the specificity of the signs for 
schizophrenia thus appeared low. Therefore, the clinical usefulness of NSS seemed 
limited. This also led to some disappointment amongst many researchers who had hoped 
that NSS would provide the trait marker for schizophrenia. Interest in NSS research waned 
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as a result of this disappointment. In fact, some researchers held the subject in contempt 
for many years, doubting whether these signs can be defined with rigour, are reliable, 
reproducible or even have neurological meaning. Others have even described the use of 
the term soft signs as diagnostic of soft thinking (Ingram et al, 1973). 
 
Research interest has re-emerged with the emergence of large scale fourth generation 
psychiatric epidemiological studies dealing with psychiatric genetics and a comprehensive 
set of biological markers including brain imaging, blood sampling and cerebrospinal fluid 
examinations. Advances in brain imaging have stimulated effort to characterize the 
neuropathology of schizophrenia, with an attendant interest in the neurology of 
schizophrenia. These studies have described the doubt on the meaning of NSS as 
'reflecting not the unreality of findings but the limitation in our knowledge' (Heinrich and 
Buchanan, 1989., Zhao et al, 2013). 
 
2.3.3. NEUROBIOLOGY OF NSS 
Although the origin of NSS is uncertain, these signs probably predate the onset of 
schizophrenia (Chen et al,2005., Chan and Gottesman, 2008., Serene et al, 2007),and are 
at least in part related to the pathogenetic process underlying the disease (Andreasen et al, 
1998., Schroder and Heuser, 2008). Studies in children at genetic risk of schizophrenia 
(Walker and O’brien, 1999., Walker and Levine, 1990., Cannon et al, 1999., Prasad et al, 
2009) and the general population (Schubert and McNeil, 2004., Crow et al, 1995., Jones  
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et al, 1994) have found evidence for an association of early disturbances in motor 
development and fine motor co-ordination with schizophrenia in adulthood.  For instance, 
a review of the school records of 400 individuals with schizophrenia by Cannon et al. 
(Cannon et al, 1999) showed that these subjects performed significantly worse than a 
group of controls in activities requiring motor coordination. Also, from the observation of 
home videos recorded during the first 2 years of life of children who later developed 
schizophrenia, Walker and Levine (Walker and Levine, 1990) described the presence of 
neuro-motor abnormalities particularly localised to the left side of the body. Therefore, 
impairment of coordination, motor dysfunction and sensory integration has been observed 
in non-psychotic individuals at increased genetic risk of developing schizophrenia. This 
suggests that NSS could be part of a genetic vulnerability to the illness. Further support of 
this proposition come from studies documenting NSS among adults with high and ultra 
high risk of developing schizophrenia but who have not yet manifested the clinical 
symptoms of psychosis (Schubert and McNeil, 2005., Kaczorowski et al, 2009., Chan et 
al, 2010 a and b., Keshavan et al, 2008). 
 
It has been confirmed by several systematic reviews and meta-analysis that NSS are 
distributed across people with schizophrenia and their first-degree relatives in a manner 
that is consistent with familial association (Gourion et al, 2003., Neelam et al, 2011). 
Neelam and others, (Neelam et al, 2011) in a systematic review of seven studies, with at 
least 1553 participants, carrying out a three way comparison of levels of NSS between 
people with schizophrenia or schizophrenia-like disorders, their first-degree relatives, and 
normal controls reported that NSS were significantly more common in first-degree 
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relatives of people with schizophrenia than in controls (pooled standardised mean 
difference (SMD) 1.24, 95% confidence interval (C.I) 0.59-1.89). The same review also 
showed that NSS were significantly more common in people with schizophrenia than in 
their first-degree relatives (SMD 0.92, 95% C.I 0.64- 1.20) (Neelam et al, 2011).  
 
 
The prevalence of NSS in schizophrenia patients and their relatives is also known to be 
relatively stable across the course of schizophrenia (Prikryl et al, 2012., Piccioni and 
Dazzan, 2009., Boks et al, 2006., Emsley et al, 2005., Bachman et al, 2005., Chen et al, 
2005., Scheffer, 2004., Mechri et al, 2009) . Emsley et al. (Emsley et al, 2005) conducted a 
study of temporal stability of NSS in a cohort of largely medication naïve South-African 
schizophrenia patients. In that study, the NES total score did not change significantly over 
a one year course of schizophrenia on treatment according to a fixed protocol. The most 
stable factor overtime was a factor for attention, as it was not influenced by changes in the 
symptom profile or the effect of antipsychotic medication. Significant changes were 
observed in the motor sequencing factor score at 3 months compared to baseline scores, 
but this factor remained stable at 6 through 12 months in the same study. Therefore, the 
authors argued that this characteristic may be specific to some individuals with 
schizophrenia. This argument was further supported by findings from a study by Keshavan 
et al. (Keshavan et al, 2003) that attentional factors correlated strongly with smaller 
volumes of the left heteromodal cortex. Another study by Mechri et al. (Mechri et al, 
2009) using data from two independently replicated studies, also found that the prevalence 
of NSS in patients with schizophrenia and their relatives remained stable and was 
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independent of geographical origin, ethnicity, or socio-economic status. There is also 
evidence to suggest that NSS are more prevalent in schizophrenia spectrum disorders 
compared to other psychiatric disorders (Cuesta et al, 2002., Chan and Gottessman, 2008). 
This fact has also been demonstrated among subjects with schizotypal personality scores 
(Mechri et al, 2010., Chan et al, 2010a and b., Kaczorowski et al, 2009., Keshavan et al, 
2008).  
 
This body of evidence suggests that NSS are associated with genetic loading almost to a 
dose-response pattern, making it a trait feature of schizophrenia. Further evidence for the 
possible heritability of NSS comes from a study that examined 96 participants from eight 
extended families. In this study,  Sanders and his colleagues, (Sanders et al, 2006) found 
that five of eleven NSS items were statistically significant in terms of hereditability h2: 
rapid alternating movements (h2=0.99 ± 0.19 for completion time), alternating fist-palm 
(h2  =0.77 ± 0.19 for completion time and h2=0.7 ± 0.32 for number of errors), fist-ring (h2 
=0.53 ± 0.23 for right-sided completion time;h2=0.7 ± 0.21 for left-sided completion 
time), go-no go (h2 =0.93 ± 0.33 for the number of correct responses), and audio-visual 
integration (h2=0.79 ± 0.54 for the number of correct responses (Sanders et al, 2006). 
However, it is noteworthy that among all the studies investigating the relationship between 
NSS in schizophrenia patients, their relatives and healthy controls, at least 3 (i.e,  Egan et 
al, 2001., Bollini et al, 2007., Compton et al, 2007) did not find any difference between 
relatives of patients with schizophrenia and healthy controls. Furthermore, Piccioni et al. 
(Piccioni et al, 2006) observed no difference in NSS between the non-schizophrenia co-
twins from monozygotic and dizygotic discordant pairs. 
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Additional evidence for the neuro-developmental origin of NSS come from studies that 
showed that they tend to decrease in frequency as the brain matures. For instance, a study 
on a small sample of young healthy adolescents with first episode schizophrenia and a 
control group of non-schizophrenia patients, Zabala and his colleagues (Zabala et al, 
2006) found an inverse correlation of NSS scores with age among the healthy adolescents, 
a trend for inverse correlation among non-schizophrenia patients and no correlation with 
age among the schizophrenia patients was observed. Specifically, it has been suggested 
that NSS represent abnormalities of neural integration (Chan et al, 2009., Zhao et al, 
2013., Gay et al, 2012). It has been reported previously that neural integration and 
neuronal maturity are likely to be impaired among those at genetic risk for developing 
schizophrenia (Zabala et al., 2006., Andreasen et al, 1998., Schroder and Heuser, 2008). 
This may lead to an increase in the frequency of NSS in this population. Furthermore, 
some authors have linked NSS with a history of obstetric complications (Gureje, 1988., 
Madsen et al, 1999., Peralta et al, 2011). It is also possible that NSS and the 
pathophysiology of schizophrenia may share a common genetic background that affects 
the neuro-developmental process. However, no specific genetic variant has been 
associated with NSS (Prasad et al 2009). It is also possible that genetic risks only partly 
determine the presence or severity of NSS.  
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2.3.4. STRUCTURAL BRAIN CORELLATES OF NSS 
Several structural brain abnormalities have long been described in psychotic disorders. 
Similarly, there is robust evidence to suggest that certain NSS correlate with region-
specific structural brain deficits in people with schizophrenia. Rubin et al. (Rubin et al, 
1994) in a study using computerised tomography (CT), and also measuring cerebral blood 
flow among patients with first hospitalisation on account schizophrenia or 
schizophreniform disorder compared with normal controls, had concluded that NSS 
correlated significantly with sulcal enlargement and reduced cerebral volume but not 
ventricular enlargement. This study was based on the manual, labour intensive Region of 
Interest (ROI) method which reduces the analyses to a few pre-selected brain regions. 
Almost a decade later, other authors investigating the structural brain correlates of NSS 
using advanced techniques such as the optimized Voxel Based Morphometry (VBM), an 
imaging techniques which allows for automated and unbiased image analysis, have 
suggested an association between some NSS factors, and volumetric reduction in areas of 
the basal ganglia (Hirjak et al, 2013., Ballmaier et al, 2008., Mamah et al, 2007., 
Keshavan et al, 2003., Jansen et al, 2009., Dazzan et al, 2004., Venkatasubramanian et al, 
2008), areas that form part of the prefrontal (Gay et al, 2012., Chan et al, 2009), as well as  
the superior and inferior temporal cortices (Zhao et al, 2013)  
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The basal ganglia motor system comprises of the caudate nucleus, which receives cortical 
projections from motor areas in the frontal lobe, as well as the putamen, globus pallidus 
and substantia nigra, which receives the information from the caudate. A reduction in the 
right and left caudate nuclei volume have been associated with increased minor motor and 
cognitive neurological abnormalities, as measured by the NES, in adults with first-episode 
psychosis (Keshavan et al, 2003., Jansen et al, 2009., Thormann et al, 2009). However, 
enlarged caudate volumes have also been reported, albeit in people with chronic 
schizophrenia, this enlargement has been proposed to occur as a result of treatment with 
first-generation but not second generation antipsychotics (Corson et al, 1999). The pre-
frontal cortex is an area involved in motor planning and working memory. It also has an 
important role in the control of sensory conflicts (Kelly et al, 2009, Chan et al, 2009). 
Specific neurological examination tasks based on sequencing of motor acts, or those 
requiring planning of motor acts, as well as its storage in working memory have been 
correlated with regional sulcation of the left dorso-lateral pre-frontal cortex in recent 
exploratory regional analyses of cortical morphology in patients with first episode 
schizophrenia (Gay et al, 2012). 
 
 
Some studies using Magnetic Resonance Imaging (MRI) technique have also found 
association between volumetric changes in the cerebella cortex and some NSS dimensions 
(Thormann et al, 2009a and b., Bottmer et al, 2005). The cerebellum is closely involved in 
involuntary movements and motor co-ordination (Giuseppe et al, 2007). Smaller volume 
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of this structure have been reported to significantly correlate with both high total NSS 
scores, and motor sub-scores for tasks such as finger tapping, and right left extinction 
(Mouchet-Mages et al, 2011., Giuseppe et al, 2007). The study by Bottmer et al. (Bottmer 
et al, 2005) found that smaller cerebella volume in the right hemisphere is associated with 
NSS in remitted first-episode psychosis patients. Similar changes were also found in 
patients with chronic schizophrenia who had abnormalities in specific tests of rhythmic 
tapping and disruptions in motion while performing the finger-thumb opposition tests 
(Bersani et al, 2007).  
 
Among the studies investigating the relationship between NSS and structural brain 
changes, Venkatasubramanian et al (2008) is one of the few reporting a negative 
correlation between at least some NSS dimensions (e.g, the motor sequencing signs) and 
total or regional grey matter volumes. 
 
The specific neuro-anatomical correlates of severity of NSS have also been localized. 
Severity of sensory integration signs have been shown to be associated with reduction in 
the volume of the anterior part of the thalamus, after voxel-based morphometry, and 
reduction of total thalamic volume after segmentation of the thalamus (Jansen et al, 2009). 
In adults with first-episode psychosis, decreased volumes of the basal ganglia structures, 
especially the putamen, thalamus, and heteromodal cortex have been associated with 
increased severity of NSS (Dazzan et al, 2006, Thorman et al, 2009a and b., 
Venkatasubramanian et al, 2008). It is noteworthy that a decrease in thalamic volume has 
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been associated with both chronic schizophrenia and a genetic predisposition to 
schizophrenia (Konick et al, 2001, Lawrie et al, 2001).  
 
 
These structural changes have led to the hypothesis that the presence of neurological 
abnormalities is associated with reduction in frontal and temporal association brain areas, 
and of sub-cortical brain structures such as the basal ganglia which are involved in the 
sequencing and integration of both motor and sensory processes, which are manifested in 
the symptoms of schizophrenia (Andreasen et al, 1998., Shroder and Heuser, 2008., 
Dazzan et al 2006). Furthermore, it appears that the assumption that NSS are 
abnormalities with non-focal neural representation now warrant a revision in the light of 
over-whelming evidence of identifiable structural correlate. 
 
 
2.3.5. BRAIN MECHANISMS OF NSS 
The dysfunctional networks involved in the pathogenesis of NSS are still not fully 
understood. Earlier studies had advocated that they emerge from deficits at sub-cortical 
levels, in such structures as the basal ganglia, the limbic systems, or the brain stem 
(Mosher et al, 1971). It has also been suggested that they reflect failure of integration 
between or within sensory and motor systems (Griffith et al, 1998). However, NSS may 
ultimately reflect the same impairment in inter-neuronal connectivity described in the  
pathophysiology of schizophrenia (Andreasen et al, 1998., Schroder and Heuser, 2008). 
This notion is supported by evidence from neuro-imaging studies suggesting that there is 
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an association between NSS and activation changes in the sensori-motor cortex and the 
supplementary motor area as well as their cerebella and sub-cortical afferents such as the 
basal ganglia and thalamus (Keshavan, 2003., Zhao et al, 2013., Mouchet-Mages et al, 
2011., Hirjak et al, 2013). These structures are known to be involved in sensory 
integration and motor coordination (Giuseppe et al, 2007., Kelly et al, 2009., Chan et al, 
2009., Dazzan et al 2006). Also, the presence of NSS has been associated with reduction 
in frontal and temporal association brain areas (Gay et al, 2012., Dazzan et al, 2004). 
Another support for the integrative hypothesis is found in the summation of Jansen and 
colleagues  that  since the thalamus functions as a central relay station of the brain, which 
filters and gates sensory inputs to the cerebral cortex, and since sensory integration 
functions, such as audiovisual integration and stereognosis, require transfer of sensory 
information from sub-cortical regions to multimodal cortical brain areas, structural 
impairment of the thalamus would appear to affect this transfer and consequently decrease 
performance in the sensory integration tasks (Jansen et al, 2009). 
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TABLE 2: MAJOR FUNCTIONAL AREAS OF THE CORTEX AND THEIR 
LOCATION 
 
Adapted from; DAZZAN P and  MURRAY R.M (2002)  
FUNCTIONAL DESIGNATION                 LOBE     SPECIFIC 
LOCATION 
Primary Sensory Cortex 
 
-Somatosensory 
-Visual 
-Auditory 
 
 
           Parietal 
           Occipital 
           Temporal 
 
 
Postcentral gyrus 
Banks of calcarine fissure 
Heschl's gyrus 
Unimodal Sensory Association Areas 
 
-Somatosensory 
-Visual 
 
-Auditory 
 
 
            Parietal 
     Occipito-temporal 
 
            Temporal 
 
 
 Posterior parietal 
Inferio-lateral surfaces of 
the occipital and temporal 
lobes 
Superior temporal gyrus 
Multimodal Sensory Association Areas 
 
-Posterior multimodal sensory integration 
(including visuospatial localization, 
language, attention) 
-Anterior multimodal motor integration 
(including motor planning, language 
production, judgement) 
-Limbic (emotion, memory) 
 
 
 Parieto-temporal 
 
 
       Frontal 
 
 
Temporal, parietal, 
frontal 
 
 
Junction between lobes 
 
 
Prefrontal cortex, rostral to 
premotor areas on dorsal 
and lateral surfaces 
Cingulate gyrus, 
hippocampal formation, 
parahippocampal gyrus, 
amygdale 
Motor association cortex 
 
-Premotor (motor preparation and programs) 
 
 
Frontal 
 
 
Rostral to primary motor 
cortex 
Primary motor cortex 
 
-Motor cortex (Movement of a joint along a 
vector) 
 
 
Frontal 
 
 
Precentral gyrus 
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Figure I. Structure of the Basal ganglia 
 
 
Image adapted from: Sukel Kayt. Basal Ganglia Contribute to Learning, but Also 
Certain Disorders. Dana. Org/ Brain work 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
  
49 
 
 
Figure II. Connections of the Basal Ganglia 
 
 
 
 
 
 
 
 
 
 
Image adapted from: Anatomy 530 lecture notes, The University of Western Ontario  
Department of Anatomy and Cell 
Biologyhttp://www.uwo.ca/anatomy/grad/531a/531a.html 
 
 
 
CEREBRAL CORTEX 
STRIATUM 
SUBSTANTIA 
 NIGRA, 
 PARS 
COMPACTA 
EXTERNAL  
     PALLIDUM 
SUBTHALAMIC  
NUCLEUS 
INTERNAL  
PALLIDUM 
    THALAMUS 
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2.4.0. NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA 
2.4.1. PREVALENCE 
The prevalence of Neurological Soft Signs (NSS) in schizophrenia, their unaffected 
relatives, and normal healthy controls has been a central issue in most of the studies on the 
subject in the last 40 years. A majority of studies report a prevalence of 50 -65% in all 
patients with schizophrenia, compared to about 5% in normal healthy controls (Heinrich 
and Buchanan, 1989., Shibre et al, 2002., Bombin et al, 2005., Chan and Chen, 2007). 
Among first episode patients,, at least one frontal sign out of a list consisting of the 
Ozereski test, tapping test, fist-ring test, fist-edge-palm test, piano test, and completion of 
two sequential drawings, has been described in 97.1%.(Cuesta et al,1996., Browne et al, 
2000., Whitty et al, 2003). Other studies of first episode schizophrenia patients have also 
reported similarly high rates (Lawrie et al, 2001., Keshavan et al, 2003., Dazzan et al, 
2004), even when a higher cut-off point for abnormality was used (Zabala et al, 2006., 
Ismail et al, 1998). Ismail and colleagues (Ismail et al, 1998) demonstrated that NSS had a 
better ability to differentiate between schizophrenia and healthy control. The authors used 
a standardized neurological assessment tool consisting of 44 items, the sum of which 
produced a score ranging from 0-24. They found that a score of at least 5 was present in at 
least 82% of patients with schizophrenia, while it was only found in 5% of healthy 
controls. 
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Neurological soft signs have also been reported in other psychiatric disorders especially 
bipolar mood disorders (Boks et al, 2000., 2004., Dazzan et al, 2008., Goswani et al, 
2006., Negash et al, 2004.,Whitty et al, 2006), obsessive –compulsive disorders (Peng et 
al, 2012., Stein et al, 1994), and impulsive personality disorders (Stein et al, 1993). A 
review of relevant studies of NSS in schizophrenia and mood disorders published between 
1966 and 1998 was conducted by Boks and colleagues (Boks et al, 2000). The review 
focused on three diagnostic groups of schizophrenia spectrum disorders, including 
schizophrenia, schizophreniform disorder and schizoaffective disorder, mood disorders 
such as depression and bipolar disorders, as well as healthy control subjects. Only those 
neurological signs assessed in at least two different studies were included. A total of 258 
studies met their eligibility criteria, of these, 17 studies presented data on the prevalence 
of specified neurological signs in one or more diagnostic groups. In the schizophrenia 
group the weighted mean prevalence of all 30 signs averaged 19.2%. The weighted mean 
prevalence of the 17 signs in the mood disorder group averaged 16.4%, but they 
encompassed a smaller selection. The weighted mean prevalence of 30 neurological signs 
in the control group was 8.9%. The result suggested the mean prevalence of most 
neurological signs is significantly different between schizophrenia patients and normal 
controls, but there were fewer differences between schizophrenia and mood disorders. The 
authors however noted that the number of patients in the mood disorder group was 
comparatively smaller than those in the other groups, as such the difference in the mood 
disorder group and the other groups may not have reached significance due to limited 
statistical power (Boks et al, 2000). Whitty et al, (Whitty et al, 2006) also did not report 
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any difference between schizophrenia, bipolar disorder and other psychotic disorders, 
neither did the recent meta-analysis of both functional and structural Magnetic Resonance 
Imaging studies of NSS in schizophrenia or mood disorders (Zhao et al, 2013). 
 
In Africa, Mubarak et al. (Mubarak et al, 1999) measured NSS in 30 Egyptian patients 
with schizophrenia and 15 healthy controls. This study found a significant higher NSS 
scores in all patients compared with the control group. This applied to both total 
Neurological Evaluation Scale (NES) scores and scores for its three main components, 
sensory integrative functions, motor in-coordination, and impaired sequencing of complex 
motor acts. Also, Shibre et al. (Shibre et al, 2002) reported on the pattern of NSS among 
200 treatment naïve schizophrenia patients and 78 healthy subjects in Butajira, a 
traditional society in Ethiopia. The impairment rate of NSS in the schizophrenia patients in 
that study was significantly higher than in controls. The authors found that 65% of 
schizophrenia patients had a score of 2 or more versus 50% of the healthy controls. They 
further noted that NSS in the treatment naïve schizophrenia cohort was as common as 
those reported in studies of subjects on neuroleptic medication. However, a controlled 
study done among a cohort of Nigerian, chronic, admitted and medicated, patients with 
schizophrenia, affective disorders, and normal control subjects over a decade earlier than 
those of Mubarak et al (1999) and Shibre et al (2002) found that the two patient groups did 
not differ from one another in prevalence of four neurological signs, but both showed 
significant differences from normal control in the occurrence of right-left confusion 
(Gureje et al 1988).  
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It is important to highlight the several methodological issues in studies reporting no 
difference between schizophrenia and other neuro-psychiatric disorders. These include 
inadequate control for common confounders such as age, educational levels and intelligent 
quotient, use of different assessment tools for measuring NSS, as well as the combination 
of bipolar and major depression as a single mood disorder group in many studies. The 
consensus of opinion from most studies in the literature is that NSS are associated strongly 
with schizophrenia across cultures and occur at low rates in the general population. 
Studies done among first episode patients such as Boks et al, (Boks et al, 2004) have 
shown that some specific NSS items such as mirror movements and smooth saccadic eye 
movements could differentiate schizophrenia from bipolar disorders or major depressive 
disorders. Other reports suggest that patients with schizophrenia have more sensory 
integration and cognitively demanding signs than patients with other psychotic disorders 
(Keshavan et al, 2003).   
 
Some studies on NSS in patients with schizophrenia that have employed a comprehensive 
assessment technique have found that motor abnormalities were more discriminative in 
differentiating patients with schizophrenia and their relatives from healthy subjects 
(Bombin et al, 2005., Mechri et al, 2009). Specifically, the description of the meaning of 
NSS by Heinrich and Buchanan (Heinrich and Buchanan, 1989) suggests that such motor 
sequencing signs better differentiate patients with schizophrenia from those of other 
psychosis. While Krebs and colleagues concluded that integrative motor functions 
differentiated patients with schizophrenia from those with mood disorders (Krebs et al, 
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2000). These assertions reinforce the idea that motor abnormalities are especially 
genetically mediated (Sanders et al, 2006) and may therefore constitute reliable markers of 
vulnerability. In factor analyses conducted on the NES, motor sequencing items such as 
fist-ring test, fist-edge-palm test, and Ozereski test, have been known to load together 
(Keshavan et al, 2003., Sanders et al, 2000). Factor analysis of the NES conducted by 
Emsley et al. (Emsley et al, 2005) as part of a study of the temporal stability of NSS in a 
cohort consisting of 66 mostly medication naïve South-African schizophrenia subjects 
also found a factor for abnormal motor sequencing. The items of this factor have 
important overlap with those of Keshavan and her colleagues. In the report by Keshavan et 
al. (Keshavan et al, 2003) motor sequencing and attention abnormalities were more 
specific to schizophrenia. This was consistent with those of other contemporary reports on 
the specificity of NSS in schizophrenia (Delevoye-Turrell et al, 2003., Sullivan et al, 
2001). The sequencing of complex motor act NSS have also been reported to be stable 
across the course of schizophrenia (Mayoral et al, 2012, Bachman et al, 2005), or in 
individuals with high schizotypy scores (Theleritis et al, 2012) regardless of symptom 
improvement or reduction in the other clusters of NSS. Impairment of motor sequencing 
tasks is indicative of problems with initiation and organization of action, activities which 
requires integration of sensory and motor functions (Piccioni and Dazzan, 2009), and an 
intact frontal lobe executive function (Bersani et al, 2004., Rao et al, 2008), as well as its 
basal ganglia connections (Heinrich and Buchanan, 1988., Dazzan and Murray, 2002., 
Jansen et al, 2009., Bersani et al, 2011) to execute.  
 
 
Stellenbosch University  http://scholar.sun.ac.za
  
55 
 
 
2.4.2. NSS AND DEMOGRAPHIC CHARACTERISTICS IN SCHIZOPHRENIA 
Available data on the relationship between NSS in patients at various stages of 
schizophrenia and demographic variables such as age, gender, educational level and 
ethnicity show conflicting results. For instance, there is no current support for a significant 
relationship between gender and the presence or severity of NSS among 10 studies 
reviewed by Hui et al. (Hui et al, 2009). However, there are isolated reports suggesting 
that NSS is especially increased among male patients with schizophrenia (Heinrich and 
Buchanan, 1989). Male patients with schizophrenia were also described as having a 
significant increase in the number of neurological abnormalities 5 years after onset in a 
follow-up study by Madsen et al. (Madsen et al, 1999). In that sample, males were also 
more likely to have had obstetric complications and a non-remitting course of illness. It is 
possible that the excess of obstetric complications and neurological abnormalities in male 
patients as well as an increased risk of other neurodevelopmental abnormalities are part of 
a greater vulnerability of the developing male brain to insults. 
 
Some studies have reported a higher prevalence of NSS among African- American 
subjects when compared to Caucasians, but with very few differences between the 
prevalence of NSS among Caucasians and Asians (Chen et al, 2003, Mechri et al, 2009). 
Similarly, another study found that non-Caucasian patients, including African–Americans 
and other ethnic groups, had more cognitive/perceptual neurological abnormalities 
(Keshavan et al, 2003). Gureje et al. (Gureje et al, 1988) in a study described earlier also 
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reported the presence of NSS among a population of Nigerians with a history of obstetric 
complications.  
 
There are some reports on the relationship between older age and the prevalence of NSS.  
Chen et al. (Chen et al, 1996) reported that the frequency of NSS increased with age in 
their sample of patients with schizophrenia. While Emsley et al.  (Emsley et al, 2005) 
found only the motor sequencing factor of the NES correlated with age in a sample of 
schizophrenia patients with a mean age of 28.1 (SD 8.5) years, and mean duration of 
illness 371 (SD 787) days (r=0.333, p=0.04). A systematic review and meta-analysis of 57 
eligible studies of NSS in schizophrenia and healthy controls found that effect sizes based 
on summary measures of NSS decreased in magnitude with increasing age of the samples. 
The controls were generally older in the studies reviewed. The authors argued that since 
NSS is known to increase in rates with increasing age in the general population, higher 
rates in the older control samples may have attenuated the effect found in the younger 
patient samples (Chan et al, 2009). The same meta-analysis found an inverse relationship 
between NSS and age in healthy control samples. This clearly contradicts the argument for 
a relationship between age and NSS. This kind of contradictions in the literature has made 
the relationship between age and NSS unclear. In fact a majority of the studies that have 
investigated the relationship between the presence of more NSS and age  reports no 
association (Keshavan et al, 2003., Mohr et al, 2003., Whitty et al, 2003). Furthermore, 
many of the studies reporting this association appear limited by methodological issues of 
design, and data analyses. These studies hardly corrected for some of the obvious 
confounding factors such as duration of illness and doses of medications (Chen et al, 
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2003., Heinrich and Buchanan, 1989).  
 
Similarly, there is inconclusive evidence for the influence of socio-economic status on the 
prevalence of NSS. While Griffiths et al. (Griffith et al,1989) reported an inverse 
correlation between social class and NSS, Gupta et al. (Gupta et al, 1995) found that NSS 
are not related to socioeconomic status of patients. This finding was later confirmed by 
Mechri et al. (Mecri et al, 2009) when using data from two independently replicated 
studies from two different geographical and ethnic population of French Caucasians and 
Tunisian Arabs. The authors also found no ethnic or geographical differences in the 
prevalence of NSS, but an inverse correlation between NSS and school levels in both 
groups was reported (Mechri et al, 2009). The South-African study by Emsley and 
colleagues (Emsley et al, 2005) described earlier, also found a corellation between 
educational level and NSS, but this was specific to factors of attention (r=0.457, p=0.005), 
and rythmicity (r=0.337, p=0.04).     
 
2.4.3 NSS AND SCHIZOPHRENIA SYMPTOM DIMENSIONS 
An association between Neurological Soft Signs (NSS), or abnormalities in specific 
neurological domains and some symptom dimensions of schizophrenia may explain which 
neurological dysfunction is an intrinsic characteristic of the illness. However, studies 
investigating the relationship between symptom dimensions of schizophrenia and NSS 
have often yielded inconsistent results. Some studies have suggested that NSS could be 
Stellenbosch University  http://scholar.sun.ac.za
  
58 
 
secondary to some psychiatric symptoms, such as impaired attention (Lawrie et al, 2001., 
Browne et al, 2000), or could characterize more severe psychopathological processes of 
schizophrenia (Mechri et al, 2009).  Others, such as Whitty et al, (Whitty et al, 2006) 
suggested that NSS was not specific to any of the diagnoses that shares the presence of 
psychotic symptoms. This is similar to reports from an Ethiopian cohort by Shibre et al. 
(Shibre et al, 2002) where there were no relationship between NSS and the clinical profile 
of schizophrenia, such as duration of illness, remission status, positive symptoms, negative 
symptoms and disorganisation. 
 
However, Malla and his colleagues in a 1997 study that relied on Liddle's three 
dimensions of schizophrenia found a modest relationship between extrapyramidal factors 
and psychomotor poverty dimensions in males. They also found a significant relationship 
between psychomotor poverty in their female subjects and neurological factors reflecting 
attention and initiative (Malla et al 1997). In more recent studies of this relationship, 
categorical ratings of Parkinsonisms, motor sequencing, release signs, and indeed total 
NSS scores have been independently related to deficit syndrome (Peralta et al, 2012) or 
severe negative symptoms of schizophrenia (Prikryl et al, 2012., Chan et al, 2010a., Chan 
et al, 2010b., Ruiz-veguella et al, 2008., Bombin et al, 2005., Smit et al, 2012). Other 
similarly designed studies have also reported that deficit syndrome was significantly 
related only to sensory integration abnormalities, while hallucination and delusions were 
not related to any neurological abnormalities (Arango et al, 2000).  Moreover, that study 
(Arango et al, 2000), and many others (Schroder et al, 1996.,  Mechri et al, 2009., 
Compton et al, 2007) have found a significant relationship between the disorganization 
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domain of schizophrenia and global neurological abnormalities, sensory integration 
deficits, as well as abnormal sequencing of complex motor acts NSS.  
 
However, Bombin et al. (Bombin et al, 2005) suggested that negative symptoms and, less 
often disorganization, could be correlated to NSS, especially signs of frontal function 
(motor) and those of parietal function (sensory integration), whereas positive symptoms 
consistently appear unrelated to NSS. On the other hand, Browne et al. (Browne et al, 
2000) described an association between NSS and total symptom severity and positive 
symptoms. These different results could reflect the complex interrelationship between the 
NSS and the clinical and therapeutic features of schizophrenia and the possible effect of 
potential confounding factors.Another possible reason for the inconsistency of these 
results may be as a result of the different scales used in measuring NSS in the various 
studies reviewed. For example, some of the studies did not use a scale that included 
measures for attention and initiative (Flykt et al, 1999). Furthermore, studies reporting an 
association between more NSS and positive symptoms have also argued that such 
association reflects attentional deficits created by the presence of florid psychotic 
symptoms especially in untreated cases (Browne et al, 2000).  
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2.4.4. NSS AND COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA 
Cognitive deficits were already described as part of the neurological examination findings 
in dementia praecox in the classic description of the construct by Emil Krepelin 
(Kraepelin, 1919). They have been consistently reported in neuropsychological studies of 
schizophrenia since then (Heinrichs and Zakzanis,1998, Heinrichs, 2005), and therefore 
recognized as an important  feature of the disease. The pattern of cognitive deficits in 
schizophrenia has been a source of much controversy in the schizophrenia literature. It 
may involve a broad range of neuropsychological functions, such as attention, abstraction, 
flexibility, learning and memory (Braff et al, 1991., Blanchard and Neale, 1994). 
However, some researchers describe a more circumscribed deficit in verbal learning as 
well as semantic and visual memory in schizophrenia (Saykin et al, 1991., 1994). Yet, 
other groups describe impairment in specific cognitive functions that are super-imposed 
on a generalized impairment in both first episode and chronic patients (Albus et al, 1996., 
1997).  
 
Neurological soft signs (NSS) have been associated with greater cognitive impairment in 
schizophrenia, as well as in children at high risk of developing the disease (Chen et al, 
2003). Similar to the controversy in the pattern of cognitive deficits in schizophrenia, the 
pattern of the relationship between NSS and cognitive impairment has also been wiewed 
differently in the literature. Some studies have demonstrated a positive correlation 
between NSS and specific impairments in the Raven progressive matrice test or other 
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measures specifically eliciting impairments in executive functions (Mohr et al, 1996., 
Wong et al, 1997., Chen et al, 2001).  Other authors however report a relationship between 
NSS and impairments in measure of generalised cognitive deficits such as Intelligent 
Quotient (I.Q) (Kennard et al, 1960., Mosher et al, 1971), or the Mini-Mental State 
Examination (Quitkin et al, 1976., Manschrek and Ames, 1984).  
 
Recently, the Aetiology and Ethnicity in Schizophrenia and Other Psychoses (AESOP) 
group (Dazzan et al, 2008) investigated the relationship between NSS and generalized as 
well as specific cognitive deficits in schizophrenia and normal controls. The study reports 
that while NSS in general was associated with worse general cognitive impairments, more 
sensory integration signs were associated with poorer specific impairment in memory, 
verbal abilities, executive function and visual perceptual skills (Mellacqua et al, 2012).  
The study also reported that primary signs such as primitive reflexes, abnormal eye 
movements, were not associated with any specific cognitive function in either the patients 
with schizophrenia or healthy individuals. A finding which replicated aspects of the results 
of the meta-analysis by Chen et al. (Chen et al, 2009) described previously, in which 
sensory integration signs were particularly related to Intelligent Quotient (IQ) scores.  
 
 
Motor NSS have also been specifically associated with cognitive disturbances in 
schizophrenia. For instance, it has been reported that timed motor speed correlated with 
cognitive impairments in schizophrenia patients with NSS, even after controlling for the 
effects of lifetime medication, extrapyramidal symptoms and abnormal involuntary 
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movements (Flashman et al, 1996). Also, Neurological Evaluation Scale (NES) motor sub-
scale has been related to verbal pairs subscale of the Wechsler’s memory scale, while NES 
sequencing of complex motor acts was associated with Stroop test and figural memory 
subscale of the Wechsler’s memory Scale in the same study (Arango et al, 1999). 
Similarly, repetitive motor tasks were observed to be related to a number of cognitive 
functions except executive function, while cognitive/perceptual tasks were associated with 
memory and executive function (Sanders et al, 2006). Yet, other investigators believe that 
the pattern of cognitive impairment in schizophrenia, where specific deficit in verbal 
memory and visuo-motor processing super-imposed on a generalised cognitive deficit 
(Albus et al, 1996., 1997), is stable and not affected by the presence of NSS. In this 
argument, NSS would appear not to have any influence on the relative performance in 
cognitive functions and therefore, they may not be related to specific brain functions 
(Mohr et al, 2003). This notion has received support from other studies comparing 
schizophrenia patients and normal controls. For instance, reporting from the AESOP study, 
Dazzan and Colleagues (Dazzan et al, 2008) suggested that after controlling for 
differences in general cognitive ability, some NSS such as sensory integration deficits are 
no longer more prevalent in patients with schizophrenia when compared with controls. In 
the same vein, deficits in sensory and motor sequencing functions have also been 
associated with worse cognitive ability in healthy individuals (Keshavan et al, 2003., 
Bombin et al, 2005).  
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It would therefore appear that general intellectual functioning affects the integration of 
sensory information irrespective of the presence of schizophrenia.One area of consensus 
in the literature is related to the observation that in every instance of the relationship 
between NSS and cognitive impairments, NSS are reflective of a more severe dysfunction 
(Chan et al, 2009).  
 
Findings of a relationship between NSS and impairment in general cognitive functioning 
are important because they may suggest that NSS are a reflection of a pre-existing global 
dysfunction in the brain, such as those emanating from neuro-developmental deficits. The 
fact of this association may also suggest that both NSS and cognitive impairment are a 
reflection of the same patho-physiological process that underlies schizophrenia (Wong et 
al, 1997, .Arango et al, 1999., Chan and Toulopoulou, 2006). Both constructs have also 
been suggested as complimentary, viable endophenotypes of schizophrenia (Bombin et al, 
2005, Chan and Gttesman, 2008). 
 
It is important to point out that many of the studies reporting a positive relationship 
between cognitive impairment and NSS are limited by methodological issues relating to 
assessment of only a limited number of items of cognition, as well as failure to control for 
several confounding variables. For instance age and IQ may influence these associations. 
While IQ may also be influenced by illness, NSS may be associated with age (Chen and 
Chan, 2003). As such the specific relationship between cognitive impairment and NSS 
remain poorly understood.  
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2.4.5. NSS AND ANTIPSYCHOTIC MEDICATIONS IN SCHIZOPHRENIA 
The relationship between NSS and antipsychotic treatments in schizophrenia has been 
examined either in the form of current antispychotic doses (Chen et al, 1995., Lane et al 
1996., Morh et al, 1996., Flashman et al, 1996., Gureje et al, 1988), lifetime antipsychotic 
exposure (Flyckt et al, 1999., Flashman et al, 1996) or in the form of longitudinal studies 
that have assessed symptom response to antipsychotic medications (Madsen et al, 1999., 
Chen et al, 2000., Scheffer et al, 2004., Bachman et al, 2005., Whitty et al, 2006., Mayoral 
et al, 2008). These studies have attempted to control for the possible contribution of 
antipsychotic medication to NSS. Many of the studies have combined scales for NSS with 
scales for extra-pyramidal symptoms, akathisia, and tardive dyskinesia. The vast majority 
of studies comparing medicated and un-medicated patients, or patients with and without 
extrapyramidal symptoms (EPS) report no association between neurological abnormalities 
and antipsychotic medication or extrapyramidal symptoms (Sheffer et al, 2004., Browne et 
al, 2000., Arango et al, 2000). This issue was more clearly addressed by Sheffer and 
colleagues when they administered the NES to 26 drug naïve and 3 drug free patients prior 
to treatment administration and after 6 week antipsychotic treatment, and found no 
significant changes in the NES scores at 6 weeks (Sheffer et al 2004). Similarly, the 
community study by Shibre et al (Shibre et al, 2002) in rural Ethiopia, which included 200 
treatment naïve patients with schizophrenia, found that NSS in the treatment naïve 
schizophrenia cohort was as common as those reported in studies of subjects on 
neuroleptic medication. Schizophrenia patients in this sample had more total, motor 
sequencing, motor co-ordination, and sensory integration signs than a group of healthy 
controls (Shibre et al, 2002).  
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Studies in first-episode schizophrenia patients have often reported more NSS in the first 
episode antipsychotic naïve patients, when compared to healthy controls (Keshavan et al, 
2003, Sheffer et al, 2004). However, similar to studies in other patient groups, significant 
differences have not been consistently reported between anti-psychotic naive and treated 
patients. For instance, the first episode Irish study (Browne et al, 2000, Whitty et al, 2003) 
reported that the rate of NSS did not differ significantly between antipsychotic naïve and 
antipsychotic treated patients, with 97.1% of antipsychotic naïve psychotic patients 
showing at least one neurological sign. 
 
Some authors have argued for a hypothetical protective effect of antipsychotics on 
neurological dysfunction (Madsen et al, 1999), or indeed a decrease in NSS seriousness 
during treatment (Bachman et al, 2005, Whitty et al, 2006., Mayoral et al, 2008). For 
instance, in the follow up study by Madsen et al. (Madsen et al 1999), there was an 
increase in NSS in patients with schizophrenia 5 years after their first presentation. This 
increase was however more marked in those who had not received antipsychotic 
medication over the same period. Signs related to the cortico-spinal tracts were over 
represented. The authors reported how the antipsychotic load in non responding patients 
was inversely related to changes in total neurological abnormalities. It is however possible 
that the positive effect observed is related to the efficacy of antipsychotics on the clinical 
presentation. This improvement of neurological function following antipsychotic 
treatment may not be present in a sub-set of patient with a more chronic illness. Thus, 
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some studies have also reported worsening of neurological functions after antipsychotic 
treatments in chronic patients (Chen et al, 2000, Dazzan and Murray, 2002). The weight of 
evidence from empirical factor analysis suggests that antipsychotic treatment has some 
effect on the distribution of NSS in schizophrenia. A study by Goldstein and colleagues, 
(Goldstein et al, 2005) investigating  the factor structure of the Neurological Evaluation 
Scale (NES) administered to 78 medicated patients with the illness, showed that the factor 
structure dramatically changed between when patients were un-medicated and when they 
became medicated. The un-medicated group had three clear factors and one factor that 
were not easy to characterize. However, after medication, the NES factors increased to 
five unclear factors. The subjects were part of 108 un-medicated patients reported by an 
earlier factor analysis by Sanders et al. (Sanders et al, 2000), and the same 12 items of the 
NES used in the earlier study were entered into the Goldstein’s factor analysis.  
 
 
Rates of NSS are reported to be similar among first episode schizophrenia patients 
exposed to conventional antipsychotics when compare to those exposed to atypical 
antipsychotics (Schroder et al, 1998., Boks et al, 2003., Jahn et al, 2006). In the study by 
Boks and colleagues, (Boks et al, 2003), tardive dyskinesia signs were an exception. They 
occurred more frequently among patients exposed to conventional antipsychotics. This 
would suggest that the type of antipsychotic treatment may have an influence on the 
appearance of tardive dyskinesia, but not on NSS in general. 
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2.4.6. NSS AND THE COURSE OF SCHIZOPHRENIA  
The evidence for a relationship between NSS and cognitive impairment in schizophrenia 
as well as those suggesting that NSS could characterise a more severe schizophrenia 
psychopathological process such as thought disorders, negative symptoms and deficit 
states, as argued by Mechri et al (Mechri et al, 2009), suggest a state-like quality of at least 
some NSS factors. Such NSS factors may be associated with a chronic course of illness 
(Smith and Kadewari, 1996, Madsen et al, 1999., Prikryl et al, 2012). Some researchers 
also believe that NSS represent a trait characteristic of chronically ill schizophrenia 
patients (Buchanan et al. 1994, Smith et al, 1999., Chen et al, 2005). In the study by Smith 
et al. (Smith et al, 1999) comparison of 25 non-responders and 20 relative responders to 
conventional antipsychotic medications was conducted on the bases of an NSS battery and 
neuropsychological tests which evaluated deficits influenced by functioning of frontal and 
non-frontal brain areas. The data indicated that differences in the number and severity of 
NSS strongly differentiated between chronic schizophrenia patients who were persistently 
symptomatic after treatment with conventional antipsychotics and those whose positive 
symptoms resolved after several weeks or months of treatment with these medications. 
The authors suggested therefore that high NSS scores may predict individuals who will 
fall into the category of schizophrenia patients who are chronic non-responders to 
conventional antipsychotics (Smith et al, 1999). Smith and Kadewari (1996) had reported 
that severity of NSS correlated inversely with the degree of reduction in positive 
symptoms in chronically hospitalized non-responding schizophrenia patients who were 
given a trial of risperidone for several months (Smith and Kadewari, 1996). Another 5 
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year prospective study has also reported an increase in the number of neurological 
abnormalities in patients who had a genetic predisposition, as well as those with a non-
remitting course (Madsen et al, 1999). In support of this finding are studies showing that 
Schizophrenia patients with few or no NSS at baseline have greater improvements on 
verbal fluency, memory and psychomotor speed following atypical antipsychotic 
treatments for 6 months when compared with those with many NSS (Das et al, 2004). 
Similarly, some studies have demonstrated that improvement in psychopathology also 
correlates positively with reduction in the rates of NSS, including those assessing the 
temporal stability of the signs over the course of schizophrenia (Emsley et al, 2005, 
Sheffer et al, 2004, Whitty et al, 2003, Prikryl et al, 2012). For instance, a study of the 
temporal stability of NSS over a one year course in antipsychotic naïve patients reported 
significant improvement in the motor sequencing factor as psychopathology improved 
over time (Emsley et al 2005). However, the same study reported that rapid alternative 
movements worsen overtime with treatment at 3 months. Similarly, Whitty et al. (Whitty 
et al, 2003) reported improvements in motor related cortical NSS at 6 months in a 
prospective study of first episode schizophrenia patients. This improvement was 
associated with improvement of psychopathology. Interestingly, rates of NSS at follow up 
may be positively related to negative symptoms. This is in consonant with the believe that 
there exist a link between NSS and a chronic course of schizophrenia (Buchanan et al. 
1994., Smith et al, 1999., Smith and Kadewari, 1996., Madsen et al, 1999., Sheffer et 
al,2004., Chen et al, 2005., Prikryl et al, 2012 ). 
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A majority of studies report no association between NSS and age at onset of schizophrenia 
(Madsen et al, 1995., Gupta et al, 1995), duration of untreated psychosis (Emsley et al, 
2005., Browne et al, 2000), relapse rates (Emsley et al, 2005), and global assessment of 
functioning (Sanders et al, 1995). It is possible that factors such as global assessment of 
functioning and occupational outcome are worse in advance phases of the  illness, and are 
therefore not associated with neurological dysfunction in the early stages of the illness. 
However, Browne et al. (Browne et al, 2000) and Peralta et al, (Peralta etal, 2011) 
described an association between NSS and poor pre-morbid social functioning. This 
association can be related to the fact that higher rates of the signs are part of a more severe 
clinical picture. Furthermore, higher rate of NSS at baseline has been associated with the 
likelihood of developing side effects to antipsychotic medications during the course of 
schizophrenia. This was especially highlighted for tardive dyskinesia in the study by 
Emsley et al. (Emsley et al, 2005) described earlier, where it was reported that although 
the profile of NSS did not change much over a 12 month course, high scores on the motor 
sequencing factor predicted the emergence of persistent dyskinesia at 24 months in a pre-
treatment antipsychotic naïve sample. A similar finding was also reported for other 
antipsychotic related effects in a French Caucasian sample of patients with schizophrenia 
by Mechri et al. (Mechri et al, 2009).  
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2.4.7. THE RELEVANCE OF NSS IN SCHIZOPHRENIA 
The importance of NSS in schizophrenia as a vulnerability marker has been emphasized 
by various studies in the literature showing that young offspring of patients with 
schizophrenia have more neurological abnormalities compared to matched controls, 
especially among male offspring, who have been noted to have increased problem with co-
ordination, right-left orientation and sensory integration (Prasad et al, 2009). These 
findings have also been replicated among other relatives of patients with schizophrenia, 
with the nature of the abnormalities clearly resembling those commonly seen in early and 
adult onset schizophrenia (Sanders et al, 2006., Neelan et al, 2011). Moreover, other 
categories of patients with elevated risk of schizophrenia such as healthy individuals with 
schizotypy (Chan et al, 2010a and b., Kaczorowski et al, 2009., Keshavan et al, 2008), 
have been shown to demonstrate increased numbers of NSS. Furthermore, a review of 
studies in children and adolescents has also shown that these abnormalities were already 
present at the first overt psychotic episode (Serene et al, 2007). Thus, there is a linear 
reduction of the risk across individuals of various genetic identities, from schizophrenia 
and normal controls. They therefore appear to be associated with genetic loading almost to 
a dose-response pattern. This pattern of distribution of NSS across schizophrenia patients 
and their relatives, or other high risk groups, is consistent with familial association, and 
appears to fit more into a mathematical model of familiar risk. Furthermore, the pattern of 
distribution of NSS across schizophrenia patients and their relatives has been found to be 
stable and resistant to external ethno-demographic influences.   
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Further evidence for NSS as a trait marker of schizophrenia comes from several 
longitudinal studies confirming the stability of NSS across the course of schizophrenia 
(Scheffer et al, 2004., Chen et al, 2005., Emsley et al, 2005., Boks et al, 2006.,  Mechri et 
al, 2009., Dazzan and Piccioni, 2009., Prikryl et al, 2012). This characteristic of NSS 
differentiates it from phenotypic measures of schizophrenia which are more maleable in 
the presence of multi-factorial and polygenic influences. They are thus attractive in the 
quest to isolate culprit genes for schizophrenia. 
 
Contemporary genetic science aims to identify genes conferring vulnerability to 
psychiatric disorders including schizophrenia, and the brain proteins they code for. This is 
with the hope that such a discovery will make it possible to develop better diagnostic 
procedures, treatments and preventive interventions targeted at the underlying illness 
process. To date however, there has only been limited progress in this quest especially for 
schizophrenia. This is because of the polygenic and quantitative nature of the disorder. The 
attention in contemporary genetic research has shifted towards endophenotypes such as 
the NSS to facilitate gene discovery (Egan et al, 2001). Endophenotypes are 
characteristics that may represent more accessible readout of gene functions such as for 
example neuro-imaging findings. Thus classifying patients based on endophenotypes may 
accelerate the process of gene discovery. It is anticipated that the genetics of a complex 
construct like schizophrenia can be studied easily in more or less Mendelian fashion if the 
construct is broken down into its constituent endophenotypes. It is natural to think that the 
more simple a construct under study, the less number of genes will be on the causal 
pathway. 
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Neurological soft signs can be elicited quickly, reliably and cheaply, and could therefore 
be used in ordinary clinical settings to establish that an individual had progressed along 
the neuro-developmental pathway to schizophrenia (Bombin et al, 2003). If viewed from 
this perspective, the presence of higher rates of NSS has the potential to augment the 
predictive power of psychopathological tests for the prodrome of schizophrenia. 
 
 
 
2.5. NSS IN OTHER MENTAL DISORDERS 
 
Neurological Soft Signs (NSS) have been reported in other neuropsychiatric conditions 
such as mood disorders, Obsessive Compulsive Disorders (OCD), personality disorders 
and substance abuse. The body of research into NSS in these other neuropsychiatric 
conditions is much smaller than in schizophrenia and sample sizes are often small. Also 
only few studies have investigated more than one neurological domain in these other 
psychiatric disorders, often focussing only on motor signs. 
 
Apart from the issue of relatively small sample sizes, these studies addressing NSS 
disorder also differed greatly in methodology. Patients were often recruited from treatment 
settings. Moreover, these studies were primarily meant to explore the magnitude of NSS in 
cases of schizophrenia using different sets of controls as references.  For instance, in a 
review of 258 literatures on NSS in schizophrenia and mood disorders, Boks et al (2000) 
found only 17 studies with useful data on one or more diagnostic   groups addressing this 
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issue. The numbers of patients in their mood disorder group were so small that they were 
unable to reach a firm conclusion. The review found a weighted mean prevalence of the 17 
signs in their mood disorder group averaging 16.4%, but encompassing a smaller 
selection. This was almost 2 times the weighted mean prevalence of 30 neurological signs 
in the control group, which was 8.9%. Therefore suggesting that the mean prevalence of 
most neurological signs is significantly different between mood disorder patients and 
normal controls, but there were fewer differences between schizophrenia and mood 
disorders. The schizophrenia group had a mean prevalence for 30 neurological signs of 
19.2%. However, because of the comparatively small sample of subjects in the mood 
disorder group, the difference between this group and the schizophrenia group may not 
have reached significance due to limited statistical power (Boks et al, 2000).  Only 
stereognosis and rhythm tapping were more frequent in mood disorder patients than in 
schizophrenia patients, where as  tactile extinction, dysdiadochokinesia, tandem walk, 
finger thumb opposition and articulation were significantly more prevalent in 
schizophrenia than in mood disorders. Nevertheless, schizophrenia patients have 
previously been found to perform similarly to patients with psychotic depression on motor 
and pursuit eye movement tasks (Jeste et al, 1996., Sweeney et al, 1999).  
 
 
In Africa, Negash et al, (2004) examined the extent to which NSS are associated with 
bipolar I disorder cases compared to healthy controls in a relatively large epidemiological 
sample in rural Butajira, Ethiopia. Their analysis was based on 224 treatment naïve  
bipolar I disorder patients and 78 healthy controls. This study also showed that cases of 
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bipolar I disorder were significantly impaired in the performance of NES items compared 
to healthy controls. The authors further noted the paucity of literature to compare their 
results with, and therefore relied on the review by Boks et al (2000) in discussing their 
results (Negash et al, 2004). 
 
 
While interpreting findings on studies on mood disorder patients, it should be considered 
that motor dysfunction shows variability related to mood (Guenther et al, 1986). The 
phase of the illness and the diurnal variation may therefore influence the result of the 
assessment. The diagnostic specificity of NSS in mood disorders remains unclear, often 
because authors fail to present the different diagnostic sub-categories. It seems that 
patients with affective psychosis shows evidence of frontal and parietal dysfunction 
(Nasralla et al, 1983), and in general an impaired motor performance (Negash et al, 2004), 
similar to those of schizophrenia patients. The occurrence of NSS in mood disorders 
points to a shared genetic vulnerability for schizophrenia and mood disorders rather than 
contradict the idea of increased NSS as a reflection of vulnerability to schizophrenia. In 
support of this view are the findings from studies demonstrating similar genetic expression 
in bipolar mood disorders and schizophrenia of homeobox genes (Kromkamp et al, 2003), 
lipid and myelin related genes (Tkachev et al, 2003), as well as numerous other 
similarities in genetic architecture (Purcell et al, 2009). Furthermore, there is evidence of 
an overlap in chromosomal regions with susceptibility genes for both bipolar disorders 
and schizophrenia (Berretini, 2000). Studies of the neurobiology of schizophrenia and 
mood disorders have also shown that both patient groups exhibit similar reduction in 
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reelin (Fatemi et al, 2000), a glycoprotein involved in neuronal migration and 
synaptogenesis, as well as down regulation of inhibitory neurotransmitters -e.g, Glutamic 
acid decarboxylase 67- (Guidotti et al, 2000). Moreover, schizophrenia and mood 
disorders also present some common structural brain abnormalities (MacDonald et al, 
2004). There is also an overlap between the symptomatology of schizophrenia and mood 
disorders (Wassink et al, 1999). These similarities suggest that schizophrenia and mood 
disorders lie on a continuum of vulnerability and may help to understand the underlying 
aetiological process. Some have proposed a model that positions both disorders on a 
similar genetic background, attributing their differences in clinical manifestation to 
environmental factors (Murray et al, 2004), while others present a ‘schizophrenia- bipolar 
boundary’ perspective (Ivleva et al, 2010), where even though both disorders are similar in 
origin, schizophrenia results from more severe affectation of the brain by the various brain 
structural and functional abnormalities, including NSS.  
 
Among anxiety disorders, patients (particularly men) suffering with obsessive compulsive 
disorders show an excess of NSS especially those related to poor motor control (Stein et 
al, 1994., Bihari et al, 1991., Peng et al, 2012). In a neuro-imaging study, NSS in this 
group were associated with reduced volume of the caudate, a structure that could also be 
mediating obsessive compulsive symptoms (Stein et al, 1994). An excess of neurological 
abnormalities has also be described in adolescents with anxiety disorders (Shaffer et al, 
1985). One study on patients with post traumatic stress disorder described abnormalities in 
motor sequencing and palmo-mental reflex in these patients (Gurvits et al, 1992), although 
these findings have not been replicated by subsequent study by the same authors (Gurvits 
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1993). Furthermore, NSS rates similar to those observed in schizophrenia have been 
observed in patients with personality disorders (Lindberg et al, 2004., Stein et al, 1993). 
Therefore, NSS including signs of motor dysfunction may not be specific to patients with 
schzophrenia. This can be clarified by investigating several neurological domains in 
groups of patients with different psychiatric diagnoses. 
 
 
2.5.1. NSS IN HEALTHY INDIVIDUALS 
Neurological soft signs are also present in healthy individuals. They have been reported to 
occur in this group at rates ranging from between 0 and 50% (Kennard, 1960; Hertzig and 
Birch, 1968; Rochford et al., 1970; Cox and Ludwig, 1979). However, the literature on 
NSS in healthy individuals is sparse. Most studies have extrapolated from findings when 
using healthy individuals as control in the investigation of NSS in schizophrenia. Such 
studies have consistently found a graded pattern of NSS prevalence and severity, with 
healthy relatives having an intermediate number between patients and healthy controls 
(Egan et al, 2001., Schubert and McNeil, 2004., Compton et al,2007).  
 
 
In one study were NSS has been investigated in an epidemiological sample of healthy 
individuals using the Neurological Evaluation Scale (NES). NSS scores were almost 
entirely reflective of abnormalities in sensory integration functions (Dazzan et al, 2006). 
The majority of subjects did not show abnormalities in tests of motor co-ordination and 
motor sequencing. The investigators further reported that higher rates of sensory 
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integration NSS was associated with volumetric reduction in several temporal and frontal 
grey matter structures. Structural imaging in the study was achieved using high resolution 
Voxel Based Morphometry procedure. In contrast, an earlier study by Keshavan and 
Colleagues (Keshavan et al, 2003) did not find associations between NSS and structural 
brain changes while using the Region of Interest analysis. 
 
 
In disparity with findings in schizophrenia patients, where higher rates of NSS were 
associated with a reduction of both cortical and subcortical areas (Dazzan et al.,2004), 
NSS in healthy individuals appear not to have any association with changes in sub-cortical 
structures (Dazzan et al, 2006). On the other hand, the same study reports that NSS in 
healthy individuals was associated with reduction in several white matter structures 
including the internal capsule. This finding is also in contrast with the report that NSS in 
schizophrenia is associated with increase in the white matter structures such as the internal 
capsule. 
 
. 
 
 
2.6.0. MEASURING NSS 
The distinction of some neurological signs as hard (reflecting impairment in basic motor, 
sensory, and reflex behaviour) or soft (reflecting impairments in coordination, sequencing 
or integration of complex sensory or motor functions) may appear ambiguous. This 
ambiguity has led to differences in categorization of neurological signs in the several 
instruments developed for their measurement. 
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Among the available instruments for assessing NSS, the most fully described and widely 
employed in adult psychiatry is the Neurological Evaluation Scale (NES) (Buchanan and 
Heinrichs,1989). Other scales that have been developed for this purpose for use in adult 
psychiatry include the Quantified Neurological Scale, a composite examination developed 
by Convit et al, (Convit et al, 1994), the Heidelberg scale (Schroder et al,1992), and the 
Cambridge Neurological Inventory (CNI), a heterogeneous inventory of neurological 
abnormalities and behavioural observations with administration guidelines and reliability 
data for use in adult psychiatry (Chen et al, 1995). Measures have also been developed to 
target specific aspects of NSS such as the Brief Motor Scale (Jahn et al, 2006), for motor 
soft signs.  
 
 
Although the batteries used in measuring NSS have varied, neurological abnormalities in 
adult patients with schizophrenia have been theoretically organized into three main 
neurological domains as follows (Heinrichs and Buchanan, 1989); 
 
1. Integrative sensory dysfunction (possibly resulting from a parietal lobe dysfunction), 
reflected in items such as bilateral extinction, agraphesthesia, astereognosis, right/left 
confusion and impaired audiovisual integration. 
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2. Motor in-coordination, reflected in items such as tandem walk, finger to nose, 
finger to thumb opposition and dysdiadochokinesis. 
 
3. Impaired sequencing of complex motor acts (possibly resulting from a fronto-basal 
ganglia circuitry), reflected in items such as the fist ring, fist edge palm and Ozerestski 
tests. 
Abnormalities in frontal release signs, eye movements, and short term memory have also 
been frequently observed in schizophrenia cohorts. 
 
 
TABLE 3. FUNCTIONAL CATEGORIES OF NEUROLOGICAL SOFT SIGNS IN 
SCHIZOPHRENIA, AND SOME OF THE TEST THAT ELICITS 
DISTURBANCES IN THESE AREAS 
 
 
Primitive 
Reflexes 
Sensory 
Integration 
Motor Coordination Motor 
Sequencing 
    
Gaze Audio-visual 
integration 
Tandem Walk Fist-Ring test 
Palmomental Stereognosis Rapid alternating 
movements 
Fist-Edge- 
Palm test 
Snout Graphaesthesia Finger Thumb 
opposition 
Ozereski 
Grasp Extinction Finger nose test  
 Right-Left 
confusion 
Rhythm tapping  
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2.6.1.0. THE NEUROLOGICAL EVALUATION SCALE 
The Neurological Evaluation Scale (NES) is based on an extensive review of NSS in 
schizophrenia by Heinrichs and Buchanan, (1988). The authors selected specific signs 
representing areas of frequent impairment noted across multiple studies focused on 
systematic reviews and controlled clinical evaluations.  
 
 
From these considerations a battery of 26 items was designed. Fourteen of these items are 
tested and scored separately for the right and left sides of the body. The instrument 
includes representative items from each of the three functional areas of interest, plus the 
assessment of cerebral dominance, short term memory, frontal release signs and eye 
movement abnormalities. All items are judged to be easily administered by a clinician at 
the bedside or in the consulting room with minimal equipment required. Each item is 
scored on a three point scale of 0=No abnormality, 1=mild but definite impairment, and 
2=marked impairment, except the snout and suck reflexes which are scored either as 0 or 
2. Descriptive anchors are provided for each score to facilitate standardized judgement. In 
addition to item scores and total scores, subsets of items are totalled to yield scores for the 
three functional areas of interest described earlier.  
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Inter-rater reliability data were derived from 39 subjects with schizophrenia and 7 
controls. The Intra-class correlation for total scores was 0.95, and 0.99 for the sensory 
integration sub-scale, 0,71 for the motor co-ordination sub-scale, and 0.89 for the 
sequencing of complex motor act subscale. The inter-rater reliability for 14 individual 
items was 0.90. The NES has been shown to predict cognitive dysfunction, severity of 
psychopathology, and response to antipsychotics (Buchanan and Heinrichs, 1989, Bombin 
et al, 2003). Apart from these important psychometric properties, the NES appear superior 
to other instruments of its kind as it assesses a moderate number of soft signs. This 
characteristic allows for minimization of administration time and maximization the 
number of relevant items of the NES. It has also been extensively used in studies of 
neurological abnormalities in schizophrenia. 
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Table IV. Items in the Neurological Evaluation scale. 
 
Sensory integration scale 
Audiovisual integration 
Stereognosis 
Graphaesthesia 
Extinction 
Right/left confusion 
 
Motor coordination subscale 
Tandem walk 
Rapid alternative movements 
Finger-thumb opposition 
Finger-nose test 
 
Sequencing of complex motor acts subscales 
Fist-ring test 
Fist-edge palm 
Ozereski test 
Rythm tapping test, B 
 
‘Others’ subscale 
Adventitious flow 
Rhomberg test 
Tremor 
Memory, 5 minutes 
Memory, 10 minutes 
Rhythm tapping test, A 
Mirror movements 
Synkinesis 
Convergence 
Glabellar reflex 
Snout reflex 
Grasp reflex 
Suck reflex 
 
 
 
Adapted from: Arango et al, 1999 
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2.6.1.1. FACTOR ANALYSES OF THE NES 
The original sub-scales of the NES were derived according to the brain functions or 
regions they were thought to represent (Henirichs and Buchanan, 1989). It contained 
factors for sensory integration, sequencing of complex motor acts, as well as motor co-
ordination. Other such conceptually derived sub-scales of the NES include those of Egan 
et al. (Egan et al, 2001) which contained sub-sets for cerebellar, frontal and parietal 
functions. Although such conceptualization of soft signs appear to have hypothetical 
significance, they have never been confirmed by empirical methods such as exploratory 
factor analysis (Sewell et al, 2010., Compton et al, 2006., Emsley et al, 2005., Goldstein et 
al, 2005., Sanders et al, 2000., Keshavan et al, 2003., Krebs et al, 2000 and Malla et al, 
1997), or confirmatory methods (Sanders et al, 2005). However, this tentative 
classification has been used in many previous studies of NSS in schizophrenia (Arango et 
al, 1999., Shibre et al, 2002., Mohr 1996, 2003., Scheffer et al, 2003., and Dazzan et al, 
2004) 
 
Factor analysis is a standard technique for reducing data sets to underlying consistent sub-
set that can be used to find principal variables among many observed variables in a data 
set through the grouping together of items with similar characteristics. Previous studies 
have shown that the NES is made up of different factors which can be subjected to factor 
analysis (Malla et al, 1997, Sanders et al, 2000, 2005). These factors are also known to 
reflect different aspects of brain functions in schizophrenia and as such, they are 
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associated with the various clinical and outcome characteristics of the disease (Sewell et 
al, 2010., Compton et al, 2006., Emsley et al, 2005). 
 
2.6.2. THE HEIDELBERG SCALE 
The Heidelberg scale is a 17-item instrument along 5 domains of motor coordination, 
integrative functions, complex motor tasks, right/left and spatial orientation, as well as 
hard signs. Ratings are given on a 0–3-point scale (no/slight/moderate/marked 
abnormality, respectively). All items except for gait, tandem walk, Ozeretzki’s test, 
articulation, and right/left orientation are assessed separately for both the right and the left 
side. Scores in the Heldeberg scale has been shown to be associated with disorganisation 
symptom dimensions, working memory impairment, increased third ventricular volume, 
as well as increased ventricular brain ratio. Cronbach's alpha derived from an assessment 
of 42 schizophrenia patients and healthy controls by two independent raters was 0.85 for 
the schizophrenia sample and 0.89 for the healthy controls. Inter-rater reliability was 0.88 
(p<0.005) (Bombin et al, 2003). 
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Table V.  Items in the Helderberg scale 
Motor Coordination 
Ozeretzki test 
Diadochokinesis 
Pronation/supination 
Finger/thumb opposition 
Articulation 
 
Sensory Integration 
Gait 
Tandem gait 
2-point discrimination 
 
Complex Motor Tasks 
Finger- to- nose test 
Fist-edge-palm test 
 
Right /Left and Spatial Orientation 
Right/left orientation 
Graphaesthesia 
Face/hand sensory test 
Stereognosis 
 
Hard Signs 
Arm-holding test 
Mirror movements 
 
Adapted from: Bachman et al, 2005 
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2.6.3. THE CAMBRIDGE NEUROLOGICAL INVENTORY (CNI) 
The CNI is a standardised comprehensive neurological examination. It includes most 
neurological signs from the Neurological Evaluation Scale (NES) along with items that 
assess extrapyramidal symptoms, tardive dyskinesia, and catatonia. It covers 3 soft signs 
domains, including motor coordination, sensory integration, and disinhibition. A rating of 
0 indicates no abnormalities; 0.5, 1 and 2 indicate equivocal, abnormal and grossly 
abnormal responses, respectively. Inter-rater reliability assessed with Kendall's w on 14 
items which were not part of an already validated scale ranged from 0.82 to 1.0 (p<0.04) 
(Chen et al, 1995) 
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Table VI. Items in the Cambridge Neurological Inventory (CNI). 
Stereognosis 
Graphaesthesia 
Extinction 
Right-left confusion 
Tandem walk 
Dysdiadochokinesia 
Finger-thumb opposition 
Finger-nosetest 
Fist-edge-palm 
Ozeretski test 
Rhomberg test 
Tremor 
Rythm tapping test 
Mirror movements 
Gaze impersistence 
Glabellar reflex 
Snout reflex 
Grasp reflex 
Gait 
Palmomental reflex 
 
Adapted from; Bombin et al, 2003.  
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2.6.4. MODIFIED QUANTIFIED NEUROLOGICAL SCALE 
This scale was designed to differentiate between violent and non-violent schizophrenia 
patients. It consists of 96 items, of which 48 assesses NSS. These items are scored as 
normal or abnormal. The scale also groups the items according to the probable localisation 
of the NSS. Kappa values for individual items ranged from 0.69 to 1.60 (Convit et 
al,1994). The modified quantified neurological scale scores correlates with symptom 
severity, poor psychosocial performance, and cognitive impairment (Bombin et al, 2003) 
 
 
Table VII. Items in the Modified Quantified Neurological scale.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adapted from; Bombin et al, 2003. 
 
Stereognosis 
Graphaesthesia 
Extinction 
Right-left confusion 
Tandem walk 
Finger-thumb opposition 
Finger-nosetest 
Fist-ring test 
Fist-edge palm 
Rhomberg test 
Hopping 
Pronation and supination 
Foot tap 
Face-hand 
Babinski 
Stellenbosch University  http://scholar.sun.ac.za
  
89 
 
 
2.6.5. OTHER SCALES FOR MEASURING NSS 
Wood Scale 
This scale contains 79 items that assesses both soft and hard signs. It is rated on a 4 point 
scale, where 0=absent, 1=mild, 2=moderate, and 3=severe. The scale also provides a 
classification of the probable aetiology of the neurological impairment (Bombin et al, 
2003).  
 
Rossi Scale 
This is a 26 item scale in which 7 items are rated bilaterally. While some of the items are 
rated as present or absent, other items are rated from 0-6. Inter-rater reliability for the total 
score as evaluated by the Spearman correlation was 0.76 (Bombin et al, 2003). 
 
The Brief Motor Scale  
The BMS specifically assesses movements and motor skills in patients with schizophrenia 
and other psychiatric disorders (Jahn et al, 2006) 
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2.7. LIMITATIONS OF PREVIOUS RESEARCH ON NSS 
Psychiatric research into NSS has employed a collection of neurological examination 
items obtained from the clinical traditions of previous studies. Some batteries were partly 
or entirely drawn from general neurology text, while others were selected from familiar 
neuropsychological batteries (e.g, Cox and Ludwig, 1979., Schultz et al, 1995., Gupta et 
al, 1995). Several scales were developed for use with children during extensive research 
into neurological aspects of paediatric psychiatry in the 1930s and 1940s (e.g, Rutter et al, 
1970., Nichols et al, 1981., Tupper, 1987), and were later modified for  application in the 
adult population. The various scales applied by researchers over the years differed in their 
definition of neurological impairments. These differences have resulted in pronounced 
variability in the reported prevalence rates of NSS in schizophrenia subjects. Studies in 
which neurological impairment is defined more broadly to include 'at least one 
neurological sign present' tended to give a higher prevalence rate (e.g, Bartko et al, 1988., 
Browne et al, 2000., Ismail et al, 1998) whereas studies using a more restrictive definition 
of neurological impairment gave a lower prevalence rate (King et al, 1991). The 
prevalence rates also depended on the scope of coverage of the neurological assessment 
scale. This has ranged from 4 signs (e.g, Gureje, 1988) to up to 108 signs in some studies 
(Braun et al, 1995). This fact on its own may explain differences in prevalence rates. 
Scales with a smaller number of signs are likely to have low sensitivity, and may omit 
signs that are relevant to schizophrenia, creating a type II error of concluding that  certain 
neurological abnormalities are not specific to schizophrenia. On the other hand, very 
comprehensive scales are likely to have low specificity and may include signs that have no 
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direct bearing on primary neurological abnormalities, and therefore classify subjects as 
neurologically impaired when in fact their signs are secondary to other variables. 
Furthermore, most of the neurological examination scales do not provide cut off scores or 
set thresholds that define the neurological impairment range. Reports that include a 
matched healthy control group are able to establish what constitute a neurological normal 
or abnormal state and hence allow for comparison with the patients with schizophrenia. 
This approach of looking for statistically significant differences among groups is less 
ambiguous than the use of subjective definitions of neurological impairment. Studies of 
these kinds that compare the prevalence of NSS in schizophrenia patients and healthy 
controls have consistently found significant differences. 
 
2.8. RATIONALE FOR THE PRESENT STUDY 
Globally, the existing evidence for the nature of Neurological Soft Signs (NSS) in 
schizophrenia has been based on wholly Caucasian population or mixed population of 
Caucasians and other races. Many more of the studies from which this evidence is derived 
have been conducted outside the African continent. Out of a total of five African studies 
reporting on the nature of NSS in Schizophrenia (Gureje et al, 1988., Mubarak et al, 1999., 
Shibre et al, 2002., Emsley et al, 2005, and Smit et al, 2012), only one was based on a first 
episode sample (Emsley et al, 2005). That study, which is also the only prospective 
longitudinal study of NSS on the African continent, was composed of a sample drawn 
from 21% white, 71% mixed, and 8% black Africans with first episode schizophrenia. 
Another important study reported on the nature of NSS in a sample comprising of 90% 
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African-Americans and 10% other races, but with considerable clinical heterogeneity 
(Compton et al, 2006). Therefore, a knowledge gap still exists on the nature of NSS in 
indigenous African subjects 
 
Recent systematic re-examination of the epoch making World Health Organisation (WHO) 
epidemiological studies in schizophrenia, as well as larger scale replications of these 
studies have revealed important  ethnic and geographical variations in many aspects of the 
disease (Mcgrath et al, 2006., Saha et al, 2005., Cohen et al, 2008). This body of evidence 
challenges the previously held axiom that schizophrenia is an egalitarian disease, with 
similar incidence and expression across all regions and cultures. Moreover, some previous 
studies have demonstrated that race or ethnicity influences the prevalence of NSS in 
schizophrenia (Chen et al, 2003., Keshavan et al, 2003., Bombin et al, 2005., Mechri et al, 
2009). It is therefore becoming more difficult to generalize findings from one 
geographical area or indeed any one sample or population. This is especially so in the 
science of population genetics and epi-genetics of mental disorders, and the immediately 
congruent concept of NSS or indeed other intermediate phenotypes. Furthermore, there are 
other evidence to suggest that there are important peculiarities among indigenous Africans 
in the genetics and clinical aspects of many other neuropsychiatric disorders, including 
major depression and dementia (Gureje, 2007). In the light of this body of evidence, 
prospective longitudinal studies of neurological abnormalities in first episode 
schizophrenia in a clinically and racially homogenous cohort of indigenous African 
subjects become pertinent, and indeed long overdue.  
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This study describes the profile of NSS across the one year course of schizophrenia, as 
well as their relationship with illness specific and outcome variables in a group of first 
episode, largely medication-naïve Yoruba Nigerians with the disease. It is expected that 
this study will provide important reference data on the nature of neurological soft signs in 
indigenous African subjects and energize the pursuit of candidate genes in the causal 
pathway of schizophrenia.  This is with the hope that such a discovery will make it 
possible to develop better diagnostic procedures, treatments and preventive interventions 
targeted at the underlying illness process. 
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CHAPTER THREE 
 
AIM AND OBJECTIVES 
3.1 AIM: 
The overall aim was to conduct a longitudinal study to investigate the frequency, stability 
and demographic and clinical correlates of neurological soft signs over a 12 month 
course of schizophrenia among a clinically and racially homogenous cohort of Nigerian 
Africans. 
 
 
3.2. OBJECTIVES: 
  1)  To investigate the frequency and the one year longitudinal profile of neurological 
soft signs in a cohort of Nigerian patients with schizophrenia  
 
2) To determine the relationship between neurological soft signs and pre-morbid 
adjustment. 
3) To determine the relationship between neurological soft signs and the clinical 
characteristics of schizophrenia. The clinical characteristics of interest will include; 
age at onset of schizophrenia, duration of untreated psychosis, symptom dimensions 
of schizophrenia, presence of depressive symptoms overtime, and insight overtime. 
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4) To determine the relationship between baseline neurological soft signs and the 
emergence of extrapyramidal symptoms over time. 
 
 
3) To determine the relationship between neurological soft signs and the outcome of 
illness over 12 months. Outcome will be determined in terms of symptom reduction, 
functionality, and quality of life. 
 
3.3. HYPOTHESES: 
1).  There will be no significant difference in the scores of NSS dimensions in patients 
with schizophrenia after three repeated measurement over a 12 month period. 
 
2).  Higher NSS scores at baseline will be associated with a poorer premorbid adjustment, 
a younger age at onset of schizophrenia, and predominant negative or disorganization 
symptoms of schizophrenia. 
 
30. Higher NSS scores at baseline will be associated with treatment emergent 
extrapyramidal symptom over a 12 month course. 
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4).  Higher NSS scores will be associated with a poorer outcome over a 12 month course, 
but will have no significant relationship with insight or the presence of depression 
symptoms over this period 
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CHAPTER FOUR 
 
METHODOLOGY 
4.1. STUDY LOCATION AND SETTING 
The study was conducted in Ibadan, Nigeria. Ibadan is located in south-western Nigeria, 
about 80 Kilometres from Lagos, and the population is mostly Yoruba speaking. There are 
two main hospitals in Ibadan with functioning psychiatric units. The University College 
hospital (UCH), which is a tertiary referral general hospital, and the Oyo state general 
hospital (Adeoyo) a secondary health-care facility.   
 
4.2. STUDY DESIGN 
This was a cohort study with a longitudinal (repeated measures) design. The cohort   
comprised of Nigerian patients with first episode, largely medication naive, schizophrenia, 
schizo-affective disorders, and schizophreniform disorder. It was racially homogenous. 
Patients were from the Yoruba ethnic group and were resident within and around Ibadan.  
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4.3. SUBJECTS 
The study was carried out among patients aged between 16 years and 45 years with first 
presentation to the psychiatric units of the UCH and Adeoyo hospitals, Ibadan. A total of 
84 patients, 47 males and 37 females, were consecutively recruited over a period of 
26months, between April, 2009 and June, 2011 from the outpatient clinics of the two 
hospitals. Patients were approached after they had been seen by the clinician, usually a 
consultant psychiatrist or a trainee psychiatrist, who was responsible for their routine 
clinical assessment at presentation. Only those who were assessed by the clinician to have 
a psychotic illness were approached for possible participation in the study. Written 
informed consent was obtained from all participants, and/ or their guardians after the 
procedure of the study was explained to them in either English or Yoruba language. On the 
basis of these criteria, 84 patients were consecutively recruited into the study. Following 
recruitment into the study, subsequent evaluations and treatment were conducted in the 
research office for the study at the University College Hospital, Ibadan. In all, 65 patients 
completed 12 months follow- up assessment, while 19 patients dropped out of the study 
for various reasons, giving a follow-up rate of 77.4%. Of these, 12 subjects were lost to 
follow-up or relocated from study location, 2 withdrew their consent during the study, and 
another 2 withdrew from the study because of poor efficacy of the prescribed anti-
psychotic medication. All the attritions occurred before the second assessment for 
neurological soft signs, which was at 6 months. They were mostly males (57.9%), and had 
a mean age of 28.7 (±5.8) years. Fourteen of them had received a diagnosis of 
schizophrenia, while the remaining 4 had a diagnosis of schizophreniform disorder. There 
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were no significant differences in the baseline characteristics of patients who dropped out 
of the study and those who completed the 12 month assessments. Only patients who 
fulfilled the research inclusion and exclusion criteria were enrolled into the study.  
 
4.3.1. INCLUSION CRITERIA 
1. Male or female, in- or outpatients 
 
2. Aged between 16 and 45 years. 
 
3. DSM IV diagnosis of schizophreniform disorder, schizophrenia or schizo-
affective disorder                
 
4. Lifetime exposure to antipsychotics of not more than 12 weeks. 
 
4.3.2. EXCLUSION CRITERIA 
1. Previous treatment with long acting depot antipsychotics. 
 
2. Physical illness of significance. This was assessed using clinical history, a full 
physical examination including neurological examination. Appropriate special 
investigations were also requested where necessary.  
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3. Mental retardation. This was determined from clinical history and general clinical 
impression. Formal testing of cognitive capacity was not done. 
 
4. Current substance abuse meeting DSM IV criteria. This was determined from 
clinical history. 
 
 
4.3.3. SAMPLE SIZE DETERMINATION 
The sample size was calculated based on the formula for repeated measures data. The 
minimum number of participants followed up for three repeated measures assuming a type 
1 error rate of 5% and a power of 90% of detecting a difference in pattern of neurological 
soft signs is given by the formula (Diggle et al, 2002)  
m = 2(Z + Z)2 2 (1 – ) 
nsx
2d2 
Where; 
m =the minimum sample size studied. 
Z  = the standard normal deviate corresponding to a type 1 error rate (2 sided level of 
significance of 5% = 1.9) 
Z = the standard normal deviate corresponding to a one sided beta error of 10% (90% 
power) = 1.28 
  = the standard deviation of the neurological symptom score obtained from a preliminary 
study = 9.9 
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 = the correlation between successive measurements = 0.44 
sx
2
=  the within subject variance of the measurements = 3.25 
d = the meaningful difference in neurological symptom score between those with soft sign 
and those without. A difference of 1 unit was assumed 
n = the number of repeated observations = 3 
This gave a minimum of 64 participants. Assuming 5% loss to follow up rates, about 67 
participants was required to be followed up. 
 
 
4.4. STUDY INSTRUMENTS 
The following instrument was employed in the diagnostic assessments of patients: 
Structured Clinical Interview for DSM-IV (SCID) (First et al, 1996).  
This instrument was developed to provide for a standardized assessment that generates 
DSM-IV diagnoses. It is a semi-structured diagnostic interview beginning with a section 
on demographic information and clinical background. There are seven diagnostic modules 
focused on different diagnostic groups: mood, psychotic, substance abuse, eating, 
somatoform and adjustment disorders. All available information, including those from 
hospital records, informants and patients’ observations are used to rate the SCID. It is 
considered a standard interview to verify diagnoses in clinical trials and is extensively 
used in other forms of clinical research.  
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The following instruments were employed in the assessment of patients with 
schizophrenia (and related disorders): 
1. The Positive and Negative Syndrome Scale (PANSS) (Kay et al, 1987).  
The PANSS include 30 items on three sub scales; seven items covering positive 
symptoms, seven covering negative symptoms and 16 covering general psychopathology. 
The PANSS requires a clinician rater because considerable probing and clinical judgment 
is required. Reliability for each scale was shown to be fairly high with excellent internal 
consistency and inter-rater reliability (Kay et al, 1987). The PANSS has become the 
standard tool for assessing clinical outcome in treatment studies of schizophrenia and 
other psychotic disorders and has been shown to be sensitive to change with treatment. 
Factor analyses by several groups over the years now overwhelmingly favour a five factor 
solution (Lancon et al, 1998., 2000., Wolthaus et al, 2000), instead of the original three 
categories. These factors include those of positive (P1= Delusion, P3= Hallucination ,P5= 
Grandiosity  ,and P6= Suspiciousness), negative (N1= Blunted affect, N2= Emotional 
withdrawal, N3= Poor rapport, N4= Passive social withdrawal, N6= Lack of flow of 
conversation, and G7= Motor retardation), disorganised/cognitive (P2= conceptual 
disorganization, N5= Poor abstraction, G9= Unusual thought content, G10= 
Disorientation, G11=Poor attention, G13=Disturbance of volition, and 
G15=Preoccupation), excitement/hostility (P4= Excitement, P7= Hostility, G8= Unco-
operativeness, G12= Lack of insight, and G14= Impulsivity), and depression/anxiety (G2= 
Anxiety, G3= Guilt, G4= Tension, and G6= Depression) dimensions of schizophrenia. 
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They are generally described as stable and unaffected by age, disease severity or 
medication use. Therefore they have found wide acceptance in several studies of the 
outcome of schizophrenia and other psychotic disorders (Monteiro et al, 2008., Llorca et 
al, 2011). 
 
The PANSS was administered to all subjects by the investigator at baseline and at three 
monthly intervals throughout the duration of this study. 
 
2. Clinical Global Impression (CGI) (Guy, 1976). 
The CGI was developed to provide a brief, stand-alone assessment of the clinician’s view 
of the patient’s global functioning prior to and after initiating treatment. The assessment 
takes into account all available information, including knowledge of the patient’s history, 
psychosocial circumstances, symptoms, behaviour, and the impact of the symptoms on the 
patient’s ability to function. The CGI comprises two companion one-item measures 
evaluating the severity of psychopathology on a 7-point scale and change from the 
initiation of treatment on a similar seven-point scale. Subsequent to a clinical evaluation, 
the CGI form can be completed in less than a minute by an experienced rater. The CGI can 
track clinical progress across time and has been shown to correlate with longer, more 
tedious and time consuming rating instruments across a wide range of psychiatric 
diagnoses. The investigator rated patients on the CGI at baseline and at 3 monthly 
intervals. 
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3). Calgary Depression Scale for Schizophrenia (CDSS) (Addington et al, 1993). 
The CDSS is a nine-item scale specifically developed for assessment of depression in 
patients with schizophrenia. It is presented as a semi-structured interview. The first 
question for each section is asked as stated, although the rater is encouraged to ask 
additional questions as he or she feels appropriate. All items are rated on a four-point 
scale. Anchor point descriptions are provided to aid differentiation between each item 
score. The first eight items are rated on the basis of the patient's responses to questions; 
the ninth item is based on the clinician's assessment of the patient over the course of the 
interview. The CDSS was administered to all subjects at baseline and 3 monthly intervals.  
 
4. Extrapyramidal Symptom Rating Scale (ESRS) (Chouinard and Margolese, 2005). 
The ESRS was designed to rate three types of extrapyramidal symptoms: Parkinsonism, 
dystonia and dyskinetic symptoms. The scale includes subjective questions covering the 
above three categories of extrapyramidal symptoms. These subjective questions help to 
differentiate subjective akinesia from depressive symptoms related to the anti-adrenaline 
effects of some antipsychotic drugs (e.g chlorpromazine). But they also help to 
differentiate akathisia from anxiety and psychotic agitation. Also included in the ESRS are 
sections for physical examination covering Parkinsonism, dystonia, and dyskinetic 
movements as well as sections for clinical global impression items. The ESRS was 
administered to all subjects by the investigator at baseline and 3 monthly intervals. 
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5. Social and Occupational Functioning Assessment Scale (SOFAS) (American 
Psychiatric Association). 
The SOFAS is a scale that focuses on the individual's level of social and occupational 
functioning and is not directly influenced by the overall severity of the individual's 
psychological symptoms. Also any impairment in social and occupational functioning that 
is due to general medical conditions is considered in making the SOFAS rating. This is in 
contrast to the older Global Assessment of Functioning (GAF) scale which seems to tie 
functioning to psychopathology. The SOFAS is usually used to rate the level of 
functioning at the time of the evaluation. However, the SOFAS may also be used to rate 
functioning for other time periods. For example, the highest level of functioning for at 
least a few months during the past year. The SOFAS was administered to all subjects by 
the investigator at baseline and 6 monthly intervals.  
 
6. The World Health Organisation WHOQOL-BREF Quality of Life Scale (WHO, 
1998). 
The WHOQOL-BREF is an abridged version of the WHOQOL-100 quality of life 
assessment scale, an instrument that allows a detailed assessment of the individual facets 
of quality of life. The WHOQOL-BREF contains a total of 26 questions arranged in a four 
domain structure of physical health, psychological health, social relationships and 
environment. To provide a broad and comprehensive assessment, one item from each of 
the 24 facets contained in the WHOQOL-100 was included in this abridged version. Two 
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items from the overall quality of Life and general health facet of the parent instrument 
were also included. The domain scores are indicative of an individual’s subjective 
perception of quality of life in the corresponding domain. Higher scores denote higher 
quality of life. The mean score of items within each domain is used to calculate the total 
domain score. The WHOQOL-BREF could be self-administered if respondents have 
sufficient ability. Otherwise, interviewer-assisted or interview-administered forms are 
used. A research nurse who received training in the use of the WHOQOL-BREF rated 
patients with schizophrenia using this instrument. 
 
7. Premorbid Adjustment Scale (PAS) (Cannon-Spoor et al, 1982). 
The PAS is a rating scale designed to evaluate the degree of achievement of 
developmental goals in the major areas at each of several periods of a subject’s life before 
the onset of schizophrenia. It assesses premorbid functioning during childhood (up to 11 
years), early adolescence (12 to 15 years), late adolescence (16 to 18 years), and adulthood 
(19 years and above). The premorbid period referred to by this measure is the period 
ending 6 months before the first episode of the psychotic disorder. The domains include 
sociability and withdrawal, peer relationships, scholastic performance, adaptation to 
school, and social-sexual functioning. Social-sexual functioning is not assessed during 
childhood. Ratings are made on a 0 to 6 point scale, with 0 indicating normal adjustment 
and 6 indicating severe impairment. Ratings are averaged across each of the domains, to 
obtain individuals scores for the childhood, early adolescence, and late adolescence 
periods. 
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In accordance with the procedure used in previous studies, separate scores were calculated 
for Social and Academic functioning at each age period. These composite domains had 
been derived by factor analytic studies of the PAS (Allen et al, 2001). The average scores 
for the sociability and withdrawal, peer relationships and social-sexual functioning items 
were calculated to generate a score for the social domain. The same method was used to 
generate an academic domain from the scholastic performance and adaptation to school 
items. The PAS was completed according to standardized procedures. A semi-structured 
interview of the patients and their family members was conducted with the requirement 
that the interviewed family member had substantial contact with the participant during 
childhood, adolescence, and early adulthood 
.  
8. Birchwood Insight Scale (BIS) (Birchwood et al 1994)  
The BIS is a self-report Insight Scale which measures three dimensions of insight: 
awareness of illness (2 items), awareness of symptoms (2 items) and awareness of the 
need for treatment (4 items). Each item is scored: 0 – no insight (yes to 2, 3, 6, and 8; no 
to the others), 1 – unsure (all items), 2 – insight (no to 2, 3, 6 and 8; yes to the others). 
Each sub-scale is given equal weight when calculating the total score. Higher score 
indicate better insight. A research nurse who had received training in the use of the BIS 
supervised the rating of insight by patients with schizophrenia. In the final analysis, lack 
of insight was regarded as no insight or being unsure about the answers to all 8 questions. 
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9. The Neurological Evaluation Scale (NES) (Heinrichs & Buchanan, 1989). 
The NSS were evaluated using the Neurological Evaluation Scale (NES) (Buchanan and 
Heinrichs, 1989), which is the most widely used instrument for assessing neurological 
deficits in schizophrenia. It is a battery of 26 discrete measures of neurological soft signs, 
of which 14 items are tested and scored separately for the right and left sides of the body. 
The instrument includes representative items from the three functional areas of interest 
(functional categories).This include a sub-scale that reflect signs of motor in-coordination 
such as tandem walk, rapid alternation movements, finger to thumb opposition, and the 
finger-to-nose test. There is also sensory integration sub-scale which reflects a dysfunction 
in integration of sensory information. This sub-scale includes such signs as audiovisual 
integration, stereognosis, graphesthesia, extinction, and right to left confusion. A third 
category called sequencing of complex motor acts sub-scale reflects the ability to perform 
complex motor acts such as the first-ring test, the first-edge-palm test, the Ozeretski test, 
and rhythmic tapping test. The NES also assesses cerebral dominance, short-term memory, 
frontal release signs and eye movement abnormalities. The items are scored with reference 
to the descriptive anchors provided, on a three-point scale (no abnormality=0; mild, but 
definite impairment=1; marked impairment=2) with the exception of “suck” and “snout” 
reflexes which are scored 0 or 2. A neurological abnormality was defined as a score of 2 in 
at least one item of the NES. This is similar to the definition of an abnormality that have 
been used in previous studies of NSS in first episode schizophrenia (Browne et al, 2000., 
Zabala et al, 2006). 
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The research psychiatrist underwent training for the NES from experienced researchers in 
the standard manner and according to the instructions of the developers of the instrument. 
Each item was tested according to a fixed order. The NES assessments were conducted at 
baseline, 6 and 12 months. To reflect the diversity of neurological abnormalities in 
schizophrenia, the total NES scores and scores for the subscales were analysed separately. 
Factor analysis of the NES was also conducted and the factor scores were analysed 
separately. 
 
4.5.1 PROCEDURE 
The diagnosis of schizophrenia, schizo-affective disorder or schizophreniform disorder 
was arrived at using criteria from the Diagnostic and Statistical Manual for Mental 
Disorders-Fourth edition (DSM-IV) (American Psychiatric Association, 1994), based on 
the assessment of the research psychiatrist conducted with the use of the Structured 
Clinical Interview for the DSM-IV Axis I Disorders, Patients edition (SCID-P) (First et al, 
1994). 
 
Baseline evaluations were performed as far as possible before antipsychotic medications 
were prescribed. In the few cases where severity of psychopathology prevented immediate 
assessment, the evaluations were conducted as soon as patients were deemed well enough 
to co-operate for the examinations. The following information was obtained from all study 
participants at baseline: demographic data, personal history, psychiatric history, medical 
history, family history. All study participants underwent full physical examination at 
baseline. This was repeated at 6 months and at 12 months. 
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Psychiatric Assessment 
The severity of the baseline psychopathology was evaluated by administering the Positive 
and Negative Syndrome Scale (PANSS) (Kay et al, 1987). The overall clinical status was 
assessed using Clinical Global Impression (CGI and CGI-Severity) (Guy et al, 1976). 
Additional assessments included the Calvary Depression Scale for Schizophrenia (CDSS) 
(Addington et al, 1993), Birchwood Insight Scale (BIS) (Birchwood et al 1994), Social 
and Occupational Functioning Assessment Scale (SOFAS), and the World Health 
Organisation Quality of Life Scale (WHOQOL-BREF) (WHO, 1998).  
 
 
Pre-morbid adjustment was assessed using the Premorbid Adjustment Scale (PAS) 
(Cannon-Spoor et al, 1982), while extrapyramidal effect of antipsychotics was assessed 
using the Extrapyramidal Symptoms Rating Scale (ESRS) (Chouinard and Margolese, 
2005). These assessments were repeated at three monthly intervals for the full 12 months. 
 
4.5.2 TREATMENT 
For patients who were on medication at the time of recruitment, there was a washout 
period of 7 days during which all psychotropic medications were discontinued. The 
standard treatment for all patients was long acting flupenthixol injection. Treatment with 
oral flupenthixol 0.5mg to 4mg per day was commenced for one week before the first 
long-acting flupenthixol dose to rule out hypersensitivity to flupenthixol. The starting dose 
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of the long-acting flupenthixol was 10mg fortnightly, with 6-weekly increments of 10mg 
allowed, to a maximum of 30mg fortnightly. However, for patients aged 16 – 18 years, the 
starting dose was 5mg fortnightly. The dose interval of long-acting flupenthixol was 
increased to 4-weekly in one subject because of the development of significant 
extrapyramidal symptoms. Additional oral flupenthixol tablets were given when required, 
at the discretion of the investigator. Furthermore, lorazepam was prescribed for sedation at 
the discretion of the investigator up to a maximum dose of 12mg per day during the acute 
phase of illness. Thereafter, doses not exceeding 4mg per day were prescribed for a few 
days for some patients who required sedation. Patients also received benzhexol, and 
propranolol for treatment of emergent extrapyramidal symptoms and akathisia. However, 
patients did not receive any additional medications for at least 12 hours before each 
assessment. 
 
Concomitant medications were allowed if they were for treatment of physical conditions 
that were present before entry into the study, or developed during the course of the 
investigation. This was also at the discretion of the investigator. 
 
To ensure adherence to the treatment protocol, additional assertive monitoring was built 
into the study. The investigator, a mental health nurse, and a social worker were 
responsible for this. A good relationship was established with the patients and carers. They 
were provided psycho-education emphasising the need for continuous treatment. A 
register was kept for patients’ appointment dates. Reminders were sent out by mobile 
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phone text messaging. In the event of a missed appointment patients or their carers were 
contacted telephonically by the nurse and social worker, and encouraged to come in for 
their scheduled treatment. Where necessary, the nurse and the social worker were 
requested to conduct home visits.   
 
4.5.3. DURATION OF UNTREATED PSYCHOSIS 
Data relating to date of onset of psychosis was obtained during interviews with the patient 
and a close relative. Duration of untreated psychosis was defined as the period in months 
from the onset of psychotic phenomena to first presentation to the psychiatric unit. In line 
with previous studies, onset of psychosis was defined as the presence for one week or 
more of one of the following psychotic symptoms; delusions, hallucinations, marked 
thought disorder, marked psychomotor disorder, and bizarre, grossly inappropriate and/or 
disorganised behaviour, with a marked deterioration of functioning. 
 
4.5.4. TRAINING 
The investigator received training on the use of the above instruments at the Tygerberg 
Hospital, Cape-Town, South-Africa. Moreover, the acceptability and reliability of the 
instruments were assessed prior to commencement of the study. 
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4.6. ETHICAL APPROVAL. 
Ethical approval for the study of this cohort of patients with schizophrenia was obtained 
from the University of Ibadan/University College Hospital Joint Ethics Committee. All 
study procedures were approved by the ethical committee, in agreement with the Nigerian 
national regulation, and followed the ethical principles of the Declaration of Helsinki. The 
ethical approval covered the study of several other aspects of schizophrenia in this cohort. 
 
4.7. STATISTICAL ANALYSIS 
All data were recorded in a case record format. Statistical analysis was conducted with the 
assistance of a bio-statistician. Data analysis was performed using the Statistical Package 
for the Social sciences (SPSS) version 16.0. 
 
Descriptive statistics such as mean and standard deviation were used to summarize 
quantitative variables including the NES scores while frequencies and proportions were 
used for discrete variables. The differences between mean scores were tested using the 
student t-test, while the chi2 test was used to examine the difference between groups. The 
Fisher’s exact test was invoked appropriately. Factor analysis was conducted on NES 
items that were abnormal in more than 10% of the entire sample. Items testing for cerebral 
dominance were excluded from the factor analysis. Factors obtained following initial 
Stellenbosch University  http://scholar.sun.ac.za
  
114 
 
maximum likelihood exploration were further rotated using the varimax procedure. 
Factors are reported when they have eigenvalues greater than unity (Andreasen et al, 
1995), and when they contribute at least 10% to the cumulative variance (Sewell et al, 
2010). In subsequent analyses, two neurological abnormality scores are used:  NES total 
scores, as well as the factor derived scores. The pattern of factor derived, and total NES 
scores from repeated measurements were explored. The repeated measures Analysis of 
variance was used to compare differences in the observed NES scores. The Mauchly’s 
sphericity assumption was tested to ensure the equality of variance of the between pairs 
values, and in cases where the assumption was violated, the Greenhouse-Geisser 
correction was invoked. The patterns of scores of the functional NES categories obtained 
from repeated measurements were also investigated using the same method. 
 
 
The correlations between indices of clinical profile, and those of clinical outcome and 
NES scores were tested using Pearson’s Correlation coefficient. The data of subjects who 
fell out of the study were included in the analysis. A significant level of <0.05 was used 
throughout the study. Corrections for multiple testing were not carried out due to the 
exploratory nature of this component of the study.  
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CHAPTER FIVE 
 
RESULTS 
A total of 84 subjects were recruited into the study after an extensive clinical history and 
assessment conducted by the research psychiatrist, including the administration of the 
Structured Clinical Interview for the DSM-IV Axis I Disorders, Patients edition (SCID-P). 
The flow chart for the study is as shown in figure III. 
 
5.1. DEMOGRAPHIC CHARACTERISTICS OF SUBJECTS 
Details of the demographic characteristics of the subjects recruited are shown on Table 8. 
Age and Gender 
The sample is composed of 38 (45.24 %) women and 46 (54.76 %) men. Their mean age 
was 28.67 (±6.41) years. Female subjects were older than males at presentation (29.47 ± 
6.64 versus 28 ±6.20 years) but the difference was not statistically significant (p=0.297). 
Similarly, female subjects were older than males at onset of the illness (26.42 ± 7.00 
versus 23.15 ±8.90 years). The difference was also not statistically significant (p=0.069).  
 
Stellenbosch University  http://scholar.sun.ac.za
  
116 
 
 
Education, Marital and Employment status 
Most of the subjects, 78 (92.86%) were unemployed, and most 62 (73.81%) were single. A 
majority of them (73.81%) had at least secondary education with the rest (26.19%) having 
less than six years of formal education. 
 
5.2. CLINICAL CHARACTERISTICS OF SUBJECTS    
Tables 9 and 10 show the clinical characteristics of the subjects at baseline. 
 
The sample included 68 (80.95%) subjects with a diagnosis of schizophrenia and 15 
(17.86) with a diagnosis of schizophreniform disorder (17.86 %). Only 1 (1.19%) subject 
met DSM IV diagnosis of schizo-affective disorder (table 9).  
 
 
The overall mean age at onset of illness was 24.63 (± 8.22) years. The mean duration of 
untreated psychosis was 38.89 (± 47.69) months, with a median of 26 months. In all, 52 
(61.90%) subjects had illness duration longer than 12 months, while the remaining 32 
(38.09%) subjects were ill for less than 12 months before recruitment into the study (table 
9). The table also shows that 73 (86.90%) subjects were right handed while the remaining 
11 (13.10) were mixed handed. Only 8 (9.52%) subjects had a family history of a serious 
mental illness. A majority of the subjects 79 (94.04%) had poor insight. Lack of insight 
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was computed as the total numbers of no insight and unsure responses to all questions 
about insight (table 9). The distributions of the mean scores for pre-morbid adjustment of 
the entire sample from childhood through late adolescents are also shown on table 9.  
 
 
Table 10 shows that the overall mean baseline Positive and Negative Syndrome Scale 
(PANSS) score of the subjects was 73.38 (± 15.88). The mean score on the Social and 
Occupational Functioning Assessment Scale (SOFAS) was 44.17 (± 12.73). The mean 
score on the Clinical Global Impression (CGI) at recruitment was 5.13 (SD 0.85). In 
addition, the mean scores for the Calgary Depression Scale for Schizophrenia (CDSS), as 
well as those of the various aspects of the Extra-pyramidal Syndrome Rating Scale 
(ESRS) are shown on table 10. 
 
Table 11 compares the baseline characteristics of patients who dropped out of the study 
and those who completed the 12 month assessments. 
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Figure III: Flow chart of the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Profile of mean total 
NSS 
Baseline=22.5 
Month 6=15.2 
Month 12=14.5 
F=22.5., p-value<0.001* 
Profile of mean total 
NSS 
Baseline=17.5 
Month 6=16.9 
Month 12=14.9 
F=1.10, p-value=0.330 
5 
Declined 
84 
Completed 
baseline 
65 (77.4%) 
Completed 
month 6 
19 (22.6%) 
Dropped out 
Lost to follow-up=11 
Relocated=3 
Withdrew consent=3 
Intractable catatonia=2 
65 (77.4%) 
Completed one year 
assessments 
Profile of mean total 
NSS 
Baseline=21.5 
Month 6=15.6 
Month 12=14.6 
F=20.6., p<0.001* 
 
49 (58.3%) 
Responders  
(50% change in 
PANSS Total 
16 (19.1%) 
Non-responders 
(<50% change in 
PANSS Total 
89 
Met study criteria 
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Table 8: Baseline Demographic Characteristics of Subjects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics Mean (SD)  
 
Age (years) 
 
Male 
Female 
Total 
 
 
 
28.0 (6.20) 
29.47 (6.64) 
28.67 ( 6.41) 
 
 
Characteristics 
 
Gender  
 
Male 
Female 
Total 
Number 
 
 
 
46 
38 
84 
Percent 
 
 
 
54.76 
45.24 
100.00 
 
Education 
 
Elementary 
Secondary 
Tertiary 
Total 
 
 
22 
31 
31 
84 
 
 
26.19 
36.90 
36.90 
100.00 
 
Marital Status 
Never Married 
Married 
Total 
 
 
 
62 
22 
84 
 
 
 
73.81 
26.19 
100.00 
 
Employment Status 
Unemployed 
Employed 
Total 
 
 
 
78 
6 
84 
 
 
 
92.86 
7.14 
100.00 
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Table 9. Clinical Characteristics of Subjects at Baseline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics Mean (SD) 
 
Median 
 
Age at Onset (years) 
 
Male 
Female 
All 
 
 
 
23.15 (8.90) 
26.42 (7.00) 
24.63 (8.22) 
 
 
 
 
Duration of Untreated Psychosis (Months) 
 
 
 
 
38.89 (47.67) 
 
 
26.00 
 
 
Characteristics 
 
Family History of Mental Illness  
 
Yes 
No 
Number 
 
 
 
8  
76  
Percent 
 
 
 
9.52 
90.48 
 
Handedness  
 
Right  
Mixed 
 
 
 
73  
11  
 
 
 
86.90 
13.10 
 
DSM IV Diagnosis  
 
Schizophrenia 
Paranoid type 
Undifferentiated 
Disorganized type 
Catatonic type 
Simple 
 
Schizophreniform Disorder 
 
Schizo-affective Disorder 
 
 
 
 
68  
30  
20  
15  
2  
1  
 
15  
 
1  
 
 
 
80.95 
35.71 
23.89 
17.86 
2.38 
1.19 
 
17.86 
 
1.19 
Insight  
 
Yes 
No  
Unsure 
 
 
5  
10  
69  
 
 
5.95 
11.90 
82.14 
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Table 10. Baseline Clinical Assessment Scores 
Scales Mean Standard  
Deviation 
Range 
 
Positive and Negative Syndrome Scale 
(PANSS) 
Positive 
Negative 
Disorganized/cognitive 
Excited 
Depression/anxiety 
Total 
 
 
11.79 
19.92 
19.68 
12.43 
5.82 
73.32 
 
 
4.86 
9.98 
7.00 
4.85 
3.02 
15.89 
 
 
4 - 23 
7 - 42 
7 - 34 
5 – 25 
4-15 
37-108 
 
Pre-morbid Adjustment Scale (PAS) 
 
Childhood 
Social/ Academica 
Early Adolescent 
Social/ Academicb 
Late Adolescent 
Social/ Academicb 
 
 
 
1.79/ 3.24 
 
3.77/ 3.34 
 
3.77/3.34 
 
 
 
2.85/2.73 
 
4.13/2.67 
 
4.13/2.67 
 
 
 
0-11/0-12 
0-15/0-12 
0-15/0-12 
Clinical Global Impression-severity (CGI-S) 5.13 0.85 3 – 7 
Social and Occupational Functioning 
(SOFAS) 
44.17 12.73  
Calgary Depression Scale of Schizophrenia  
(CDSS)a 
1.69 3.37 0 – 15 
 
Neurological Evaluation Scale (NES) 
 
Sensory Integration 
Motor Co-ordination 
Motor Sequencing 
Total NES 
 
 
 
2.99 
5.71 
4.63 
21.48 
 
 
 
1.87 
3.95 
2.00 
11.11 
 
 
 
0 – 6 
0 – 13 
0 – 6 
2 – 44 
 
a = One observation missing 
b = Four observations missing 
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Table 11. Comparison of the baseline characteristics of completers and drop-out 
subjects  
 
a = Fisher’s exact test 
Characteristics Drop-out 
N=19 
Completers 
N=65 
2 p-value 
 
Gender (%) 
Male 
Female 
 
 
       57.89 
42.11 
 
 
       53.85 
46.15 
 
0.097 
 
0.755 
 
Marital status (%) 
Never married 
Married 
 
 
       78.95 
21.05 
 
 
72.31 
27.69 
 
0.335 
 
0.768 a 
 
Education (%) 
Elementary 
Secondary or higher 
 
 
26.32 
73.68 
 
 
26.15 
73.84 
 
0.0002 
 
1.000 
 
DSM IV diagnosis (%) 
Schizophrenia 
Other psychosis 
 
 
73.68 
26.32 
 
 
84.62 
15.38 
 
7.155 
 
0.069 
 
Insight (%) 
Present 
Absent 
 
 
15.79 
84.21 
 
 
3.08 
96.92 
 
4.244 
 
0.074 a 
Characteristics. Mean (SD)   t-test p-values 
 
Age at presentation.  
 
28.74 (5.77) 
 
28.65 (6.63) 
 
0.054 
 
0.957 
Duration of Untreated Psychosis 27.32 (35.5) 39.35 (56.0) 0.885 0.379 
Positive and Negative Syndrome 
Scale (PANSS) 
69.95 (2.94) 74.35(2.06) 1.072 0.287 
Clinical Global Impression (CGI) 4.95 (0.21) 5.19 (0.10) 1.075 0.286 
Social and Occupational Functioning 
(SOFAS) 
44.63 (2.97) 44.03 (1.58) 0.180 0.858 
Neurological Evaluation Scale (NES) 22.21(10.4) 22.26 (11.4) 0.356 0.745 
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5.3. PROFILE OF NEUROLOGICAL SOFT SIGNS (NSS) 
The mean Neurological Evaluation scale (NES) score for a total of 26 items in the entire 
sample was 21.48 (± 11.11), with the scores ranging from 2 to 44. A higher mean score 
was recorded for items conceptually regarded as representing motor co-ordination (5.71 ± 
3.95, range 0-13)  and motor sequencing abnormalities (4.63 ± 2.0, range 0-6)  as 
described in the study methodology (Table 9). There was a mean score of 2.99 (± 1.87; 
range of 0-6) for items that represent sensory integration functions. These three functional 
areas of interest are subsequently referred to in this dissertation as the ‘functional 
categories’, as distinct from the empirically derived categories of NSS.  
 
 
 Neurological abnormality, defined as the rating of at least 2 on any   1 item on the NES, 
was elicited in 81 (96.43%) subjects in the sample. This definition is based on that of 
Browne et al. (Browne et al, 2000). It has been used in subsequent studies of NSS in first 
episode schizophrenia (Zabala et al, 2006., Dazzan et al, 2008).  
 
 
5.4. FACTOR ANALYSIS OF THE NEUROLOGICAL EVALUATION SCALE 
(NES) 
Exploratory factor analysis of the baseline Neurological Examination Scale (NES) scores 
was conducted using the methods of previously reported  works dealing on  Neurological 
Soft Signs (NSS) in schizophrenia (Malla et al, 1997., Sanders et al, 2000, Keshavan et al, 
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2003., Emsley et al, 2005.,  Compton et al, 2006., Sewell et al, 2010). Items that were 
present in less than 10% of the entire sample were eliminated. These included NES items 
2, 4, 5, 9, 11, 23, 24, and 26. Items that test for cerebral dominance (NES 5 a, b, and c) 
were also eliminated from the factor analysis. This was necessary as cerebral dominance is 
not regarded as an abnormal NSS. It is included in the NES for the purpose of determining 
the dominant side of subjects, information that is useful in the examination of bilaterally 
occurring signs where the dominant side is required to be tested first. The following 18 
NES items were included in the analysis after the eliminations as described; 1, 3, 6, 7, 8, 
10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, and 25 (table 12 ). The maximum likelihood 
factors were rotated using the varimax procedure. The factors were derived according to 
the following criteria;  
1). Eigenvalue greater than unity (Andreasen et al, 1995), and  
2). A total of 10% variance contributed by each factor (Sewell et al, 2010)  
 
 
The first five NES factors had eigenvalues greater than unity and accounted for 61.9 % of 
the total variance. However, only the first 4 factors contributed up to 10% variance 
individually. These four factors accounted for 54.1% of the total variance (table 13). The 
table also shows the results of the principal component matrix with the factor loadings of 
the analysis after orthogonal varimax rotation. 
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The first factor which contributed 18% to the cumulative variance is comprised of audio-
visual integration, fist-edge-palm, rhythm tapping, extinction, and right-left confusion. 
The fist-edge palm test for functions associated with sequencing of complex motor acts. 
The rhythm tapping test has also been associated with such functions by some other 
authors (e.g, Bombin et al, 2005). The remaining components of factor 1 are items that test 
for perceptual functions. Factor 2 comprised of items testing synkinesis, convergence, and 
gaze impersistence. This factor is unique as it represents eye movement abnormalities in 
schizophrenia. Factor 3 includes tandem walk, adventitious flow and graphaesthesia. 
Whereas tandem walk and adventitious flow are items that test for primary motor 
functions, graphaesthesia is recognizable as a sensory integration function. Factor 4 
comprises of stereognosis, another sensory integration function. 
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Table 12. Prevalence and mean baseline Severity scores of NES Items   
NES Items Number Percent Mean Standard 
deviation 
Audiovisual integration 45 53.6 1.21 0.91 
Fist-edge-palm 60 71.4 1.56 0.77 
Rythm tapping 47 56.0 1.29 0.87 
Extinction 32 38.1 0.91 0.93 
Right/left confusion 41 48.1 1.19 0.87 
Synkinesis 22 26.2 0.70 0.86 
Convergence 22 26.2 0.75 0.85 
Gaze impersistence 30 35.7 0.93 0.89 
Tandem Walk 14 16.7 0.50 0.77 
Adventitious flow 5 6.0 0.24 0.55 
Graphaesthesia 44 52.4 1.26 0.85 
Stereognosis 15 17.9 0.51 0.78 
Memory 63 75.0 1.30 0.82 
Rapid alternating movements 25 29.8 0.77 0.88 
Finger/thumb opposition 30 35.7 0.87 0.92 
Mirror movement 16 19.0 0.51 0.80 
Finger to nose test 15 17.9 0.57 0.78 
Grasp reflex 21 25.0 0.50 0.87 
Total NES score 84 100 21.5 11.1 
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           Table 13. Factor structure of the NES Items 
 
NES Items 
                                                       Factors 
1 2 3 4 
Audiovisual integration 0.6179 0.3813     0.1862     0.0691 
Fist-edge-palm 0.8403 -0.0635    -0.0507     0.0175 
Rythm tapping 0.6279 0.4463     0.3077     0.0460 
Extinction 0.6112 0.2675     0.2758     0.2573 
Right/left confusion 0.5355 0.1595     0.3305     0.0876 
Synkinesis -0.0250    0.7128 0.2598     0.2451 
Convergence 0.1743     0.7300 -0.0335    -0.0300 
Gaze impersistence 0.2665     0.6417 -0.1330    -0.1574 
Tandem Walk 0.1647    -0.0166     0.6718 0.0700 
Adventitious flow 0.1534     0.0558     0.7188 -0.0706 
Graphaesthesia 0.0702     0.3899     0.5443 0.2191 
Stereognosis 0.2321     0.1389     0.0706     0.8562 
Memory 0.4459     0.1318     0.3792     0.3235    
Rapid alternating 
movements 
0.3139     0.4897     0.1705     0.3702    
Finger/thumb opposition 0.4290     0.4148     0.2145     0.3418     
Mirror movement 0.3394     0.3911     0.1305     0.3925     
Finger to nose test 0.0312     0.1174     0.1409     0.0929     
Grasp reflex 0.3895     0.2048     0.1155    -0.6424     
Explained variance (%) 18.1 15.5 10.4 10.1 
Severity. Mean (SD) 6.44 (3.3) 2.38 (2.0) 2.00 (1.6) 0.51 (0.8) 
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5.5. TEMPORAL STABILITY OF NEUROLOGICAL SOFT SIGNS  
To examine the longitudinal profile of the Neurological Soft Signs (NSS) across the one 
year course of schizophrenia, the mean total and sub-scale scores on the Neurological 
Evaluation Scale (NES) at baseline, month 6, and month 12 were compared. A repeated 
measures analysis of variance (ANOVA) of the NES scores across these three time periods 
was conducted for both the empirically derived factors of the NES and the functional 
categories of the NSS. The NES total score was also included in this analysis. 
 
 
Table 14 shows the results of the repeated measures ANOVA for the total NES score, the 
derived NSS factors as well as the ‘functional’ categories of NSS. The mean scores for 
factor 1 of this study (Perceptual and motor sequencing) was not significantly different 
across the three time periods of baseline, month 6 and month 12 (F= 1.262, p=0.287). The 
sphericity assumption was also not violated (sig. 0.130) (Table 14). However, the mean 
scores of the other derived NES factors changed significantly between the three time 
periods. The sphericity assumption was violated for factor 4 (sig <0.0001) (table 14). 
When the functional categories of the NSS were considered, the mean scores for 
sequencing of complex motor acts category did not change significantly from baseline 
through month 6 to month 12 (F=1.870, p=0.158). The sphericity assumption was also not 
violated (sig = 0.372) (table 14). The mean scores for the remaining two functional 
categories changed considerably across the same time frame. The sphericity assumption 
was violated for the motor co-ordination category (sig <0.0001) (table 14). The mean total 
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NES scores also changed considerably over time (F=20.56, p<0.0001). The sphericity 
assumption for equal variance was also violated (sig=0.006) (table 14). 
Stellenbosch University  http://scholar.sun.ac.za
  
130 
 
         Table 14. Repeated Measures ANOVA of the mean scores for total NES, derived factors, and functional categories 
across three time periods (Baseline, month 6, and month 12) 
 
 
          Asterisks *= Non-significant repeated Measures ANOVA 
 
          NES= Neurological Evaluation Scale 
 
 
Baseline 
 
Month 6 
 
Month 12 
 
Sphericity 
test 
significance 
 
F-test 
 
P-value 
 Mean S.D Mean  S.D Mean S.D 
 
Factor 1 
 
6.400 
 
3.436 
 
5.723 
 
3.731 
 
6.000 
 
3.640 
 
0.130 
 
1.262 
 
0.287* 
Factor 2 2.400 1.983 1.615 1.608 1.369 1.626 0.120 11.32 <0.001 
Factor 3 2.062 1.590 1.508 1.214 1.415 1.158 0.054 7.286 0.001 
Factor 4 0.539 0.792 0.292 0.631 0.769 0.322 0.000 10.98 <0.001 
Sensory 
integration 
3.108 1.905 2.123 1.526 2.062 1.519 0.291 14.64 <0.001 
 
Motor  
co-ordination 
 
5.723 
 
4.049 
 
3.631 
 
3.476 
 
3.508 
 
3.317 
 
0.001 
 
15.14 
 
<0.001 
 
Motor 
Sequencing 
 
4.539 
 
2.092 
 
4.000 
 
2.264 
 
4.139 
 
2.297 
 
0.372 
 
1.870 
 
0.158* 
 
NES total 
 
21.48 
 
11.11 
 
15.62 
 
9.661 
 
14.62 
 
8.732 
 
0.006 
 
20.56 
 
<0.001 
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Figure IV: Repeated Measures ANOVA of the mean scores for the derived factors 
across three time periods (Baseline, month 6, and month 12) 
 
 
 
Note: The derived factor 1 is relatively stable across the three time periods 
regardless of the clinical profile of the schizophrenia 
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Figure V: Repeated Measures ANOVA of the mean scores for total NES, and the 
functional categories across three time periods (Baseline, month 6, and month 12) 
 
 
 
Note: The motor sequencing NSS appear stable across the three time periods 
regardless of the clinical profile of schizophrenia 
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5.6. RELATIONSHIP BETWEEN NEUROLOGICAL SOFT SIGNS AND THE    
CLINICAL CHARACTERISTICS OF SCHIZOPHRENIA 
Tables 15 a and b summarise the relationship between the empirically derived factors as 
well as the ‘functional’ categories of neurological soft signs (NSS) and the clinical 
characteristics of schizophrenia. There were no significant correlations between the 
empirically derived factors and the age at onset, duration of untreated psychosis (DUP), 
or the pre-morbid adjustment of patients in the sample (Table 15 a). Similarly there were 
no significant differences between the age at onset, duration of untreated psychosis 
(DUP), or the pre-morbid adjustments (Social or academic) of patients with a higher 
mean number of (NSS), defined here and after by a score above the mean Neurological 
Evaluation Scale (NES) total score, and those with a lower number, defined here and 
after by a score below the mean total NES score. The mean total NES score was 21.5 
(Table 15 b). This categorization of the NES total score by a split at the mean score was 
done in accordance with the method described in some previous studies of neurological 
soft signs in first episode psychosis in which the NES had been used (e.g, Ruiz-Veguilla 
et al, 2009).  
 
Sensory integration abnormalities as a ‘functional’ category correlated significantly and 
inversely with the age at onset of schizophrenia (r= -0.22, p=0.040) (table 15 a). Other 
than the motor sequencing ‘functional’ category which correlated significantly with the 
depression/anxiety factor of the Positive and Negative Syndrome Scale (PANSS) (r=0.29, 
p=0.007), the other ‘functional’ categories, the empirically derived factors, as well as the 
Stellenbosch University  http://scholar.sun.ac.za
  
134 
 
NES total score correlated significantly with the negative as well as with the 
cognitive/disorganised factors of the PANSS (table 15 a). Similarly, the derived factors 1 
and 2, the NES total score, as well as the motor co-ordination ‘functional’ category 
correlated significantly with the excitement/hostility factor of the PANSS (table 15a). In 
all, the total baseline NES score, the functional categories, as well as the derived factors 
correlated significantly and positively with the severity of the disease as rated by the 
Clinical Global Impression scale (CGI-severity) (table 15a). Similarly, there was a 
significant difference in symptom  severity of schizophrenia between patients with a 
higher mean number of NSS and those with a lower number of NSS, with the former 
tending to have a higher mean severity score  compared to the latter (t=5.21, p<0.001) 
(table 15b). In summary, while the baseline motor sequencing scores had no association 
with the clinical characteristics of schizophrenia, the total NES scores, as well as the 
scores for the other major sub-categories correlated with a more severe psychopathology 
especially in terms of negative and cognitive/disorganization symptoms. The NES total 
score, the motor co-ordination functional category as well as the derived factors 1 and 2 
also correlated with the excitement/hostility factors of the PANSS.  
 
 
Baseline NSS did not correlate significantly with the development of depression over 
time (r=0.031, p=0.803., r=-0.008, p=0.953, for Months 6 and 12 total NES respectively) 
(table 15a). However, there was a significant inverse correlation between baseline motor 
sequencing ‘functional’ category signs and treatment emergent extra-pyramidal 
symptoms at 6 months and at 12 months (r= -0.27, p=0.033., r= -0.27, p=0.033, 
respectively) (tables 15a).  
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Table 15a. Pearson correlation of baseline NSS and the clinical characteristics of schizophrenia 
 
 DERIVED NES FACTORS NES FUNCTIONAL CATEGORIES 
 1 
Perceptual/ 
motor 
sequencing 
2 
Eye signs 
 
3 
Motor 
coordination 
/graphaesthesia 
4 
Stereognosis 
Sensory 
Integration 
Motor 
coordination 
Motor 
Sequencing 
NES Total 
Age at onset -0.079 0.023 -0.050 -0.180 -0.224* -0.034 0.202 -0.004 
 
D.U.P 
 
0.037 
 
-0.021 
 
0.116 
 
-0.042 
 
-0.006 
 
-0.005 
 
0.016 
 
-0.005 
 
Pre-morbid 
adjustment 
CHILDHOOD 
(Social/academic) 
ADOLESCENT 
(Social/academic) 
 
 
 
0.019/0.123 
 
0.067/-0.011 
 
 
 
0.075/0.120 
 
0.045/-0.132 
 
 
 
0.003/-0.051 
 
-0.006/-0.055 
 
 
 
0.074/0.078 
 
0.059/0.052 
 
 
 
0.029/0.010 
 
0.031/0.069 
 
 
 
0.051/0.136 
 
0.116/-0.082 
 
 
 
0.031/0.158 
 
0.088/0.061 
 
 
 
 
0.034/0.101 
 
0.039/-0.081 
 
PANSS 
Positive 
Negative 
Disorganized 
Excited 
Depression 
 
 
-0.058 
0.472** 
0.525** 
0.238* 
0.157 
 
 
0.010 
0.328** 
0.384** 
0.224* 
0.090 
 
 
-0.072 
0.239* 
0.305** 
0.204 
0.113 
 
 
-0.080 
0.302** 
0.349** 
-0.036 
0.009 
 
 
-0.020 
0.412** 
0.463** 
0.030 
0.128 
 
 
-0.102 
0.493** 
0.567** 
0.272* 
0.107 
 
 
0.211 
0.069 
0.173 
0.145 
0.293** 
 
 
-0.075 
0.456** 
0.559** 
0.228* 
0.169 
 
CGI-severity 
 
0.558** 
 
0.506** 
 
0.228* 
 
0.297** 
 
0.388** 
 
0.555* 
 
0.420** 
 
0.566** 
 
CDSS 
Baseline 
Month 6 
Month 12 
 
 
0.065 
0.051 
-0.009 
 
 
0.020 
-0.027 
-0.101 
 
 
0.134 
0.138 
0.240 
 
 
0.076 
-0.059 
-0.060 
 
 
0.155 
0.040 
-0.031 
 
 
-0.0004 
0.038 
-0.021 
 
 
0.137 
-0.021 
-0.017 
 
 
0.095 
0.031 
-0.008 
ESRS 
Month 6 
Month 12 
 
-0.138 
0.032 
 
-0.100 
-0.045 
 
-0.004 
0.049 
 
-0.138 
-0.070 
 
-0.135 
0.077 
 
-0.099 
-0.038 
 
-0.269* 
-0.265* 
 
-0.154 
-0.056 
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Significant Pearson Correlation Coefficient; *<0.05, **<0.01 
PANSS= Positive and Negative Syndrome Scale, CGI= Clinical Global Impression, CDSS= Calgary Depression Scale of 
Schizophrenia, ESRS= Extra-pyramidal Symptoms Rating Scale 
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Table 15b. Relationship between baseline NES total score and clinical characteristics  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                      Asterisk * = Significant p-value of an unpaired t-test 
 
                     CGI= Clinical Global Impression 
                     CDSS= Calgary Depression Scale of Schizophrenia 
                     D.U.P= Duration of Untreated Psychosis
Characteristics  NES score  
<21.5 (n=43) 
NES score 
21.5 (n=41) 
Statistics p-value 
 
Age at onset 
 
24.93 
 
24.32 
 
0.340 
 
0.735 
 
D.U.P (In months) 
 
35.02 
 
38.32 
 
0.288 
 
0.774 
 
Pre-morbid 
Adjustments 
CHILDHOOD 
(Social/academic) 
ADOLESCENT 
(Social/academic) 
 
 
 
 
1.81/2.98 
 
3.61/3.40 
 
 
 
 
1.78/3.51 
 
3.95/3.27 
 
 
 
 
0.053/0.895 
 
0.382/0.208 
 
 
 
 
0.957/0.374 
 
0.703/0.836 
 
CGI-severity 
 
4.72 
 
5.56 
 
5.210 
 
<0.001* 
 
CDSS  
Baseline 
Month 6 
Month 12 
 
 
1.42 
1.58 
1.29 
 
 
1.98 
1.94 
2.49 
 
 
0.750 
0.458 
1.356 
 
 
0.455 
0.648 
0.180 
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5.7. NEUROLOGICAL SOFT SIGNS AND OUTCOME OF SCHIZOPHRENIA 
Outcome was assessed in terms of symptom reduction and percentage change in the 
Positive and Negative Syndrome Scale (PANSS) scores between baseline and month 12. 
Additional measurements of outcome such as functioning, quality of life and the 
development of insight overtime were also employed. Table 16 shows the response rate 
measured on the PANSS from baseline to month 12. Response rate was defined as at least 
50% or more reduction in the PANSS scores from baseline to month 12. In all, 75.8% of 
the subjects who completed month 12 assessments met the criteria for response using this 
definition. Apart from the PANSS depression scores on which a response rate of 18.1% as 
defined was observed, the other PANSS subscales scores had a response rate of over 60% 
at one year follow-up. Up to 78.8% of the subjects had at least 50% reduction in the 
scores for cognitive/ disorganization factor of the PANSS from baseline to month 12 
(table 16).  
 
There were  significant differences in the percentage change in PANSS negative, 
disorganization, and total  scores between patients with higher mean number of 
Neurological Soft Signs (NSS) and those with a lower number of NSS at baseline (Table 
17 a). Baseline scores for the derived NES factors 1, 2 and 3 correlated significantly and 
positively with the percentage change in the PANSS negative symptoms scores from 
baseline to month 12. Also,  baseline scores for factors 1 and 4 correlated significantly 
and positively with the percentage change in the PANSS cognitive/disorganized scores 
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from baseline to month 12 (table 17b). In all, baseline scores for the derived NES factors 
1, 2 and 4 correlated significantly and positively with the percentage change in the 
PANSS total scores from baseline to month 12 (table 17 b). In the case of the functional 
categories of the NES, table 17b reveals a similar pattern for the PANSS negative and 
cognitive/disorganization sub-scale. The baseline scores for the sensory integration, 
motor coordination and the NES total scores correlated significantly and positively with 
the percentage change in the PANSS negative and cognitive/disorganization scores from 
baseline to month 12 (table 17 b). Interestingly, there were no correlation between the 
baseline motor sequencing category scores and the percentage change in the PANSS total 
or sub-scale scores from baseline to month 12 (table 17 b).  
 
Table 17a also shows that subjects with a higher number of baseline NSS tended to have 
a significantly lower rating of functioning, as measured with the SOFAS, at month 6 and 
month 12 (p=0.02 and p=0.04 respectively) (table 17a). However, while baseline scores 
for the derived factors 1 and 3 correlated significantly and inversely to the ratings of the 
functioning at month 6, only the baseline scores for the derived factor 3 correlated with 
the functioning at month 12 (table 17 b). In the case of the functional categories, it was 
observed that while the baseline scores for sensory integration, motor co-ordination and 
the NES total scores correlated significantly with a lower rating for functioning at month 
6, only the baseline sensory integration scores correlated significantly with a poorer level 
of functioning at month 12. (table 17b). As it was with the PANSS rating for 
psychopathology, the motor sequencing scores at baseline did not show significant 
correlation with functioning at any stage of the disease as measured in this study. 
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Similar to what was found for functioning, the baseline score of the derived factor 3  
correlated significantly with a poorer rating on both the total quality of life domain of the 
WHO-QoL and the month 12 rating for the psychological health domain (table 17b). The 
derived factor 3 represents motor coordination/graphaestheia. Interestingly, when 
considering the functional categories, only the baseline score for motor coordination 
correlated with a poorer rating of quality of life at month 12. Specifically, this correlation 
was significant for the psychological health domain of the WHO-QoL (table 17 b). Also 
similar to what was observed for functioning, the baseline motor sequencing scores did it 
show correlations with the quality of life ratings. Therefore, while the motor sequencing 
signs had no bearing on the outcome of schizophrenia, the motor co-ordination scores at 
baseline is associated with a poorer quality of life at one year (table 17 a). Also, a 
preponderance of NSS at baseline is associated with poorer ratings of functioning at 
month 6 and month 12 (tables 17a and b). Functioning was rated by means of the Social 
and Occupational Functioning Scale (SOFAS), while quality of life was rated using the 
brief version of the World Health Organization Quality of Life rating measure (WHO-
QOL-BREF).  
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Table 16. Twelve month clinical Response of subjects as measured on the PANSS 
 
PANSS category <50% reduction 50% reduction 
 N % N % 
 
Positive 
 
20 
 
30.3 
 
45 
 
69.7 
Negative 24 36.4 41 63.6 
Cognitive /disorganized 14 21.2 51 78.8 
Excitement/hostility 22 33.3 44 66.7 
Depression/anxiety 53 81.8 12 18.2 
Total 16 24.2 49 75.8 
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Table 17a. Relationship between baseline NES total score and the 12 
month    outcome of schizophrenia 
 
 
 NES<21.5 NES21.5 t-test p-value 
PANSS  
(Percentage change) 
Positive 
Negative 
Disorganized 
Hostility 
Depression 
Total 
 
 
160.4 
68.16 
106.6 
91.90 
25.16 
87.25 
 
159.3 
168.6 
154.2 
125.2 
26.40 
125.1 
 
0.035 
3.237 
2.108 
1.144 
0.084 
2.487 
 
 
0.973 
0.002** 
0.039* 
0.154 
0.933 
0.016* 
 
SOFAS (means) 
Month 6 
Month 12 
 
 
 
 
BIS. % 
Month 6 
Month 12 
 
 
76.14 
80.18 
 
 
NES <21.5 
 
 
6.25 
3.13 
 
 
67.72 
72.72 
 
 
NES21.5 
 
 
0.00 
9.09 
 
 
2.14 
2.07 
 
 

2
 
 
 
3.000 
1.002 
 
 
0.019* 
0.043* 
 
 
p-value 
 
 
0.223 
0.606 
 
    
 
WHO-QOL. % 
Physical Health 
Psychological Health 
Social relationships 
Environment 
Total 
 
 
22.90 
20.77 
9.07 
27.26 
80.24 
 
 
23.33 
19.55 
7.93 
26.90 
77.25 
 
 
0.545 
1.967 
1.587 
0.420 
1.201 
 
 
0.588 
0.054* 
0.118 
0.676 
0.235 
 
                    Asterisks *= p 0.05., **=p<0.01 
 
                   PANSS= Positive and Negative Syndrome Scale 
                   BIS= Birchwood Insight Scale 
                   SOFAS= Social and Occupational Functioning Scale 
                   WHO-QOL= World Health Organization- Quality of Life 
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                Table 17 b. Pearson correlation of baseline NSS and the outcome of schizophrenia 
 
                Significance of Pearson correlation coefficient= * p<0.05., ** p<0.01 
                PANSS= Positive and Negative Syndrome ScaleSOFAS= Social and Occupational Functioning Scale 
                WHO-QOL-BREF= Brief version of the World Health Organization- Quality of Life
 DERIVED NES FACTORS NES FUNCTIONAL CATEGORIES 
Characteristics 1 
Percptual/ 
motor 
sequencing 
2 
Eye 
signs 
3 
Motor 
coordination/
graphaesthesi 
4 
Stereognosis 
Sensory 
Integration 
Motor 
coordination 
Motor 
Sequencing 
NES Total 
PANSS 
(percentage change) 
Positive 
Negative 
Disorganized 
Excited 
Depression 
Total 
 
 
-0.065 
0.327** 
0.318** 
0.125 
0.142 
0.311* 
 
 
0.094 
0.249* 
0.149 
0.141 
0.135 
0.264* 
 
 
-0.056 
0.261* 
0.147 
0.069 
-0.021 
0.178 
 
 
0.093 
0.229 
0.341** 
0.013 
0.036 
0.251* 
 
 
0.004 
0.251* 
0.276* 
0.007 
0.049 
0.226 
 
 
-0.055 
0.448** 
0.372** 
0.178 
0.140 
0.407** 
 
 
0.117 
0.186 
0.145 
0.076 
0.239 
0.198 
 
 
-0.008 
0.401** 
0.345* 
0.134 
0.157 
0.374** 
 
SOFAS 
Month 6 
Month 12 
 
 
-0.352** 
-0.207 
 
 
-0.232 
-0.124 
 
 
-0.466** 
-0.268* 
 
 
-0.148 
-0.138 
 
 
-0.431** 
-0.270* 
 
 
-0.335* 
-0.161 
 
 
-0.141 
0.015 
 
 
-0.349** 
-0.171 
 
WHO-QOL-BREF % 
Physical Health 
Psychological Health 
Social relationships 
Environment 
Total 
 
 
0.098 
-0.175 
-0.223 
0.100 
-0.124 
 
 
-0.009 
-0.168 
-0.014 
0.129 
-0.005 
 
 
-0.207 
-0.318* 
-0.250 
-0.192 
-0.360** 
 
 
0.036 
-0.009 
0.026 
0.137 
0.123 
 
 
-0.068 
-0.091 
-0.214 
0.025 
-0.156 
 
 
0.070 
-0.258* 
-0.187 
0.054 
-0.096 
 
 
0.163 
-0.134 
0.054 
0.225 
0.078 
 
 
0.072 
-0.234 
-0.175 
0.071 
-0.109 
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Figure VI: NES and the percentage change in the PANSS ratings from baseline to 
month 12 
 
*= p<0.05., **= p<0.01., NES = Neurological evaluation scale., PANSS= Positive and 
negative syndrome scale 
Note: Baseline NSS were unrelated to change in positive or depression symptoms
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Figure VII: Baseline NES total score and the 12 month outcome of schizophrenia 
 
 
 
 
 
 
 
SOFAS= Social and occupational functioning scale 
WHO-QoL= Brief version of the World Health Organization quality of life scale 
 
Note: Baseline NSS was related to a poorer rating of functioning and quality of life 
at month 12 
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CHAPTER SIX 
 
DISCUSSION 
Neurological abnormalities are an important subset in the heterogeneous manifestation of 
schizophrenia. Their importance is derived from their potential as easy-to-measure 
vulnerability indicators of schizophrenia. They have also been suggested as correlates of 
both clinical and functional outcome. The most convincing evidence for these assertion 
comes from prospective longitudinal studies of first episode patients with the disease, or 
from studies of those without prior exposure to antipsychotic treatments (Dazzan et al, 
2004., Emsley et al,  2005). Other evidence come from studies of first degree relatives of 
schizophrenia patients (Neelam et al, 2011., Mechri et al, 2009) or those investigating 
patients with schizophrenia spectrum disorders (Cuesta et al, 2002., Chan and 
Gottessman, 2008). Such studies are few and far between in the African continent. There 
is at least one longitudinal study of NSS in a cohort of predominantly mixed South-
African first episode schizophrenia patient (Emsley et al, 2005), and another among a 
cohort predominated by African-Americans (Compton et al, 2006). Globally, the existing 
evidence has been based on wholly Caucasian populations or mixed population of 
Caucasians and other races. The present study describes the profile of NSS across the one 
year course of schizophrenia, as well as their relationship with a wide range of illness and 
outcome variables in a group of first episode, largely medication-naïve Yoruba Nigerians 
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with the disease. Neurological assessment in this study was based on the 26 item 
Neurological Evaluation Scale (NES). The items on this scale have been previously 
reduced to three main sub-scales of ‘meaningful’ theoretical and functional significance.  
 
 
6.1. SUMMARY OF MAIN FINDINGS 
The following findings were demonstrated in chapter five; 
 
1. Neurological soft signs (NSS) were already present at a high rate in this cohort of 
patients with first episode schizophrenia or schizophreniform disorder, even before the 
introduction of antipsychotic drugs. 
 
 
2. Neurological soft signs (NSS) demonstrated in this cohort, using the Neurological 
Evaluation Scale (NES), comprised of four empirical factors derived by the method of 
factor analysis: perceptual and motor sequencing, eye movements, motor co-ordination 
and graphaesthesia, as well as stegreognosis. 
 
 
3. Some NSS categories exhibited a relative stability across the 12-month course of 
schizophrenia, and across three measurements. This was true for signs in the derived 
perceptual and motor sequencing category, as well as those in the motor sequencing 
functional category. 
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4. The motor sequencing signs were not associated with the clinical characteristics of 
schizophrenia. Other signs were associated with a predominant negative, and 
disorganization psychopathology. A preponderance of NSS was also associated with more 
severe schizophrenia psychopathology. 
 
 
5. Baseline motor sequencing signs were also not associated with the outcome of 
schizophrenia. This was true when outcome was considered in terms of percentage 
change in psychopathology ratings from baseline through month 12, functioning, or 
quality of life. However, a higher cumulative number of NSS was associated with poorer 
outcome in terms of functioning and quality of life. Motor co-ordination NSS (functional 
or empirical) at baseline were especially associated with poor quality of life at one year. 
 
 
These findings will be discussed within the context of the strengths and limitations of this 
study. The findings were made from the study of a sample comprising of men and women 
with first episode of mental illness diagnosed as mostly schizophrenia, or 
schizophreniform disorder using a structured interview according to the criteria codified 
in the Diagnostic and Statistical Manual for mental disorders (DSM IV) (American 
Psychiatric Association, 1994). The sample is derived from a homogenous population of 
black Africans native to the continent, and to the best of the knowledge of the 
investigator, it is the first to generate data on a comprehensive range of neurological 
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abnormalities in schizophrenia as it presents in this population. To achieve clinical 
homogeneity, only patients aged 16years to 45 years were included. Efforts were made to 
exclude patients with major medical or psychiatric co-morbidities. Patients were also 
mostly anti-psychotic naive, with only 5 (6.0%) subjects in the entire sample having a 
lifetime exposure to oral antipsychotic medication of one month or less before 
recruitment. Also, patients were treated with a uniform dose of flupenthixol depot 
according to a fixed protocol. Using a depot antipsychotic removed the important 
potential confounder of covert non-adherence. The study is designed as a prospective 
longitudinal investigation with repeated cross-sectional assessments at several critical 
time periods in the one year course of schizophrenia. These assessments were done using 
an array of validated measures targeting several aspects of a multi-dimensional disorder 
like schizophrenia. This report describes the profile of NSS across the one year course of 
the disease without relying on a single method of classifying the signs. In this way, 
empirically derived sub-sets of NSS were followed up longitudinally and in parallel with 
the functional categories of these signs classified in theory by Buchanan and Heinrichs 
(Buchanan and Heinrichs, 1989), as well as the total NES score. This was so as to 
separate NSS with trait-like characteristics for schizophrenia from those that have state 
defining features for a certain profile of the disease. 
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6.2. BASELINE CHARACTERISTICS OF SUBJECTS 
6.2.1. BASELINE DEMOGRAPHIC CHARACTERISTICS  
There were slightly more males than females meeting the inclusion criteria and hence 
recruited into this study. The male to female ratio was 1.2 to 1. Earlier studies of the 
epidemiology of schizophrenia as well as the information documented in Diagnostic and 
Statistical Manuals (DSM) (American Psychiatric Association, 1994) suggest equal rates 
of the disorder among male and female subjects. However, more recent findings with 
improved methodology as well as systematic reviews of the older studies have shown that 
men are more likely to receive a diagnosis of the disorder than women (McGrath et al, 
2004., McGrath, 2007., Aleman et al, 2003). These reviews suggest that for every 3 male 
diagnosed with the disease, there are 2 females. However, rates of schizophrenia 
diagnosis in females may increase to catch up with the rate in male subjects as the mean 
age of the relevant sample increases. In this study, only subjects aged between 16 and 45 
years were recruited. The mean age of the sample was 28.7 (SD 6.4) years and female 
subjects were older at onset and at presentation with the disease. Schizophrenia is known 
to have a later onset in females compared to males (Mcgrath et al, 2004). Female patients 
with the disease are also known to present or seek treatment later than males especially in 
low and middle income countries, as a lower priority is often given to paying for 
treatment for females with health problems compared to males (Large and Nielsen, 
2008). There may also be some apprehension that a diagnosis of a psychotic disorder may 
affect a woman’s prospect of getting married. All the participants in this study had at 
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least elementary education. Basic education is free and compulsory in most part of 
Nigeria, and this may have influenced the high rate o literacv in this sample. At a mean 
age of onset of 29 years, a majority of subjects in the sample (73.8%) had completed 
secondary or higher education. However, schizophrenia often leads to a deterioration of 
personal functioning. This is reflected in the finding in the present study that 92.9% of 
the subjects were unemployed, while 73.8% were un-married at recruitment into the 
study despite their pre-morbid educational attainment.
 
6.2.2. BASELINE CLINICAL CHARACTERISTICS  
6.2.2.1. DURATION OF UNTREATED PSYCHOSIS 
The mean duration of untreated psychosis was 38.9 months and a median of 26 months, 
with 61.9% of the subjects having illness duration longer than 12 months. Such a long 
duration of untreated psychoses is a common feature in low and middle income countries 
(Gureje, 1991., Murphy et al, 1998., Tang et al, 2007).  In fact, some studies have 
suggested a causal relationship between low income and treatment delays in low and 
middle income countries (Large et al, 2008). In the absence of insurance, the cost of 
health-care may prevent many patients from seeking treatment. Qualitative mental health 
care may also be absent altogether in many areas (Mcready and Ohaeri, 1994). However, 
it is pertinent to note that this study relied on subjects presenting at the psychiatric unit 
for the first time with schizophrenia, having never received any orthodox treatment. A 
large proportion of psychotic patients in low income countries may present initially to 
traditional or faith healers because of socio-cultural beliefs about psychosis (Naqvi et al, 
2009).  
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In the present study, onset of psychosis was defined as the presence, for one week or 
more, of one of the following psychotic symptoms; delusions, hallucinations, marked 
thought disorder, marked psychomotor disorder, and bizarre grossly inappropriate and/or 
disorganised behaviour, with a marked deterioration of functioning. The investigator 
relied on information provided by the patients and a close relation. Therefore, it was 
difficult to estimate the influence of factors such as recall bias or cultural differences in 
the conceptualisation of illness, on the exactness of the reported date at onset. Inclusion 
into the study was also limited to those who were between 16years and 45 years. The 
upper limit of 45years was used to ensure the generalisability of the results, while also 
avoiding the inclusion of late onset cases. Late onset of illness is a common characteristic 
of female subjects, and those with paranoid schizophrenia.  
 
 
This strategy is by no means full proof, and the possibility of bias in recruitment of 
subjects with certain illness profile remains. Therefore, while the average age at onset of 
illness of 24.6 years reported in this study may fall within the usual expected range, 
factors inherent in the methodology of this study may also have influenced this value. 
Epidemiologic studies from developing countries report a wide variation  in the age at 
onset of schizophrenia (Eranti et al, 2012). This observation has previously led to 
speculations that differences exist between developed and developing countries in the age 
at onset of schizophrenia (Gangadhar et al. 2002). The variation in the age at onset of 
schizophrenia across studies may be related to differences in definition, settings, age limit 
for inclusion, and diagnostic criteria employed in the different studies. 
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6.2.2.2. SYMPTOM DIMENSIONS OF SCHIZOPHRENIA 
In this study, the Positive and Negative Syndrome Scale (PANSS) five factor solution 
was used to generate a parsimonious reduction of the multi-dimensional psychopathology 
of schizophrenia. This is in view of the stability and widespread acceptance of the five 
factor model, at least in more recent studies of the outcome of schizophrenia (Llorca et al, 
2011). The schizophrenia psychopathology in this sample was well distributed along the 
lines of the five empirical factors, with a mean total PANSS score of 73.3 and a mean 
Clinical Global Impression of severity (CGI-S) score of 5.1, suggesting a sample 
populated by markedly ill schizophrenia patients at baseline. It would be expected that 
such a degree of illness severity would be associated with serious social, occupational 
and school functioning as well as poor insight. The mean Social and Occupational 
Functioning Assessment Scale (SOFAS) at baseline was 44.6, and about 94% of the 
subjects had poor insight. There was no attempt to selectively include patients with a 
certain distribution of psychopathology, or indeed a certain degree of severity of illness in 
this study so as to recruit a sample that is as close to the real life situation as possible. 
 
 
6.2.2.3. PREMORBID ADJUSTMENT 
The mean scores for pre-morbid academic and social functioning in this study were 
higher than those reported in the original work on the Pre-morbid Adjustment Scale 
(PAS) by Cannon-Spoor et al. (Cannon-Spoor et al, 1982). Patterns similar to those 
reported in the original report on the scale as well as in subsequent studies of 
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schizophrenia patients were however found in this study. The most prominent finding in 
this cohort was that of a poorer pre-morbid academic functioning from childhood through 
adolescence, whereas, the childhood social functioning was comparatively better. 
However, social functioning deteriorated through early to late adolescence. This may 
suggest that a rapid deterioration in pre-morbid social functioning in the individual may 
herald the onset of schizophrenia. Some have argued that pre-morbid deterioration either 
represents the onset of schizophrenia, or is an ‘ultra at risk-factor’  for the disorder 
(Buchanan et al, 1990., Peralta et al, 2012). Later onset deterioration of social functioning 
has always been seen as a clear sign of pre-morbid mal-adjustment, especially when they 
involve activities in interpersonal relationship occurring in settings outside the home 
(Strauss et al, 2012). Such activities occur in the pathway to the establishment of close 
emotional and sexual contacts in these circumstances. A certain level of social-sexual 
functioning is expected in the adolescent before the attainment of adult level functioning. 
Indeed some investigators have suggested that such rapid deterioration in social 
functioning in early adolescence may be a harbinger of certain types of poor prognostic 
psychotic disorders such as deficit schizophrenia (Buchanan et al, 1990., Strauss et al, 
2012., Peralta et al, 2012). These studies also reported patterns of deterioration in 
academic functioning in relation to social functioning as is seen in the present study. This 
pattern is such that whereas social deterioration was observed during the early adolescent 
years, poor pre-morbid academic functioning was observed from childhood, and 
remained poor through the adolescent years.  It is pertinent to note that childhood pre-
morbid functioning measured using the PAS are those occurring from the age of 6years 
and 11 years. As such it may be difficult to determine if the onset of the deterioration 
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observed for academic functioning occurred earlier than the assessed period. A plausible 
conclusion would be that deterioration in academic functioning exists before social 
dysfunction is observed in the prodrome to schizophrenia.  
 
 
6.3. PREVALENCE OF NSS 
This study replicates many previous studies showing an increased prevalence of 
Neurological Soft Sign (NSS) in patients with first episode schizophrenia (Browne et al, 
2000., Lawrie et al, 2001., Keshavan et al, 2003., Whitty et al, 2003., Scheffer et al, 
2004). However, the direct comparison of the prevalence of NSS in first episode 
schizophrenia in this study with those reported across the different studies in the literature 
is complicated by the fact that many previous studies evaluated NSS using a variety of 
measures. The mean total NES score in this study was 21.5. When a neurological 
abnormality was defined as an abnormality in 1 item on the Neurological Evaluation 
Scale (NES), represented by a score of 2 on the corresponding item on the scale in this 
study, 96.4% of the subjects in the sample had NSS. Similar to this finding, at least one 
NSS, among a list that included the Ozereski test, tapping test, fist-ring test, fist-edge-
palm test, piano test, and completion of two sequential drawings was described in 97.1% 
of a sample of 35 treatment naïve patients with first episode schizophrenia at a mean age 
of 26.4 years in the Irish first episode sample (Browne et al, 2000., Whitty et al, 2003). 
The Irish sample also used a cut-off of 2 in an item of the NES in defining the presence of 
(NSS). When the same criterion was used for the definition of abnormality among 24 
adolescents with first episode psychosis, Zabala et al, (Zabala et al, 2006) reported that 
Stellenbosch University  http://scholar.sun.ac.za
 156 
 
100% of their sample had NSS. The same study reported that 89% of the subjects had 
greater than one NSS abnormality.  Studies that have deployed a higher cut-off point for 
NSS have also reported similarly high prevalence. For instance, Ismail and colleagues 
(Ismail et al, 1998) demonstrated that at least 82% of their subjects had NSS even when 
the cut-off was raised to a score of 5 on items of the scale. However, in a community 
study in rural Ethiopia, Shibre et al. (Shibre et al, 2002) reported 65% of medication 
naive schizophrenia patients had a score of 2 or more on a neurological evaluation scale. 
Expectedly, community studies would include subjects with a wider spectrum of the 
stages and the severity of illness, including neurological abnormalities. The present study 
is based on a sample selected on the basis of contact with psychiatric services. 
 
 
The mean total NES scores in this study also mirror those found in many previous studies 
of  NSS in first episode schizophrenia (Buchanan and Heinrichs, 1989., Arango et al., 
1999., Yacizi et al, 2002., Morh et al, 2003). However, some studies have recorded lower 
values when a conservative method of scoring the NSS abnormalities was used (Griffith 
et al, 1998., Dazzan et al, 2006). Such conservative estimation results from the recording 
of the lower values for NES items that are measured for both sides of the body.  
 
 
 
 
 
Stellenbosch University  http://scholar.sun.ac.za
 157 
 
 
6.4. FACTOR ANALYSIS OF THE NEUROLOGICAL EVALUATION SCALE 
The factor analysis reported in this study was based on 18 items from the Neurological 
Evaluation Scale (NES) which were abnormal in more than 10% of the sample of 84 
schizophrenia patients.  Similar to previous factor analyses, it was difficult to identify the 
neuro-anatomical and conceptual meanings of the statistically derived sub-set of NSS. 
The first factor comprised of audio-visual integration, fist-edge palm, rhythm tapping, 
extinction, and right-left confusion. All the signs in this factor require a certain degree of 
sustained attention for successful performance. The fist-edge palm tests for functions 
associated with sequencing of complex motor acts (Buchanan and Heinrichs, 1989., 
Dazzan and Murray, 2002., Piccioni and Dazzan, 2009). The rhythm tapping test has also 
been suggested as an integrative complex motor act function (Bombin et al, 2005). The 
remaining components of factor 1 are items that test for cognitive processing of 
perceptual stimuli. As such, this factor may be conceptualized as representing perceptual 
and motor sequencing signs. Perceptual functions in this case are somato-sensory, visual 
or auditory. Sensory functions are generally understood as originating from the 
connections in the primary sensory cortex or the sensory association cortices in the 
parietal (somato-sensory), occipito-temporal (visual), and temporal lobes in the case of 
auditory sensations (Gay et al, 2012). In line with this hypothesis is the evidence from 
some structural correlation studies that have confirmed the association of NSS 
representing perceptual abnormalities with volumetric reduction in the pre-frontal (Zhao 
et al, 2013., Heuser et al, 2011), as well as the temporal cortices (Keshavan et al, 2003., 
Dazzan et al, 2004) in patients with schizophrenia. The motor sequencing signs such as 
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the fist-edge palm which also loaded in this factor is suggestive of difficulties with 
initiation and organization of complex actions. This is a well known frontal executive 
function (Ovsiew, 1994., Bersani et al, 2004., Emsley et al, 2005., Rao et al, 2008). 
However, sequencing of complex motor acts abnormalities are thought of as originating 
from defects in fronto-basal ganglia circuitry (Heinrich and Buchanan, 1989, Dazzan and 
Murray, 2002., Tosato and Dazzan, 2005). Learning and performance of complex motor 
sequencing tasks has also been shown to involve the superior temporal lobe and the 
cerebellum (Keshavan et al, 2003., Strangman et al, 2005). In sum, factor one of this 
study is a combination of the motor and sensory abnormalities that have been described 
as intrinsic to schizophrenia. These abnormalities are derived from dysfunctions in 
several cortical, sub-cortical and cerebellar brain regions. Schizophrenia is known to be 
associated with such widespread disturbances in the brain (Andreasen et al, 1998., 
Schroder and Heuser, 2008).  
 
Factor 2 comprised of items testing synkinesis, convergence, and gaze impersistence. 
This factor is unique as it represents eye movement abnormalities that have been 
consistently described to be associated with schizophrenia even before the onset of the 
behavioural phenotype (Ross et al, 2000). Such eye movements are possible in the 
presence of intact sensory integration functions that require visuo-spatial localization. 
This function requires multi-modal sensory association and integration; as such it is a 
parieto-temporal function (Tosato and Dazzan, 2005., Jansen et al, 2009., Gay et al, 
2012). However, volumetric reduction in the heteromodal cortex has not been specifically 
related to sensory integration abnormalities in the published structural correlation 
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analyses of NSS in schizophrenia (Dazzan et al, 2006., Thormann et al, 2009). The 
evidence from Thormann et al, (Thormann et al, 2009) suggests that such volumetric 
reduction in the heteromodal cortex may be non-specific in terms of its relationship to 
functional categories of NSS, rather, such brain changes are seen in schizophrenia 
patients with increasing NSS in general. However, Jansen et al. (Jansen et al, 2009) has 
argued that the severity of sensory integration abnormalities in schizophrenia has a 
significant correlation with total and anterior thalamic volume reduction. The thalamus is 
known to function as a central relay station of the brain, which filters and gates sensory 
inputs to the cerebral cortex. As such, structural impairment of the thalamus would 
appear to affect this transfer and consequently decrease performance on the sensory 
integration subscale (Jansen et al, 2009). 
 
Factor 3 includes tandem walk, adventitious flow and graphaesthesia. Whereas tandem 
walk and adventitious flow are items that test for balance, a motor function conceptually 
localised to the cerebellar cortex (Sanders et al, 2000., Guiseppe et al, 2007), 
graphaesthesia is recognizable as a sensory integration function localised to the parieto-
occipital areas of the brain (Bombin et al, 2005., Gay et al, 2012). Most of the structural 
correlation analyses of NSS in schizophrenia have shown that abnormalities of motor 
functions are associated with volumetric changes in the basal ganglia and its connections 
(Keshavan et al, 2003., Dazzan et al, 2004., Jansen et al, 2009., Thormann et al, 2009., 
Mouchet mages et al, 2011., Hirjak et al, 2013). Factor 4 comprised of stereognosis, 
another sensory integration function. 
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The factors derived from this study have not exactly replicated any of the previous 
published works on NSS in schizophrenia. This has also been the case in previous 
exploratory factor analyses (Sewell et al, 2010., Compton et al, 2006), and suggests 
considerable variablility in the expression of NSS in schizophrenia. Studies that appear to 
have replicated previous works have either relied on the same items or number of items 
in the study they attempt to replicate. For instance, Goldstein et al (Goldstein et al, 2005) 
and Keshavan et al, (Keshavan et al, 2003) included the same 13 items previously used 
by Sanders et al, (Sanders et al, 2000) in their exploratory factor analysis. Similarly, 
Emsley et al. (Emsley et al, 2005) used 13 items that bore similarities with those of 
Keshavan et al. (Keshavan et al, 2003). Apart from the work by Emsley and colleagues 
(Emsley et al, 2005), many of the attempts at replication have also relied on very similar, 
if not the same sample for their analysis (Goldstein et al, 2005., Keshavan et al, 2003., 
Sanders et al, 2000., 2006), making the findings of such replications difficult to 
generalize.  The difficulty in replicating the NES factors empirically had led Compton 
and his colleagues, (Compton et al, 2006) to recommend that a one factor model be used 
in research until a consistently replicable factor model is found for the NES. The authors 
reached this conclusion when they derived three factors which could not replicate those 
of Sanders, Keshavan or Goldstein despite using the same 13 NES items relied on by 
these studies. This recommendation re-echoed an earlier suggestion by Sanders and his 
colleague that only the total NES is useful, having found one factor (fist-ring test, fist-
edge palm test, Ozeretski test, and rapid alternating movements), out of a total of four 
with eigenvalue greater than unity, accounting for 20% of the total variance, out of a total 
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of 58% contributed by the four factors (Sanders et al, 2000). Similarly, it has always been 
difficult to replicate the functional categories of Buchanan and Heinrich, (Buchanan and 
Heinrich, 1989) using statistical derivations.  
 
 
Nevertheless, the factor analysis reported in this study has considerable overlap with 
those of several other attempts at empirical classification of the neurological 
abnormalities in schizophrenia using the NES. An important similarity between this 
report and previous efforts at exploratory factor analysis of the NES is derived from the 
extent to which motor and sensory abnormalities have been separated. The result of the 
factor analysis in this study includes a factor for the important eye movement 
abnormalities known to be associated with the vulnerability to schizophrenia and the 
disease process itself, as a distinct factor. 
 
The factor analysis reported here is most similar to those of Malla et al. (Malla et al, 
1997) to the extent that 18 NES items were included in the analysis. But also because a 
strong factor that was very similar to the strongest factor in that study was generated. The 
second factor in this study which may be best described as an eye movement factor is 
very similar to the factor 1 of the study by Malla and colleagues, (Malla et al, 1997) in so 
far as all 3 items testing for eye movements loaded in the derived factors of both studies. 
Whereas factor 2 of this study distinctly grouped eye movement together, the factor 1 of  
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Malla et al, (Malla et al, 1997) included right-left orientation difficulties. Although this 
did not change the functional relevance of this factor in as much as all the items included 
tests for sensory integration function, it made the factor less characterizable as an eye 
movement factor. Interestingly, factor 1 of this study which may be described as a 
perceptual and motor sequencing factor bore resemblance to the second factor of the 
much repeated and seldom replicated exploratory factor analysis by Sanders et al. 
(Sanders et al, 2000., Keshavan et al, 2003., Prasad et al, 2009). In this study factor 1 
contains the same factors testing for perceptual functions as those derived by Sanders and 
colleagues, (Sanders et al, 2000). Whereas factor 1 of this study included a factor for 
motor sequencing (fist-edge-palm), factor 2 of Sanders included a factor for cognition 
(memory). Furthermore, the first factor in this study also shows considerable overlap with 
sensory integration functional category conceptualised by Buchanan and Heinrich, 
(Buchanan and Heinrich, 1989). Similarly, the second factor, which is a factor for eye 
movement has been reported in a separate work by the same group while describing the 
usefulness of the signs and includes the same eye movement abnormalities present in the 
factor 2 of this study (Heinrichs and Buchanan, 1989., Sewell et al, 2010). Three out of a 
total of five items theoretically grouped together as representing sensory integraton 
functions by these authors also loaded together in the perceptual functioning factor of this 
study. Factor 3 of this study is best described as a motor and graphaesthesia factor. Factor 
4 comprised of stereognosis, a function similar to graphaesthesia in so far as both test for 
complex somatosensory functions. Graphaesthesia has previously been reported to load 
with motor functions as seen in the factor 4 of Goldstein et al, (Goldstein et al, 2005) and 
in the exploratory factor analysis by Compton and colleagues, (Compton et al, 2006). 
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Whereas in this study graphaesthesia loaded with a primary motor function, it was 
grouped with a motor integration function in the analysis of Goldstein who used 
medicated subjects from the sample described by Sanders. Graphaesthesia in the African-
American sample of Compton (Compton et al, 2006) loaded with a combination of 
primary motor functions of balance, and motor integration function.  
 
 
6.5. TEMPORAL STABILITY OF NEUROLOGICAL SOFT SIGNS  
An important reason for the surge in interest in the subject of Neurological Soft Sign 
(NSS) in schizophrenia is because of their potential as trait markers for the disease. They 
predate the onset of the disease (Chan and Gottessman, 2008., Chen et al, 2005., Serene 
et al, 2007). In addition to patients with schizophrenia, they also occur in vulnerable but 
well individuals relative to normal controls in a fairly stable continuum of severity 
(Mechri et al,2010., Chan and Gottesman, 2008., Shubert and McNeil., 2005.,Prasad et 
al, 2009., Sanders et al, 2006., Keshavan et al, 2008., Kaczorowski et al, 2009, Chan et al, 
2010a and b., Neelam et al, 2011). An ideal trait marker would also be expected to exhibit 
a degree of stability across the course of the relevant disease. In this study, the mean 
scores for factor 1(Perceptual and motor sequencing) were not significantly different 
from baseline, month 6 and month 12. This is despite a general improvement in the 
symptoms profile of subjects. About 75% of subjects who completed the 12 months 
assessments had more than 50% reduction of their symptoms. Evidence exists in the 
literature to suggest that performance in perceptually demanding tasks is more impaired 
in schizophrenia compared to other psychoses or indeed normal controls, and as such 
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may be more specific to schizophrenia (Keshavan et al, 2003., Prasad et al, 2009). If this 
is true, then it is not surprising to find the factor for perceptual functions exhibiting 
considerable stability across the course of schizophrenia, showing clearly they are 
probably intrinsic to the disease. Keshavan and her group (Keshavan et al, 2003) relied 
on an empirically derived factor of the NES while working with a heterogenous group of 
medication naive schizophrenia patients. Using the same factor derived categories, they 
also confirmed that a cognitive/perceptual factor differentiated high risk siblings of 
patients with schizophrenia from normal controls after controlling for age and gender 
influences (Keshavan et al, 2003., Prasad et al, 2009). The memory item on the NES 
loaded with the items for perceptual functions to produce a factor for cognitive/perceptual 
functions in that study. The items in that factor have some similarities with the items 
loading for perceptual function in this study. In terms of clinical relevance of the 
correlation between the perceptual/cognitive factor and a diagnosis of schizophrenia, it is 
difficult to determine the differential influence of the perceptual or memory disturbances 
on this relationship. While the same study found a strong correlation between the derived 
cognitive/perceptual factor and neuropsychological tests for executive function, it is 
difficult to discountenance the influence of abnormal synthesis of perceptual stimuli in 
the process of schizophrenia. Similarly, it is difficult to determine the differential 
influence of the perceptual, or indeed the motor sequencing components of the factor 1 of 
this study in its relative stability across the course of schizophrenia. This is especially so 
in light of the strong evidence in the literature that supports sequencing of complex motor 
acts as a vulnerability marker of schizophrenia (Heinrich and Buchanan, 1988., Krebs et 
al, 2000., Sulivan et al, 2001., Delevoye-Turell et al, 2003., Keshavan et al, 2003., 
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Bombin et al, 2005., Bachman et al, 2005., Sanders et al, 2006., Peralta et al, 2011., 
Mayoral et al, 2012). It is noteworthy that that the rhythm tapping test which also loaded 
on factor 1 has also been classified as a complex motor act task by some authors (Bombin 
et al, 2005). Therefore, factor 1 of this study is a combination of the motor and sensory 
abnormalities that have been described as intrinsic to schizophrenia. Emperically derived 
factors often show this kind of heterogeneity and difficulties with interpretation in terms 
of functional and neuro-anatomical relevance. This may be related to the multi-
dimensional nature of schizophrenia. It is the view of several authors that schizophrenia 
is associated with structural changes in widely distributed network of cortical and 
subcortical structures (Andreasen et al, 1998., Schroder and Heuser et al, 2008) especially 
the heteromodal association cortices (Cannon et al, 2002., Keshavan et al, 2003., 
Bachman, 2005). Similarly, NSS that are specific to schizophrenia may reflect 
abnormalities in cortico-cortical and cortico-subcortical inter-neuronal connections 
(Dazzan and Murray, 2002., Dazzan et al, 2004., Piccioni and Dazzan, 2009). Therefore, 
the same widespread abnormalities that characterise NSS also characterise schizophrenia. 
In line with this heterogenous nature, Keshavan and colleagues (Keshavan et al, 2003) 
have also demonstrated that the perceptual/cognitive factor were strongly correlated with 
smaller volumes in the left heteromodal association cortex and the cerebellum. This 
finding reflects the importance of perceptual factors in the process of schizophrenia, and 
indirectly gives strength to the finding of temporal stability of the perceptual and motor 
sequencing factor of this study. Interestingly, perceptual /cognitive factors were also 
reported to be more prevalent among African-Americans when compared to Caucasians 
with schizophrenia (Keshavan et al, 2003., Mechri et al, 2009). This may be relevant to 
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the findings of the present study, which was conducted in a population of Nigerian 
Africans. 
 
The NES total score and the mean scores for the other derived factors showed 
considerable differences from baseline, month 6 and month 12 with a trend towards 
reduction in the mean scores as the patients improved. Of particular interest was the eye 
movement abnormalities that loaded on factor 2. The evidence reviewed by Ross et al 
(Ross et al, 2000) suggests that eye movement abnormalities are intrinsic to 
schizophrenia since they also occur in unaffected relatives, and as such are expected to be 
stable across the course of the disease. This study could not replicate this expected 
stability. In an earlier study, Ross and colleagues (Ross et al, 1997) have argued that eye 
movements correlated strongly with sensory integration function. This is supported by 
evidence suggesting that sensory integration signs are not specific to schizophrenia as 
they occur with equal frequency in patients with  psychotic disorders including patients 
with psychotic depression (Keshavan et al, 2003). Sensory integration signs have also 
been shown to decrease in seriousness in the presence of a stable total NSS scores, during 
the clinical course of first episode schizophrenia (Bachman et al, 2005., Prikryl et al, 
2012).  It was therefore not unexpected in this study that the eye movement factor, which 
basically tests for sensory integration functions, did not show significant stability across 
the one year course of schizophrenia. 
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It has been argued that if indeed NSS are an ideal biological marker for schizophrenia, 
then the total NES score as well as the sub-scale scores should reflect a similar pattern of 
stability across the course of schizophrenia (Bachman et al, 2005., Smith et al, 1999). 
While this argument may have some validity, it may not be sustainable in practice. It is 
more likely that a group of 26 hand-picked neurological examination items would 
represent different aspects of a heterogenous disorder like schizophrenia. In this case, 
some items may have potentials as trait markers while others may have potentials for 
defining the different clinical aspects of the disease. Indeed, different items may 
contribute to the total NES score at different stages of the disease. It may also be more 
clinically meaningful to have a small group of signs testing for specific aspects of the 
disease, rather than a long battery of test for one aspect of a multi-dimensional disease. It 
is for this reason that factor analysis of the NES or indeed other measures of NSS became 
an important statistical tool for a parsimonious reduction of the signs. Nevertheless,  there 
are studies in the literature that have found both the NES total score and some sub-scale 
scoreS to be stable across the course of the disease (e.g Emsley et al, 2005), while some 
others have found only the total NES score showing temporal stability (e.g Bachman et 
al, 2005., Prikryl et al, 2012).  
 
When the functional categories of NSS were considered, this study found that the 
sequencing of complex motor act signs was stable across the one year course of 
schizophrenia. This was true when the measurements were taken at baseline, month 6 and 
month12. A similar study that tested the temporal stability of the functional categories of 
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the signs across a 14 month course of the disease also found a relative stability of the 
motor sequencing sign in schizophrenia (Bachman et al, 2005). However, in that study, 
the NES total score showed a stronger level of stability across the same time frame, 
compelling the authors to conclude that the NES total score may be a better trait marker, 
but admitted that it is quite ambiguous (Bachman et al, 2005., Smith et al, 1999). A study 
of the one year stability of the signs in a South-African sample also found that although 
the most stable factor was the factor for attention, the motor sequencing factor was also 
stable  when measured  at baseline, month 6 and month 12 (Emsley et al, 2005). 
However, when measurement of the signs at month 3 were entered into the analysis, the 
authors found that there was a significant reduction of the mean scores for motor 
sequencing that coincided with symptom reduction. However, the finding of a reduction 
at 3 months may be related to the initial effect of antipsychotics in reducing the acute 
symptoms of the disease, including NSS resulting from them. There is evidence from the 
literature on neuroleptic naive schizophrenia patients suggesting that the state defining 
characteristics of the active disease process may predominate during the early course of 
the disease as symptoms fluctuate, whereas, the trait-like characteristics that are 
representative of the baseline vulnerability to the disease may become more prominent 
after the resolution of the acute symptoms (Whitty et al, 2009., Bachman et al, 2005., 
Browne et al, 2000). Thus, in the background of evidence that NSS at onset of 
schizophrenia is associated with more severe psychopathology including positive and 
inattention symptoms (Mittal et al, 2007., Whitty et al, 2009), the initial response to the 
introduction of antipsychotics by the florid acute phase symptoms including inattention 
also results in an initial reduction in the NSS which are secondary to these symptoms. On 
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the other hand, the NSS which are intrinsic to the disease remain persistent or become 
more obvious after the removal of the acute phase symptoms. A corollary to this fact is 
the finding of increasing severity of NSS in some studies of chronically ill patients 
(Smith et al, 1999., Chen et al, 2000). This feature of NSS is a reflection of a genetically 
determined neuro-developmental origin, or an evidence for a pre-morbid acquired 
permanent deficit. In fact, sequencing of complex motor acts signs were recently 
confirmed as evidence of the latter, in so far as they were correlated with an excess of 
obstetric complications and pre-morbid deterioration in psycho-social functioning 
(Peralta et al, 2011). Indeed the study of the temporal stability of NSS in the South-
African sample concluded that attentional and motor sequencing signs are replicable 
across studies of NSS using the methods of exploratory factor analysis (Emsley et al, 
2005). Also, the description of the meaning of NSS by Heinrich and Buchanan (Heinrich 
and Buchanan, 1989) suggests that such motor sequencing signs better differentiate 
patients with schizophrenia from those of other psychosis, while Krebs and colleagues 
concluded that integrative motor functions differentiated patients with schizophrenia from 
those with mood disorders (Krebs et al, 2000). Many of the items in the sequencing of 
complex motor act category were also found to show significant heritability in the 
confirmatory factor analysis by Sanders and colleagues (Sanders et al, 2006). 
 
 
The other two functional categories (motor co-ordination and sensory integration) 
showed significant changes across the one year course of schizophrenia, with trends 
towards a reduction of the signs as patients improved on treatment. The study by 
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Bachman and colleagues among chronically hospitalised patients also showed that 
sensory integration signs are not stable through the course of schizophrenia, varying as 
the symptom profile changed (Bachman et al 2005). In the same study, motor co-
ordination signs showed only a moderate level of stability.  
 
 
In all, the results of this investigation strongly support the first hypothesis: proposing that 
there will be no significant difference in the scores of NSS dimensions in patients with 
schizophrenia after three repeated measurements over a 12 month period. This is true to 
the extent that the neurological abnormalities that have been described as intrinsic to 
schizophrenia (and as such have a trait defining characteristics) remained stable after 
three measurements at different times in the one year course of the disease. The fact that 
the total NES score did not exhibit stability across this time frame may be linked to the 
heterogeneous nature of the 26 items contributing to this score. Different items are likely 
to contribute to the total score at different stages of the disease. 
 
 
6.6. NEUROLOGICAL SOFT SIGNS AND THE CLINICAL CHARACTERISTICS 
OF SCHIZOPHRENIA 
An important finding in this study is the significant correlation between baseline 
neurological soft signs (NSS) and certain symptom dimensions of schizophrenia when 
the five factor model of the Positive and Negative Syndrome Scale (PANSS) was 
adopted. This correlation was present when the total Neurological Evaluation Scale 
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(NES) score at baseline as well as the functional categories proposed by Buchanan and 
Heinrichs, (Buchanan and Heinrichs, 1989) were considered. It was also present when 
using the empirically derived factors of this study. Specifically, apart from the motor 
sequencing ‘functional’  category which correlated significantly with the 
depression/anxiety factor of the PANSS, the other ‘functional’  categories, the NES total 
score, as well as the empirically derived factors correlated significantly with the negative 
as well as the cognitive/disorganised factors of the PANSS. Factors 1 and 2 of the NES 
from this study, as well as the total NES score correlated significantly with the 
excitement factor of the PANSS. However, this correlation was only observed with the 
motor co-ordination sub-set when the ‘functional’  categories were considered. In line 
with this finding, the baseline NES total and subscale scores (functional or empirical) 
correlated with more severe psychopathology. The importance of the association between 
NSS, or abnormalities in specific neurological domains, and some symptom dimensions 
of schizophrenia is in the ability of such association to explain which neurological 
dysfunction is an intrinsic characteristic of the illness. Association of certain NSS with 
psychopathology may help to explain aspects of the underlying neurobiology of the 
disorder. However, some authors have suggested that NSS could be secondary to some 
psychiatric symptoms, such as impaired attention (Lawrie et al, 2001., Browne et al, 
2000). 
 
The finding of a relationship between NSS and a more severe schizophrenia 
psychopathological process, including the presence of negative symptoms, as well as 
cognitive/disorganization symptoms may suggest a state-like quality of some NSS 
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categories. A high total NSS score as well as a preponderance of sensory integration and 
motor coordination signs appear to be specifically suggestive of a more severe form of 
the disease and as such have implications for prognosis. Therefore, these signs appear to 
have the potentials of a state marker of severe psychopathology, and possibly poor 
prognosis (Chen et al, 2005., Prikryl et al, 2006., 2007., Kong et al, 2012). A similar 
argument has been presented previously by Mechri et al (Mechri et al, 2009) when the 
authors suggested that the association between some NSS categories and cognitive 
dysfunction, deficit or disorganized syndromes of schizophrenia may be related to a more 
chronic course of the disease. Also other studies of the relationship between NSS and 
outcome of schizophrenia has reported important associations with poor response to acute 
treatments (Prikryl et al,2006., 2007), higher number of relapses (Chen et al, 2005), and 
other characteristics of unfavourable course of the disease ( Kong et al, 2012). In line 
with the finding of a correlation between NSS and a more severe schizophrenia 
psychopathology, we report that sensory integration abnormalities (functional category) 
correlates significantly and inversely with the age at onset of schizophrenia. Many cases 
of deficit and disorganised schizophrenia are also known to be associated with a younger 
age at onset of schizophrenia. Studies in the literature reporting similar inverse 
correlation between NSS and age at onset concludes that early onset schizophrenia is 
clearly associated with neuro-developmental abnormalities including NSS (Nicholson et 
al, 2000., Biswas et al, 2007). However, the failure of this study to find a relationship 
between DUP and NSS was perhaps unexpected given the relationship found with 
negative and cognitive PANSS factors. 
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Several studies in the literature have reported associations between NSS and negative 
(Schroder et al, 1992., Malla et al, 1997., Arango et al, 2000., Dazzan and Murray, 2002., 
Scheffer et al, 2004., Bombin et al, 2005., Ruiz-Veguilla et al, 2008., Chan et al, 2010a 
and b., Prikryl et al, 2012., Smit et al, 2012), cognitive (Chan et al 2009) or 
disorganization (Arango et al, 2000., Mechri et al, 2009) psychopathology of 
schizophrenia as reported in this study. The study by Malla et al, (Malla et al, 1997) relied 
on Liddle's three dimensions of schizophrenia. The authors found a modest relationship 
between a factor derived extrapyramidal domain of neurological signs (i.e, Rhomberg 
test, adventitious flow, and tremor) and psychomotor poverty dimensions (similar to the 
negative dimensions of the PANSS) in males. Whereas this same symptom dimension 
was associated with neurological factors reflecting attention and initiative (which was 
rhythm tapping in that study) in their female subjects (Malla et al, 1997). While the study 
by Arango and colleagues (Arango et al, 2000) found a significant relationship between 
the disorganization domain of schizophrenia and global neurological abnormalities. The 
same study reported that deficit syndrome was significantly related only to sensory 
integration abnormalities, while hallucination and delusions were not related to any 
neurological abnormalities (Arango et al, 2000). Also Browne et al. (Browne et al, 2000) 
described an association between NSS and total symptom severity and positive symptoms 
in the Irish first episode psychosis study. However, Bombin et al. (Bombin et al, 2005) 
suggested that negative symptoms and, less often disorganization symptoms, could be 
correlated to NSS, especially signs of frontal functions (motor) and those of parietal 
functions (sensory integration), whereas positive symptoms consistently appear unrelated 
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to NSS. Furthermore, Scheffer et al, (Scheffer et al, 2004) suggested that higher NSS 
scores correlated with persistence of negative symptoms after commencement of 
antipsychotic treatment. Whereas Das et al, (Das et al, 2004) argued that the relationship 
between a higher NSS score and negative symptoms occurred after antipsychotic 
medications were switch from first generation to second generation in patients with 
schizophrenia.  
 
There are also some important studies in the literature finding no correlation between the 
symptoms dimension of schizophrenia and the baseline neurological abnormalities. For 
instance, Shibre et al. (Shibre et al, 2002) reporting from a study in an Ethiopian cohort 
did not find a relationship between NSS and negative or disorganisation symptoms. Also, 
Whitty et al, (Whitty et al, 2006) suggests that NSS are not specific to any of the 
diagnoses that share the presence of psychotic symptoms. As in many cases of such 
conflicting reports, methodological differences in the studies account for a majority of the 
variation in findings. An important methodological similarity between this study and 
those reporting a significant relationship is the use of out-patient hospital subjects. The 
report by Shibre and his colleagues (Shibre et al, 2002) is based on a rural community 
sample. 
 
Consistent with the finding of relative stability of the motor sequencing sign across three 
measurements in the one year course of schizophrenia in this study, is the absence of a 
significant correlation between baseline scores for this sign and the psychopathology 
dimensions as measured on the Positive and Negative Syndrome scale (PANSS). It would 
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therefore appear that signs suggesting abnormal sequencing of complex motor acts do not 
to have state defining qualities for identifying certain types of schizophrenia 
psychopathology. By extension, their prognostic value may be somewhat doubtful. 
However, the characteristics of the motor sequencing NSS in this study further 
strengthens the already robust evidence for a trait-like characteristic of this group of signs 
in schizophrenia (Heinrich and Buchana, 1988., Krebs et al, 2000., Keshavan et al, 2003., 
Bachman et al, 2005., Sanders et al, 2006., Mayoral et al, 2012., Theleritis et al, 2012). 
As such, they may have endophenotype potentials. The finding that a relationship exists 
between baseline abnormal sequencing of complex motor acts and the depression/ 
anxiety factor of the PANSS may be due to the need for adequate motivation and 
attention in the performance of complex movement that requires repetition according to a 
particular pattern. The depressed schizophrenia patient may not have the required 
motivation or sustained attention to perform such complex movements. Indeed, Lawrie et 
al, (Lawrie et al, 2001) and Browne et al, (Brown et al, 2000) had proposed that some 
soft signs are secondary to certain aspects of the psychopathology of schizophrenia rather 
than being intrinsic to the disease. In this case, depression may impair the ability to 
perform complex sequential movements. In line with this argument is the fact that 
baseline NSS did not correlate significantly with the development of depression over 
time. It would appear that depression developing during the treatment of schizophrenia is 
of a different origin and process compared to neurological soft signs. Whereas depression 
in the course of schizophrenia may be secondary to certain psychopathological processes 
(such as delusions and hallucinations), treatment, or the elevated responsibility of 
acquiring insight, NSS on the other hand may be intrinsic to the disease. 
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There was a significant inverse correlation between baseline NSS and treatment emergent 
extra-pyramidal symptoms at 6 months and at 12 months. This is in contrast to some 
reports  suggesting that baseline NSS predicted the presence of treatment emergent 
extrapyramidal symptoms , especially tardive dyskinesia (Emsley et al, 2005., Yacizi et 
al, 2002). In this study, in order to remove the important confounding effect of covert 
non-adherence, a relatively low mean dose (10 milligrams fortnightly) of depot 
antipsychotic (flupenthixol) was used in the treatment of patients. As such, the mean total 
Extra-pyramidal Symptoms Rating Scale (ESRS) score for the entire sample was 
generally low (0.26 ± 0.07). A closer look at the data also suggests that although there 
were no significant differences between the mean total ESRS scores of those who were 
followed up (0.31±0.75) and those who dropped out of the study (0.11±0.32), p=0.255, 
those who dropped out had significantly more tardive dyskinesia symptoms (0.37±1.21), 
p=0.022. Therefore, the attritions (22.6%) may have had the effect of diluting the overall 
mean ESRS at month 12, especially with respect to tardive dyskinesia which is the extra-
pyramidal symptom most associated with NSS. Nevertheless, the very high rates of NSS 
(96.4%) at first presentation in this study, and in other first episode, antipsychotic naive 
schizophrenia samples around the world (Browne et al, 2000., Scheffer et al, 2004) would 
suggest that NSS may not be related to anti-psychotic effect. Moreover, the vast majority 
of studies comparing medicated and un-medicated patients, or patients with and without 
extra-pyramidal symptoms report no association between neurological abnormalities and 
antipsychotic medication or extra-pyramidal symptoms (Sheffer et al, 2004., Browne et 
al, 2000., Arango et al, 2000). 
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This study also reports a correlation between the excitement/hostility dimension of the 
PANSS and baseline NSS. The correlation existed for factors 1 and 2 derived from the 
NES as well as the motor co-ordination ‘functional’  category and total NES score. The 
excitement/ hostility factor of the PANSS is comprised of mania-like symptoms in 
schizophrenia, such as uncooperativeness, poor impulse control, excitement and hostility. 
The literature on the relationship of NSS and psychopathology dimension of 
schizophrenia appears to be silent on the associations with this dimension. This may be 
because the earlier studies of this relationship have been based on the conventional three 
factors of the PANSS (Kay et al, 1987), which do not include a separate factor for 
excitement/hostility. The five factor solution now has widespread acceptability in more 
recent outcome studies of schizophrenia (Monteiro et al, 2008., Llorca et al, 2011) after 
the establishment of its psychometric properties in clinical practice (Serreti and Olgiatti, 
2004., Van de Gaag et al, 2006). Nevertheless, recent brain activation studies that have 
used the five factor model of the PANSS suggest that in patients with schizophrenia, the 
excitement score of this model positively correlates with activation in the right pre-frontal 
cortex and other fronto-polar regions (Nishimura et al, 2011). This finding is in 
congruence with studies reporting a relationship between the prefrontal activities during 
response inhibition and impulsivity, violent behaviour and co-morbid anti-social 
personality disorder in schizophrenia (Horn et al, 2003., Asahi et al, 2004., Joyal et al, 
2007., Naudts and Hodgins, 2006). The pre-frontal cortex plays an important role in the 
control of sensory conflict, and both functional and structural abnormalities in the pre-
frontal cortex have been consistently associated with both total NSS and motor co-
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ordination or integration signs (Mohr et al, 1996., Dazzan et al, 2004., Rao et al, 2008., 
Dazzan and Piccioni, 2009). Therefore, the association between NSS and the 
excitement/hostility dimension of schizophrenia which was found in this study, indirectly 
confirm the evidence from studies reporting an association the fronto-polar region, which 
also sub-serves integrative functions, and the excitement factor of the PANSS. The direct 
association would require further verification in future studies. 
 
 
This study could not replicate the findings of Peralta et al, (Peralta et al, 2011) that 
certain neurological abnormalities were associated with poorer pre-morbid functioning. 
This association was also not found in earlier studies such as those of Gupta et al, (Gupta 
et al, 1995) and Buchanan et al, (Buchanan et al, 1990). In the study by Peralta and 
colleagues, an argument was presented for the relevance of sequencing of complex motor 
acts NSS as a marker of poor pre-morbid functioning because of its association with 
obstetric complications among a cohort of 177 medication naive first episode 
schizophrenia patients. The possibility exists that this relationship was not confirmed 
because this study did not directly measure the association between obstetric 
complications and NSS. Nevertheless, this study confirmed, to a large extent, our second 
hypothesis which proposed that a preponderance of NSS at baseline will be associated 
with negative and disorganization psychopathology, as well as earlier age at onset of 
schizophrenia. 
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6.7. NEUROLOGICAL SOFT SIGNS AND THE OUTCOME OF 
SCHIZOPHRENIA. 
A striking and consistent finding in this study is the pattern of the sequencing of the 
complex motor acts ‘functional’  category signs across the one year course of 
schizophrenia. This category of signs did not only remain stable after measurements 
across time intervals from baseline through month 6 and month 12, it had no significant 
relationships with the psychopathology dimensions at presentation. The baseline scores 
for the sequencing of complex motor acts was also not related to the outcome of 
schizophrenia as measured by the percentage changes in the PANSS scores, as well as the 
social and occupational functioning and the quality of life at one year. As earlier 
highlighted, abnormalities of these signs reflect difficulties with organization and 
planning (Piccioni and Dazzan, 2009). This is a recognized frontal lobe executive 
function (Bersani et al, 2005., Rao et al, 2008). Abnormalities of sequencing of complex 
motor acts have been shown, and reported to be specific to schizophrenia (Heinrichs and 
Buchanan, 1988., Krebs et al, 2000., Keshavan et al, 2003., Emsley et al, 2005., Bombin 
et al, 2005., Delevoye-Turell et al, 2003., Sullivan et al, 2001). They have also been 
demonstrated to be more prevalent in high risk individuals (Theleritis et al, 2012), and 
siblings of patients (Prasad et al, 2009., Neelam et al, 2012) compared with normal 
controls. Furthermore, many individual items in the category have been shown to exhibit 
significant heritability (Sanders et al, 2006). Similar to previous studies, this category of 
signs did not load as a separate factor in the exploratory factor analysis of this study. 
They have also repeatedly loaded together combination with other individual signs, in 
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previous factor analyses of the signs in schizophrenia (Malla et al, 1997., Sanders et al, 
2000., Keshavan et al, 2003., Emsley et al, 2005). And as previously highlighted, the 
motor sequencing NSS has been shown to be stable across the course of schizophrenia in 
first episode medication-naive cases (Emsley et al, 2005., Mayoral et al, 2012), and in 
chronic patients with the disorder (Bachman et al, 2005). In sum, this feature of the motor 
sequencing signs strengthens the idea that motor abnormalities, especially those 
involving the performance of complex motor acts may constitute a reliable vulnerability 
marker for schizophrenia. This assertion has previously been made by Bombin et al, 
(Bombin et al, 2006) and Gourion et al (Gourion et al, 2003), and reported by Mechri et 
al, (Mechri et al, 2009). The profile of the motor sequencing sign as a vulnerability 
marker was recently confirmed by Peralta and colleagues (Peralta et al, 2011). In that 
study, signs of sequencing of complex motor acts were associated with obstetric 
complications as well as deterioration in pre-morbid functioning among a cohort of 177 
medication-naive first episode schizophrenia patients. For this reason, the authors argued 
that the sign is more of an environmental marker for schizophrenia, rather than a genetic 
marker for the disease (Peralta et al, 2011).  
 
 
The baseline scores of the other functional categories (i.e, motor co-ordination and 
sensory integration), as well as those of the derived NES factors of this study were found 
to correlate with the percentage changes in negative and cognitive/disorganization 
symptoms of the PANSS. This finding is a corollary of the evidence demonstrated in this 
study, and elsewhere that a preponderance of NSS is associated with negative and 
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cognitive/disorganization dimensions of the PANSS (Schroder et al, 1992., Malla et al, 
1997., Arango et al, 2000., Dazzan and Murray, 2002., Scheffer et al, 2004., Bombin et al, 
2005., Ruiz-Veguilla et al, 2008., Chan et al, 2010a and b., Prikryl et al, 2012., Chan et al 
2009., Mechri et al, 2009).  
 
A clearer reflection of the relationship between NSS and outcome is the finding that a 
higher cumulative number of NSS at baseline is associated with a poorer level of 
functioning, not only at 6 months, but also at 12 months in some cases. This association 
was present for the derived NES factors and the functional categories. However, the most 
interesting finding in the relationship between NSS and outcome is that a preponderance 
of motor co-ordination signs at baseline correlates with a poor quality of life rating at 
month 12. This is especially so for the ratings on the psychological domains of quality of 
life. This finding was consistent for both the derived motor co-ordination/graphaesthesia 
factor and the motor co-ordination functional category of Buchanan and Heinrichs, 
(Buchanan and Heinrichs, 1989). It also confirmed the third hypothesis of this study that 
a preponderance of NSS at baseline will be associated with a poorer outcome of 
schizophrenia at one year. 
 
This study reports a relationship between NSS and functioning independent of 
psychopathological limitations. In relying on the Social and Occupational Functioning 
Scale (SOFAS), functioning was rated independent of illness related confounders. The 
literature on the use of the SOFAS in investigating the relationship between NSS and 
functional outcome appears to be very sparse. A previous assessment of the relationship 
Stellenbosch University  http://scholar.sun.ac.za
 182 
 
between NSS and functioning has relied on the Global Assessment of Functioning (GAF) 
(Mechri et al, 2009), a measure of functioning that is heavily influenced by 
psychopathology. The authors found a relationship between NSS total score and GAF 
score while using a comparative case control design. Earlier attempts at establishing a 
relationship between NSS and functioning in the later stages of the course of the disease 
reported absence of a relationship (Sanders et al, 1994., Dazzan and Murray, 2002). 
However, the consensus in the literature is that baseline NSS is associated with a poorer 
current social functioning (Whitty et al, 2009.,Bombin et al, 2005., Galderisi et al, 1999).  
 
 
To the best of the knowledge of this investigator, this is the first description of the 
relationship between NSS and quality of life. Most of the previous investigations of NSS 
and outcome of schizophrenia have relied on symptom reduction (Emsley et al, 2005., 
Das et al, 2004), relapse rates (Emsley et al, 2005), length of hospital stay (Gureje, 1987), 
or global functioning using the GAF (Mechri et al, 2008) in describing and inferring the 
relationship between NSS and the outcome of schizophrenia.  
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CHAPTER SEVEN 
 
LIMITATIONS 
7.1. SELECTION BIAS 
In this study, the recruitment of patients was based on contact with psychiatric services, 
either as in- or out-patients. Every patient presenting to the psychiatric units in the study 
location within a particular time frame was asked to take part in the study. Given the 
observation suggesting that many patients with psychosis in the community have not 
sought formal biomedical care, it is likely that the sample studied may have been self-
selected on the basis of access to the facilities and by illness severity. A large scale 
community study would eliminate a possible referral bias. Also, this study did not include 
a control group. The presence of several types of controls such as unaffected relatives, or 
normal comparison group would have allowed blinding of the unvestigators and clarified 
the differential prevalence of NSS along this spectrum of exposure levels. 
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7.2. SAMPLE SIZE 
This study is further limited by a relatively small sample size especially at follow-up. 
Similar to most longitudinal studies of patients with psychosis, there was a problem with 
attrition. Although 84 subjects were recruited into study at inception, only 65 subjects 
completed one year assessment. Nevertheless, the follow-up rate of 77.45 still provided 
sufficient power (90%) to detect differences in the variables explored. 
 
 
7.3. MEASUREMENT BIAS 
The investigator was not blind to the clinical state of the subjects. This may have 
introduced an observer bias in the measurement of Neurological Soft Signs (NSS). 
Similarly, some of the improvements observed may have been due to learning effects on 
some of the signs. 
 
7.4. STATISTICAL ANALYSIS 
Corrections for multiple testing were not carried as part of the statistical analysis, because 
of the exploratory nature of this study. Such corrections would have clearly delineated the 
key points of change in the total or sub-scale scores of NSS in the one year course of 
schizophrenia.The investigator have relied on exploratory factor analysis in describing 
the structure of NSS in this population in line with previous studies of NSS in the 
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literature. Only one previous confirmatory factor analysis had been done on the NES 
previously (Sanders et al, 2006), and the finding was not less difficult to interprete 
compared to those using exploratory methods.  
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CHAPTER EIGHT 
 
CONCLUSIONS 
The presence of a high prevalence of Neurological Soft Signs (NSS) at first 
presentation with schizophrenia or schizophreniform disorder in this study, as well as 
in some other similar studies in the literature, even before exposure to antipsychotics, 
would suggest that NSS are intrinsic to the process of schizophrenia. They therefore 
have potential as biological markers for the disease. They appear more common when 
compared to some of the more frequently suggested phenotypes of the schizophrenia 
syndrome. 
 
Some of the NSS categories exhibit significant temporal stability across the short to 
medium term course of the disease. The categories of sequencing of complex motor 
acts as well as the signs of cognitive processing of perceptual stimuli remained 
persistently abnormal across the one year course of the disease. The sequencing of 
complex motor act signs were especially resistant to the influence of the clinical 
profile of the disease throughout the duration of the study. The evidence from this 
finding and others in the literature lends credence to the conceptualization of NSS as a 
trait marker for schizophrenia. It is however doubtful if all available heterogenous 
items in a neurological examination scale have this trait defining characteristic. The 
sequencing of complex motor act signs, as well as signs representing cognitive 
processing of perceptual stimuli appear to be markers of the vulnerability to 
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schizophrenia. Future studies should help clarify if these abnormalities are genetically 
determined or they are acquired permanent pre-morbid defects. 
 
 
Other NSS categories as well as the NES total scores are markers of a more severe 
negative and disorganization psychopathology. A preponderance of NSS may also be 
related to higher degree of hostility in patients with schizophrenia. Positive symptoms 
were not significantly associated with NSS at presentation. This finding may suggest 
that some NSS or the ability to perform some of the test may be secondary to the 
influence of the psychopathology dimensions. It may also suggest that these NSS are 
markers of a poorer prognosis in terms of residual symptoms and possibly the 
potentials for relapse. Such patients may therefore require longer term treatment even 
in the first episode.  
 
The NSS that were related to certain psychopathology dimensions before treatment 
with antipsychotics also decreased in frequency and severity as the relevant 
psychopathology decreased in severity in response to treatment. This finding is in 
support of the previous suggestion that some NSS categories may be secondary to 
certain psychopathology dimensions. 
 
A higher cumulative number of NSS at baseline is associated with a poorer level of 
functioning at 6 months, and also at 12 months in some cases. Although the 
assessment of functioning in this study was independent of psychopathology, this 
finding is in support of the argument that the relationship between a cumulative 
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amount of NSS and a more severe schizophrenia psychopathology may also be a 
marker for poor prognosis, including functional outcome in this case.  
 
 
Also in line with the previous finding on outcome, a preponderance of motor co-
ordination abnormalities is associated with a poorer quality of life at one year. This is 
especially related to outcome in terms of psychological health. This finding may be 
related to a possible presence of residual symptoms at one year in patients with 
predominant motor co-ordination abnormalities at baseline. This may suggest a need 
for longer term monitoring and treatment for patients with such signs at presentation.  
 
 
8.1. RECOMMENDATIONS 
Attempts at replicating the theoretical categories of signs compiled by Buchanan and 
Heinrichs from the Neurological Evaluation Scale (NES) using statistical derivations 
have often failed. It has also been difficult to replicate any of the previous factor 
analyses in the many attempts around the world. This probably reflects the 
heterogeneity in symptom expression of the illness. The nearest approximation to 
replicating a previous factor analysis has been achieved by studies that relied on 
similar items or number of items. Many of these approximations have also been 
achieved while relying on the same subject sample.  
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The functional categories of Buchanan and Heinrichs appear more meaningful 
compared to any factor derived category. As such, it is the recommendation of this 
investigator that in the mean time, the functional categories be relied upon in the 
many attempts at unravelling the true meaning of NSS in schizophrenia until a 
standard and replicable sub-categories of NSS is found. 
 
 
The total NES score which is a combination of the scores for 26 items may be too 
heterogenous to tell any specific story about the process of schizophrenia. It is also 
too long and time consuming to be meaningful for the clinician. It is the 
recommendation of this investigator that a shorter version of the NES be designed 
from the original 13 items that made up the three main functional categories of 
Buchanan and Heinrichs. This version of the NES should be standardized for use in 
research and in clinical settings, using first episode antipsychotic naive samples. 
 
 
There is presently no agreement on what constitutes an abnormality in most of the 
scales for assessing NSS around the world. As such researchers have used several 
thresholds in defining abnormalities. It is the recommendation of this investigator that 
a standardized shorter version of the NES should also include an agreed cut-off for 
abnormalities. This cut-off point should be the point with the best validity for 
identifying the vulnerability to schizophrenia or a poorer prognosis in patients. This 
may help the clinician with identification and early initiation of effective therapies in 
patients or high risk persons. 
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Ongoing advances in imaging techniques may help to further clarify the underlying 
neural substrates of NSS in general. In this way, such studies should also provide 
important information on the pathogenetic processes that underlie schizophrenia and 
other neurodevelopmental disorders such as Attention Deficit and Hyperactivity 
Disorders, Autistic spectrum disorders, and Obscessive Compulsive Disorders. 
 
 
Future studies should also help to clarify the point of influence of the vulnerability 
marking NSS along the pathway to the overt disease. This may lead to novel 
interventions in schizophrenia. 
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ADDENDUM A 
 
Consent Form (English) 
 
 
IRB Research approval number: 
This approval will elapse on: dd/mm/yy 
 
Title of the research: A study of the profile and determinants of outcome in 
recent onsetschizophrenia. 
 
 
Name and affiliations of researchers 
This study is being conducted by Professor Oye Gureje of the Department of 
Psychiatry, University of Ibadan. Nigeria. 
 
Who are the sponsors of research? 
The purpose of this research is to study patients with a first episode of schizophrenia 
and related psychotic disorder and follow the, up over some years. Schizophrenia and 
its related disorders are chronic and sometimes disabling disorders. We are conducting 
the study to learn more about the illness, particularly ways of improving the outcome. 
In order to do so, we plan to study 80 people with the illness, treat them all with the 
same medication and follow them up for one or two years. Medication is often used 
treat people with psychiatric conditions, and for your illness it is absolutely necessary. 
 
 
What happens during the research? 
You will be interviewed and physically examined during some of your visits during 
the research. We may need to take a blood sample as part of a general investigation of 
your health. These procedure are not dangerous but can cause some local pain. Your 
blood will not be used for any other purpose aside from what has been stated.  You 
will also be placed on free drug treatment after recruitment into the study. The 
compound that will be used to treat you is called Fluanxol depot. Although oral 
medication (tablets) is available, there are several benefits to using this long acting 
injection. First it ensures that the medication is being taken correctly since people 
often find it difficult to remember to take tablets everyday, or sometimes, when they 
become ill they don’ t believe that they need any medication. At each visit you will be 
asked several questions related to your illness by the doctor and nurse. As some of the 
visits your blood pressure, pulse and weight will be taken. 
 
Expected duration of research and of participants’ involvement: 
In total, the study will last 5b years, but we expect you to be involved in this research 
for 2 years. You should not spend more than 1hour at each clinic visit.  
 
What do I benefit by participating in the research? 
The possible benefits of participating are that you will receive expert care and you 
will be assisting us to learn more about your illness so that we can provide improved 
care to you and others in future. You will also be receiving free medication and 
detailed assessment of your health at more frequent intervals than is usual. 
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Confidentiality  
All information collected in this study will be kept strictly confidential. No stored 
information can be linked to you in anyway and your name or nay identifier will not 
be used in nay publication or reports from this study. 
 
 
Am I free to opt out of the study any time? 
You are free to choose whether or not you want to take part in this study. If you do 
not, it will not affect the way you are looked after. You can also choose to withdraw 
from the research at anytime. Please note that some of the information that has been 
obtained about you before you choose to withdraw may have been modified or used in 
reports and publications. These cannot be removed anymore. However the researchers 
promise to make good faith effort to comply with your wishes as much as is 
practicable. 
 
 
What if suffer any injury or unwanted effect because I participated in the study? 
If you suffer any injury as a result of your participation in this research, you will be 
treated at the University College Hospital Ibadan and the research will bear the cost of 
this treatment.  
 
 
If you wish to participate in this study, you are requested to kindly go home with this 
form, discuss the study and your participation in the study with your relatives before 
signing the form. 
 
Statement of person obtaining informed consent: 
I have fully explained this research to ----------------------------------and have given 
sufficient information, including risks and benefits, to make an informed decision. 
 
DATE:---------------------------  SIGNATURE:-----------------------  Thumb print-
------------- 
 
NAME:----------------------------------------------------------------------------------------------
------------- 
 
Statement of person giving consent: 
I have read the description of the research or have had it translated into language 
understand. 
I have also talked it over with the doctor to my satisfaction. I understand that my 
participation is voluntary. I know enough about the purpose, methods, risks and 
benefits of the research study to judge that I want to take part in it. I understand that I 
may freely stop being part of this study at any time. I have received a copy of this 
consent form additional information sheet to keep for myself. 
 
 
DATE:------------------------------------------SIGNATURE:-----------------------------------
------------- 
 
NAME:----------------------------------------------------------------------------------------------
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------------- 
 
NAME OF RELATIVE and RELATIONSHIP (if  applicable)------------------------------
------------ 
 
 
SIGNATURE OR RELATIVE (if applicable)-------------------------------------------------
------------ 
 
WITNESS’ SIGNATURE (if applicable):------------------------------------------------------
------------ 
 
WITNESS’ NAME (if applicable):--------------------------------------------------------------
------------ 
Detailed contact information including contact address, telephone, fax, e-mail and any 
other contact information of researcher, institutional HREC and head of institution: 
This research has been approved by the Health Research Ethics committee of the 
University of Ibadan and the chairman of this  committee can be contacted at the 
Biode building, Room T10, IMRAT, College of Medicine, University of Ibadan. The 
e-mail address is uiuchr@yahoo.com. In addition if you have any question about your 
participation in this research, you can conct the principal investigator, Professor 
Gureje at his office at the psychiatry department, College building, third floor 
University College Hospital, Ibadan. The phone number and e-mail address are +234-
8033464284, e-mail ogureje@comui.edu.ng. 
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Consent Form (Yoruba) 
 
 
IWE ATEWOBO PE MO GBA (TI MOLEBI) 
IRB Research approval number: 
This approval will elapse on: dd/mm/yy 
 
Title of research: A STUDY OF THE PROFILE AND DETERMINANTS OF 
OUTCOME IN RECENT ONSET SCHIZOPPHRENIA  
 
ORUKO ATI AWON TO GBE ETO IWADI YII KALE: 
A gbe eto iwadi yi kale inpase Ojogbon Oye Gureje ti eka awon to n toju alarun opolo 
ni ile iwosan Oritamefa, Ibadan. 
 
AWON WO LO SE AGBATERU RE? 
Awon to se agbeteru eto iwadi ni awon to fowosowopo ki ile adulawo le dara si (New 
Partnership for Africa’s Development NEPAD) 
 
KI NI IDI GAN TI A FI GBE ETO IWADI YII KALE? 
A gbe iwadi yi kale lori awon alaisan to ni apeere arun opolo fun igbe akoko ati awon 
miran to far ape. Asi maa toju won fun odun die. Aun se eto iwadi yi lati mo inpa 
aisan yii, paapaa julo awon ona ti a le gba lati je ki ara eni naa da ti ko ni fe si wahala 
Kankan mo. Lati le se yi, a fen i imo ijinle lori awon ogorin eniyan ti won ni iru ailera 
yi, a o fun won ni ogun kan naa, a o si ma wo fun bi odun kan si meji. A ma n saba lo 
ogun lati fi toju awon alarun opolo, fun ailera ti molebi yin ni yii, lilo oogun se Pataki. 
 
KI NI YO SELE NIGBA TI A BA N SE ETO IWADI YII? 
A o gba oro lenu molebi yin, a o si ye ara re won nigba ti o ba n wa fun ayewo lee 
kookan. Ni ekookan yii, a le gba eje die ni ara re fun awon iwadi Kankan nipa ilera re. 
Eje  gbigba yi ko le wu sugbon o le dun yin die. A o ni lo eje re fun nkankan yato si 
iwadi ti a fe se yi, e ma jaya. A o fun n ni ogun ofe leyin ti a ba gba a wole sinu eto 
iwadi yi. A ti se eto abere sile fun won ti an pen i Fluanxol depot. Ogun oniworo naa 
wa pelu, anfani pupo lo wa nipa lilo abere yi ti yo sise fun igba pipe: 
Ekini, o je ki aridaju wa wipe a n lo ogun yi bo se ye ka lo, nitoripe awon eniyan wa o 
n fe logun ni ojoojumo paapaa nigba ti won ban i ailera kan. Bi o ba se n wa  a o ma 
beere awon ibeere to jo mo ailera yi lati enu dokita ati noosi lo wo re. ni ekookan bi o 
bat i n wa a o si ma ye ifunpa re wo, ati bi o se gbe iwon si. 
 
 
IWONGBA TI ETO IWADI YI MA WA ATI IGBA TI A MA NILO YIN SI? 
Ni apapo, a o se eto iwadi yi fun odun marun sugbon a fe ki o darapo mow a ninu 
iwadi yi fun odun meji. A o si ripe ko loju wakati kan lo ti o bat i wa. 
 
 
KINI AWON ANFANI TI  A MA RI GBA NINU BI BAYIN SEPO NINU ETO 
IWADI YI? 
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Anfani ti o romo kikopa yi ni pe, molebi yin o gba itoju ti o peye, yio sit un ma ran wa 
lowo lati ni imo si  nipa ailera yi, eyi yio si jeki awa naa le ma pese ojulowo itoju fun 
yin ati awon miran ni ojo iwaju. Oogun ofe ari ekunrere itoju bi ailera re se ri ni e o 
ma gba  
 
 
ASIRI 
Gbogbo oro tie yin tabi molebii yin ba so fun wa nipa molebii yin yoo je nkan asiri. A 
ko ni lo oruko, bee sin i oro akole Kankan ti aba ko lori eto iwadi yi. 
 
NJE MO LE FI ETO YII SILE PE MI KO SE MO NIGBA KANKAN 
Molebi yin ni anfani lati ko pa tabi lati ma ko pa. Ti o ba se ipinu lati ma ko pa,  
Ko ni di bi a se n se itoju re lowo leyin naa. O ni anfani lati so wipe nko se mo 
nigbakugba. 
A fe ki e mop e, awon idahun ti e ba ti fun wa, a ti le lowon lati koi we ko to dipe e 
pinu lat ma kopa, mo, akosile wa ko le kuro mo. Bakana oluwadi ti yo ma ko pa ninu 
itoju yin yio ma sa ipa won lati faramo ipinu yin ati lati fowosowopo pelu yin. 
 
KI LO MA SELE TI MO BA FARAPA TABI TI OHUN BURUKU KAN BA 
SELE NITORIPE MO KO PA NINU IWADI YIN? 
Ti molebi yin ba farapa nipa iwadi yi, yio o gba itoju lati ile iwosan Oritamefa, Ibadan 
ati wipe awon eleeto iwadi yin i yio ma san owo itoju yin. 
 
STATEMENT OF PERSON OBTAINING CONSENT: 
 
 
MO TI SALAYE ETO IWADI YI NI KIKUN FUN---------------------------------------
------------ 
 
ATI WI PE MO TI SO NI KIKUN NIPA ANFANI ATI EWU TO RO MO LATI 
LE SE IPINU. 
 
DEETI-------------------------- IBOWOLUWE------------------------------ ITEKA----
------------- 
 
ORUKO--------------------------------------------------------------------------------------------
------------- 
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STATEMENT OF PERSON GIVING CONSENT. 
 
MO TI KA GBOGBO NKAN TI A SO NIPA ETO IWADI, WON SI TI KO NI 
EDE TI MO MOO KA, TO SI TI YE MI. 
 
MO SITI MO NI KIKUN LATI ODO DOKITA TO SI YE MI. MO WIPE KIKOPA 
MI JE KO PO DANDAN. MO MO DARADARA NIPA NKAN TI WON FE SE. 
ONA TI WON FE GBE GBA, EWU ATI ANFANI ETO IWADI YI, LA TI SE IPINU 
NI KOKO PE MO FE DARAPO MO. O SI TI YE MI WIPE MO LE PINU LATI MA 
KO PA NIGBAKUGBA. MO TI GBA IKAN NINU ILEWO TI MO FI DARAPO YI 
ATI ELEYI TI MO LE MU LO SILE. 
 
 
DEETI---------------- IBOWOLUWE---------------------------------- 
 
ORUKO------------------------------------------ 
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ADDENDUM C 
 
SCID-I/P VERSION 2.0 (for DSM IV) 
 
OVERVIEW 
 
Ma beere lowo yin nipa idamu tabi wahala te e le tini ri, ma de ma ko si le bi mo se n 
biyin ni 
ibere ka to beere 
DEMOGRAPHIC DATA – 
SEXOKUNRIN 
(male) 
OBIRIN (female) 
DOB (Igbawo ni a biyin) - ------ --------- ------ AGE----------- 
OSU OJO ODUN 
MARITAL STATUS 
Se ni iyawo(if male) 
tabi oko(If female)? 
To ba je rara se ti loko tabi iyawo ri? 
(1) Married (wa nipo lokolaya) 
(2) Widowed (Ti di opo) 
(3) Divorced (ko oko tabi aya sile) 
(4) Separated (Ti ya pa) 
(5) Never married (Ko loko laya) 
Any children? (what are their ages?) Se e ti bi omo (omo dun melo ni won) ------------ 
If yes: How many? To ba je beeni,melo ni won?--------- 
Where do you live? Ibo ni won gbe---------- 
Who do you live with? Tani iwo ‘n ba gbe? ------------------------------------------------------ 
Education and Work History 
How far did you get in school? Iwe meelo le e ka? 
(1) Primary 6 certificate or did not graduate 
(2)Graduated from secondary school 
(3)Did not graduate from secondary school 
(4)NCE, Grade2, Hsc/A-levels 
(5) Graduated from university 
(6)Did not graduate from university 
(7)Professional/masters 
178 
If failed to complete a programme in which they were enrolled: Why didn’ t you 
finish? 
Ki lo de te e fi pari------------------------------------ 
What kind of work do you do? (do you work outside your home?) 
Ise wo len se------------------------------------------- 
ONSET OF PRESENT IILNESS/EXACERBATION 
When did this beging 
Ni gba wo lo beere?------------------------------------------------------------------------------------
-------- 
(Igbawo le ripe nkan kan sele)---------------------------------------------------------------------- 
When were you last feeling o.k? 
Igba wo le rip e ara ya gbeyin? 
NEW SYMPTOM OR RECURRENCE 
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Is there something new or a return of something you have had before? (What made you 
come for 
help now?) 
Se nkan to sese sele ni tabi aisan to pada si yin lara-(Ki lo gbe yin wa si ile iwosan)--------
--------- 
------------------------------------------------------------------------------------------------------------
--------- 
------------------------------------------- 
ENVIRONMENTAL CONTEXT AND POSSIBLE PRECIPITANTS OF PRESENT 
ILLNESS OR EXACERBATION (USE CODE AXIS 10) 
What was going on in your life when thid began? 
Ki lo n sele laye yin nigba ti nkan yii sele----------------------------------------------------------
--------- 
--------------------------------------------------------------------------------------------------- 
Did anything happen or changed just before anything started? 
Se iyato kan wa ki iyato yii to sele tabi leyin to sele----------------------------------------------
-------- 
-------------------------------------------------------------------------------------------------- 
COURSE OF PRESENT ILLNESS OR EXACERBATION 
Nigba to beere ki lo tun sele ------------------------------------------------------------------------ 
(se awon nkankan n damu yin lokan?) 
----------------------------------------------------------------------------------------------------------- 
Igba ti isele yii sele,igba wo le ripe o buru jayi----------------------------------------------------
--------- 
--------------------------------------------------------------------------------------------------- 
IF MORE THAN A YEAR AGO: To ba je bii odun kan seyin ,igba wo le leri pe o buru 
jayi? 
Se e n sise nisi yii? ------------------------------------------------------------------------------------ 
TO BA JE BEENI: Lati igba wo leti n sise nibe? -------------------------------------- 
TO BA JE OSU MAFA SI SIYIN:ki lo de tefi kuro nise ten se tele?--------------------------
---------- 
------------------------------------------------------------------------------------------------- 
Se e ti ma n se ise yen tele? -------------------------------------------------------------------------- 
To ba je rara:ki lo de tofi jebe?------------------------------------------------------------------ 
Iru ise wo le ti se ri? ----------------------------------------------------------------------------------- 
179 
Bawo le se n toju ara yin nisi yii? ------------------------------------------------------------- 
TI E BA MO:Nje igba kankan wa ti e ko le sise tabi losi ile iwe?------------------------------
--------- 
--------------------------------------------------------------------------------------------------- 
To ba je beeni:Nigbawo ni?Ki lo de to fi sele bee?------------------------------------------------ 
------------------------------------------------------------------------------------------------- 
OVERVIEW OF PRESENT ILLNESS 
Ti e ko ba mo: CURRENT TREATMENT STATUS 
(PAST MONTH) 
Se e ti gba itoju kankan lawon osu to ti koja? 1. Current in patient (including 
residential treatment) 
2.Current outpatient 
3. Other (e.g. 12 step program) 
4. No current treatment 
IF CURRENTLY IN TREATMENT: Date admitted on that kind of treatment 
Or outpatient fascility for present illness: 
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Number of weeks since admission to fascility 
1. <1week 
2.1-4weeks 
3. >4weeks 
When did you come to the (hospital, clinic) ------------------------------------------------------ 
CHIEF COMPLAINT AND 
DESCRIPTION OF PRESENTING PROBLEM 
Ki lo je ki e wa ni asiko yii?atipe kini isoro ten la koja te fi wa---------------------------------
--------- 
-------------------------------------------------------------------------------------------------- 
If does not give details of presenting problem: E so fun mi ni kikun atipe ki ni itumo re----
-------- 
--------------------------------------------------------------------------------------------------- 
TREATMENT HISTORY 
I gbawo le ri enikankan nipa ero okan yin tabi arun opolo?(Ki lo wa fun)---------------------
------- 
------------------------------------------------------------------------------------------------- 
Awon ogun wo ni won ko fun yin atipe itoju wo le gba?-----------------------------------------
--------- 
------------------------------------------------------------------------------------------------------------
--------- 
------------------------------------------------------------------------------------- 
Nje e ti gba ogun ri fun ogun oloro kankan tabi oti mimu?--------------------------------------
----- 
--------------------------------------------------------------------------------------------------- 
THE LIFE CHART ON PAGE V1 OF OVERVIEW MAY BE USED TO DOCUMENT 
A 
180 
COMLICATED HISTORY OF PSYCOPATHOLOGY AND TREATMENT 
Nje e ti fi igbakan je ailasan ni ile iwosan awon to ni arun opolo? Bi emelo ni won ti da 
yin duro nibe(do not include transfers) 0 
1 
To ba je beeni,ki lo wa fun? 2 
E meelo ni? 3 
4 
5(or more) 
IF GIVES AN INADEQUATE ANSWERS, CHALLENGE GENTLY: 
e.g Ti ko ba si nkan mi nibe,awon eniyan okan saa dede lo si ile iwosan awon to ni arun 
opolo 
boya nitoripe o re won tabi fun eru tabi aya jija---------------------------------------------------
--------- 
------------------------------------------------------------------------------------------- 
Se ti wa si ile iwosan ri fun aisan ara miran--------------------------------------------------------
--------- 
--------------------------------------------------------------------------------------------------- 
To baje beeni?fun ki ni?-------------------------------------------------------------------------------
--------- 
-------------------------------------------------------------------------------------------------- 
OTHER CURRENT PROBLEMS 
Nje e ni ailera kankan losu to ko ja? ----------------------------------------------------------------
--------- 
-------------------------------------------------------------------------------- 
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Bawo le se le sowipe e sen farada nkan ti awon ba se fun si? --------------------------------
--------- 
------------------------------------------------------------------------------------------------ 
Ba wo le se le sowipe ara yin daa si tabi se e ti ni arun kankan ri ti o gba itoju?(use this 
information on code axis 111-------------------------------------------------------------------------
--------- 
------------------------------------------------------------------------------------------------- 
Se e ma mu ogun to yato si eleyi te ti so fun mi tele bii ogun a teje se? -----------------------
-------- 
------------------------------------------------------------------------------------------------- 
To baje beeni : meelo le ma n mu atipe e meelo ni lojumo?------------------------------------- 
Se won ti so fun yin wipe ke d a kan duro ke si ma lokan ri? -----------------------------------
--------- 
---------------------------------------------------------------------------------------------------- 
Bawo lese mu oti si seyin? ---------------------------------------------------------------------------
--------- 
-------------------------------------------------------------------------------------------------- 
Se e ti ma n mu ogun oloro kankan ri bii igbo,kokaini ati awon ogun oloro miiran----------
--------- 
--------------------------------------------------------------------------------------------------- 
CURRENT SOCIAL FUNCTIONING 
Ba wo le sen lo asiko yin si?--------------------------------------------------------------------------
-------- 
--------------------------------------------------------------------------------------------------- 
Ta le ma n ba lo asiko yin?-------------------------------------------------------------------------- 
Most likely current diagnoses: -----------------------------------------------------------------------
-------- 
--------------------------------------------------------------------------------------------------- 
181 
Diagnoses that need to be ruled out: ----------------------------------------------------------------
--------- 
-------------------------------------------------------------------------------------------------- 
AGE (OR DATE) Description (symptoms,triggering events) Treatment 
---------------------- ------------------------------------------------- ----------------------------- 
-------------- ------------------------------------------------- -------------------------------------- 
----- ----------------------------------------------- ------------------------------------------- 
---------------------------------------------- -------------------- ----------------------- ------ 
---------------------------------------- ------------------------------------------- ---------------- 
------------------------------ -------------------- ---------------------- ------------------------- 
-------------------- ------------------------------------------- ----------------------------------- 
------------ ------------------------------------------- --------------------------------------------- 
-- ------------------------------------------ ------------------------------------------------ -- 
---------------------------------------- ------------------------------------------------ ----------- 
------------------------------- ------------------------------------------------ -------------------- 
----------------------- ------------------------------------------------ ----------------------------- 
------------- -------------------------------------------------- -------------------- 
 
RETURN TO OVERVIEW PAGE 1V, OTHER CURRENT 
182 
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SCID (DSM-IV)VERSION 2.0(FEB 1996 FINAL)Screening Questions screening 
–page1 
 
SCID SCREENIG MODULE (OPTIONAL) 
Ni bayi mo fe beere awon ibeere kan 
Nipato nipa isoro ti e le ti niri .a o ma 
yan nana re to baya. 
 
RESPONSED TO POSITIVE RESPONSES WITH: We’ ll talk more about that later. 
 
1. Nje e ti mu oti ri nigbakan nigbesi aye yin                               Circle” NO” on E 1 
Circle” yes“ on E 1 
bii burukutu, emu ,gulder ni idiwon tumbila mewa 
ati paraga,ogogoro ni idiwon tumbila meta nijoko ekan 
 
2. Nje e ti mu oogun oloro kankan ri?                                     Circle” NO” on E 10 
Circle” yes “ on E 10 
(Bii igbo,kokain ati bebe lo) 
 
3. Nje oogun kan ti dokita ko tabi ti e ra ni chemist                Circle” NO” on E 10 
Circle” yes “ on E 10 
Ti di baraku fun yin ti e lo ju iye to ye ki e lo lo 
 
4. Nje e ti ni idojuko eru tabi ijaya ojiji ti o mu ki                   Circle” NO” on F.1 
Circle” yes F. 1 
awon apere kankan ma fi ara han lara yin 
 
5. Nje o ti sele ri wipe eru ati jade ninu ile                               Circle” NO” on F 7 
Circle” yes “ F.7 
Ma n nba yin,wiwa ni arin ero,diduro 
lori ila tabi ririn irin ajo ninu oko 
tabi reluwe? 
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6. Nje ohun kankan wa ti eru e ma n bayin                            Circle” NO” on F. 11 
Circle” yes” on F . 11 
ati se,tabi ti ara yin ki bale ati se laarin 
awon elomiran bi sisoro, jijeun, 
tabi ki a ma kowe? 
 
7. Nje awon nkankan wa ti e n beru ni pato                              Circle” NO” on F16 
Circle” yes” on F16 
bi fifo ninu balu,riri eje,iro ibon,ibi giga, 
alafo ti o di pa tabi awon eranko kan tabi kokoro 
 
8. Nje o ti sele ri wipe ki ero ti ko mogbon dani                     Circle” NO” on F20 
Circle” yes” on F20 
ma damu okan yin kosi tun ma wa leralera ti 
e ba ti e gbiyanju ati ma ro? 
 
9. Nje awon ohun kan wa ti e ko le ma se,ti e si ma               Circle” NO” on F 2 1 
Circle” yes” on F 2 1 
nse leralera bi ka fo owo nigbogbo igba,tabi ki a ye 
nkan wo ni igba pupo lati le mo boya a ti se daradara? 
 
10. Ni osu mefa sehin see se alaifara bale tabi gbon riri?     Circle” NO” on F. 3 1 
Circle” yes” on F. 3 1 
 
 
 
11. Nje igba kankan wa ti o je wipe iwon yin diku si            Circle” NO” on H. 1 
Circle” yes “ on H. 1 
ohun ti awon eniyan ro wipe iwon yin je? 
 
12. Nje e ma nsaba ni awon igba ti o je wipe e ma                Circle” NO” on H. 4 
Circle” yes “ on H. 4 
n jeun lai bikita? 
 
 
SCID-I/P VERSION 2.0 (for DSM IV) 
 
PSYCHOTIC AND ASSOCIATED SYMPTOMS 
 
Ipale yii wa fun awon to ni arun opolo ati awon to fara pee to ti leni ri 
 
If already has acknowledged psychotic symptoms:  
Eti so fun mi nipa arun opolo te ni, mo wa fe bere lowo yin nipa nkan to ti le se yin ri. 
Nje igbakan ti wa to dabi pe awon kan soro nipa yin ninu okan yin ti won si n ba yin soro 
lona oto 
 
DELUSION 
 False belief based on incorrect inference about external reality and firmly sustained 
in spite 
of what almost everyone else believes in spite of what constitutes incontrovertible and 
obvious 
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proof or evidence to the contrary. The belief is not one ordinarily accepted by other 
members of 
person’ s culture or subculture. Code overvalued ideas(unreasonable and sustained beliefs 
that are 
maintained with less than delusional intensity)as “ 2”  
 
Delusion of reference i.e. events, objects, or ?  Other people in the individuals immediate 
Environment has a particular or unusual significance. 
 
To ba je beeni, se erope won soro Nipa yin tabi erongba okan re ni Eso ni kikun: Nje 
awon yii ma n fun yin ni imoran lati ori television tabi redio tabi ninu iwe iroyin tabi bii 
ati se to nkan Se e le so wipe awon to n ba yin soro yin tabi mu inira bayin tabi se yin 
ni ijanba ?  
 
Persecutory delusion i.e.  the individual 
(or his or her group )is being attacked,harassed,cheated,persecuted,or conspired against 
you 
Eso ni kikun Nje e ti ro ri wipe e je eniyan  
 
Grandiose delusion i.e content involves ? 
Pataki ni ilu wa yii tabi eni agbara exaggerated power, knowledge,or importance 
lati se nkan ti ara yoku ole se or a special relationship to a deity or famous person 
Describe: 
N je e ti sa ki a si wipe e  
 
Somatic Delusion i.e content involves? change or disturbance in body appearance or 
functioning 
ni ailara kan ni ara yin botile sepe  dokita yin ni ko si nkankan mu yin bii arun jejere tabi 
awon arun miiran Nje e ti mo ni pato wipe eya Eso ni kikun Ara kan ko se daradada tabi 
bi o se ri? N je e ti sa kiyesi wipe nkan ti o ye Kan se le bi nkan ajeji n se le si Eya ara yin 
kankan? N je e ti gba esin sodi ri?  
Other Delusion ?  
 
Check if: 
-Religious delusions 
-Delusion of Guilt 
-Jealous Delusions 
-Eromatic Delusions 
 
N je e ti se nkan ti o da fun yan ri tabi ese kan 
to le je ki e jebi idajo 
I f never had a delusion and there is no suspicion 
Of any psychotic features 
Descibe(eso ni kikun): 
 
Check here and Go to  
 
Delusion of being controlled i.e feelings impulses, thoughts, or actions are experienced as 
being Under control of same external force 
 
N je e ti ro wipe eniyan kankan Tabi nkankan nita ara yin soro Sinu okan yin tabi pe ke e 
se  
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Nkan ti e Fe se.  
 
Check if: 
 
-thought insertion 
-thought withdrawal 
 
Nje o ti seleri wipe awon ero Kan ti ko se tiyin ti man wa si okan yin 
Se awon ero yii ma n jade Kuro lokan yin 
 
Describe: (Eso ni kikun) 
 
Thought Broadcasting i.e the delusion that one‘s thought are audible to others 
ma so sita ki awon ara yoku 
 
N je e ti ro wipe awon ero yii legbo nkan ti e n ro lokan 
Se e ti ro wipe awon Kan le mo nkan Ti e n ro lokan tabi ti e fe so 
 
Describe (E so ni kikun) 
 
How do you explain content Of delusion? 
 
Bizarre Delusion i.e. involving a  individual‘s Subculture would regard as totally 
Implausible e.g. the person’ s brain has been removed and replaced with someone else’ s 
brain 
Describe; 
 
 
 
 
 
Auditory Hallucination 
Hallucinations (psychotic) 
A Sensory perception that has the compelling sense of reality of a true perception but 
occurs without external stimulation of relevant sensory organ. Code 2 for hallucination 
that is as transparent as to be without Diagnostic significance. 
 
Auditory Hallucinations when ?fully awake, heard either inside or outside your head 
 
A voice keeping up a running connection  on the individual’ s behaviour or thoughts as 
they occur 
 
 
 
Tabi oro awon kan ti a so kelekele N je e ti ma n gbo nkan ti A won kan ole gbo tabi 
ariwo Si yin leti (nje e ko sun ni gba yen)  
 
To ba je beeni: ki le n gbo? E so ni kikun B awo le se ma n saba gbo ohun Yii? 
 
To ba je ohun (voices): se won fesi si nkan ti e n se tabi ro lokan 
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Go to visual hallucination below 
 
Visual Hallucinations 
 
Visual Hallucination ? 
N je e ma ri iran tabi Ri nkan ti awon yoku o ri Describe (se e e ko sun nigba yen) 
 
NOTE: Distinguish from an Illusion i.e a misperception of A real external stimulus. 
Nj e e ma n ri ki nkankan Ma run lara yin?  
 
Describe: 
Nj e e ma n gborun ti awon Miiran ko gbo  
Other Hallucination e.g gustatory, olfactory 
Check if: 
-gustatory 
-olfactory 
Describe: 
 
Other Symptoms 
I f No suggestion that there have ever been psychotic symptoms,Check Here --- and skip 
to 
module D 
(Let me stop for a minute and make some full notes…….) 
 
The following items are rated Catatonic behaviour based on observation And history 
consults Old charts, other observers E.g. family members, Therapeutic staff) 
 
-tabi ko kotikun si nkan ?  
-lilera laisepe won so fun yin ?  
-tabi ko ma sare malo bii ko ma se giragira laisepe e so fun te ba ni ko ma se bii ko gbese 
kuro legbe ina ,ko si ma dahun 
-bii ko ma rin ni ona to je pe ohun nikan lo ye bii gbowo lejika fun igba pipe ? 1 2 3 
-so oro tele yin tabi se ohun te ba n se ?  
 
Describe: 
 
Grossly Disorganised Behaviour  
E yi tile beere lati igba to wa ni Kekere ti o ma n se ipanle si ailenisuru Ti o ma ri bi eni ti 
won toju tabi mura ni,ma woso ti o bar a mu bii wo aso meeji meta po tabi wo aso erun 
nigba ojo,ati bi ko ma yo oko sita ladubgbo, tabi si dile,ati ki o ma pa ariwo laito tabi sepe 
 
Describe: 
 
Grossly Inapproprite Affect:  
Nje igba kan leti wa ti oro re ko Ba tara ye yoku mu,bii ko ma Dun nu ju,tabi sokun laito , 
Idunnu yii le wa fun igba pipe Tabi ki e ma ba soro ko ma tara ye mu 
 
Describe: 
 
Disorganized Speech:  
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Eyi ma n sele nigba mi bii ko o Ma a soro ti oni jora won tabi Fo lati ori oro kan si oro 
mii ti a Ko bii tabi ti o jo mo oro to n so, Tabi ko kan farape die.Awon Oro mi ko ni mu 
ero gidi lowo Tobege wipe awon oro yen o ni Itumo. 
 
DESCRIBE: 
 
N egative Symptoms 
F or any Negative Symptoms Coded 3 ,Determine whether the symptoms is definitely 
Primary or whether it is possible or definitely Secondary i.e related to another mental 
disorder e.g(depression),a substance or a general medical condition (e.g medication 
induced Akinesia) or to a psychotic symptoms(e.g) command hallucinations not to move 
 
 
IF UNKNOWN; 
Bawo lese ma n lo asiko yin?  
 
AVOLITION:  
Nje gbogbo nkan ti e ba gbero Pe e fe se le ma n lese?Se e ti ro wipe e fe paro ise kan si 
kan Tabi e n le lati se nkan,tabi e fe Se itoju ara yin,se e ma n le se? 
 
ALOGIA: 
 nje o ma n  Ro ero miiran ti a ko ni ri itumo Kankan mu jade tabi ni iwuwa, 
Idahun re nigbami le kere si oroTe bi,oro re nigbami le ma to iye ti afe so tabi ko je pe 
awon oro to 
Ni itumo re le ma po,tabi ko maMu ogbon wa,tabi ko ma so tele yin Tabi ko ma ni 
patterni kan 
 
Affective Flattening:   
Eyi ma n sele nigbati ko fe e Si tabi ko sin kan to feran tabi Ko ma fi apeere han ti nkan 
ayo Tabi nkan buruku ba sele 
 
C. Differential Diagnosis of Psychotic Disorders 
Note: Both primary psychotic system and psychotic systems that are substance induced or 
due to a general medical condition may be present in the same individual at the time. this 
may 
require multiple ‘passes’  through the algorithms in this module. 
If: All psychotic symptoms in module B are due to a substance or A general medical 
Condition, Go to Gmd substance C16. 
If: there are no items coded 3 in B psychotic and associated symptoms 
Check Here_____ and skip to next module 
 
 
 
SCHIZOPHRENIA CRITERIA  
CHECK FOR PRESENCE OF ACTIVE  (NOTE: CRITERIA ARE IN 
DIFFERENT ORDER THAN IN DSM-IV) 
PHASE SYMPTOMS    A. Two (or more) of the following, each 
present for   
REFER TO ITEMS CODED “ 3”  IN   a significant portion of time during a one 
month  
THE PSYCHOTIC AND ASSOCIATED  period (or less id successfully treated): 
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SYMPTOMS MODULE (MODULE B)  
 
1) Delusions 
2) Hallucinations  
3) Disorganized speech (e.g., 
frequent derailment or 
incoherence) 
4) Grossly disorganized or 
cataonic behavior  
5) Negative symptoms, i.e., 
affective flattening, alogia, or 
avolitio. 
(Note: only one A symptom is 
required if delusions are bizarre 
or hallucinations consists of a 
voice keeping up a running 
commentary on the person’s 
behavior or thoughts, or two or 
more voices conversing with each 
other.) 
D. Schizoaffective Disorder and 
mood Disorder with Psychotic 
Features have been ruled out 
because either: 
IF UNCLEAR: Has there ever been a time  1) No major Depressive, Manic 
or Mixed  
when you had (SXS FROM ACTIVE PHASE) episodes have occurred 
concurrently with  
at the same time that you were (down/high/  the active phase symptoms (i.e., 
the “ A”   
irritable / OWN EQUIVALENT)?   Symptoms listed above) 
 
NOTE: CODE “ 3”  IF NEVER 
ANY MAJOR DEPRESSIVE OR 
MANIC EPISODES OR IF ALL 
MAJOR DEPRESSIVE AND 
MANIC EPISODES 
OCCURRED DURING THE 
PRODROMAL OR RESIDUAL 
PHASE. 
CODE “ 1”  IF ANY MOOD 
EPISODES OVERLAP WITH 
PSYCHOTIC SYMPTOMS. 
 
NOTE: BECAUSE OF THE 
DIFFICULTY IN 
DISTINGUISHING THE 
PRODROMAL AND 
Stellenbosch University  http://scholar.sun.ac.za
 246 
 
RESIDUAL SYMPTOMS OF 
SCHIZOPHRENIA FROM A 
MAJOR DEPRESSIVE 
SYNDROME, THE  RATER 
SHOULD RECONSIDER ANY 
PREVIOUSLY CODED MAJOR 
DEPRESSIVE EPISODE TO BE 
SURE IT IS UNEQUIVOCAL. 
 
IF UNCLEAR: How much of the time   2) the total duration of mood 
episodes  
that you have had (SXS FROM ACTIVE   (occurring during the 
disturbance) has been  
AND RESIDUAL PHASES) would you say  brief relative to the total duration of the  
you have also been (depressed / high/irritable/  active and residual phases. 
OWN EQUIVALENT)? 
 
 
NOTE: CODE “ 1”  IF 
SYMPTOMS MEETING 
CRITERIA FOR A MAJOR 
DEPRESSIVE, MANIC, OR 
MIXED EPISODE HAVE BEEN 
PRESENT FOR A 
SUBSTANTIAL PORTION OF 
THE TOTAL DURATION OF 
THE ACTIVE AND RESIDUAL 
PHASES 
 
NOWMAKE A DIFFERENTIAL    C. Continuous signs of the 
disturbance  
DIAGNOSIS BETWEENSCHIZOPHRENIA  persist for at least six months. 
This six -  
AND SCHIZOPHRENI FORM DISORDER month period must include at 
least one  
       Month of symptoms that meet 
criterion A  
 (i.e., active phase symptoms), and 
may 
 IF UNCLEAR: Between (MULTIPLE  include periods of prodromal or 
residual  
 EPISODES), were you back to your   symptoms. During these 
prodromal or  
 normal self? How long did each episode  residual periods, the signs of the 
disturbance  
 last?      may be manifested by only 
negative sxs (i.e.,  
 affective flattening, alogia, 
avolition) or two  
 or more symptoms listed in 
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criterion A  
 present in an attenuated form 
(e.g., odd  
 beliefs, unusual perceptual 
experiences). 
 
IF NOT ALREADY KNOWN: When you   B. For a significant portion of the 
time since  
(HAD “ A”  CRITERION SXS), were   the onset of the disturbance, one 
or more  
You (working, having a social life, taking   major areas of functioning such 
as work, 
care of yourself)?     Interpersonal relations or self-
care is  
       markedly below the level 
achieved prior to  
       the onset (or when the onset is in 
childhood  
       or adolescence, failure to achieve 
expected  
       level of interpersonal academic, 
or  
       occupational achievement). 
 
IF NOT KNOWN: Were you taking any  E. The disturbance is not due to 
the direct  
drugs of medicines during this time?   Physiological effects of a 
substance (e.g., a  
       drug of abuse, a medication) or to 
a general  
IF NOT KNOWN: Were you physically ill  medical condition. 
at this time?        
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
       Etiological general medical 
conditions  
       include: neurological conditions 
 
IF THERE IS ANY INDICATION 
THAT THE PSYCHOTIC SXS MAY 
BE SECONDARY (I.E., A DIECT  
PHYSIOLOGICAL CONSEQUENCE 
OF A GMC OR SUBSTANCE, GO TO 
*GMC/SUBST* C. 16, AND 
RETURN HERE TO MAKE A 
RATING OF “ 1”  OR “ 3” . 
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(e.g.,  
       neoplasms, cerebrovascular 
disease,  
       Huntington’s disease epilepsy, 
auditory  
       nerve injury, deafness, migraine, 
central  
       nervous system infections); 
endocrine  
       conditions (e.g., hyper – and 
hypothyroidism,  
       hyper – and hypoparathyroidism,  
       hypocortisolism); metabolic 
conditions (e.g., 
       hypoxia, hyper carbia, 
hypoglycemia); fluid  
       or electrolyte imbalances; hepatic 
or renal  
       diseases; and autoimmue 
disorders with  
       central nervous system 
involvement (e.g.,  
       systemic lupus erythematosis). 
 
       Etiological substances include: 
alcohol,  
       amphetamine, cannabis, cocaine,  
hallucinogens, inhalants, opioids  
(meperidine), phencyclidine 
sedatives, hypnotics, and 
anxiolytics, and other or known 
substances.  
 
 
 
 
*SCHIZOPHRENIA TYPES* 
NOW DETERMINE THE CURRENT PHENOMENOLOGIC TYPE: 
 
Paranoid Type: currently:  
 
A. Preoccupation with one or more 
delusions or frequent auditory 
hallucinations. 
 
B. None of the following is  
prominent: disorganized speech, 
disorganized behavior, flat of 
inappropriate affect or catatonic 
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*PARANOID TYPE*    
  
      
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
behavior.  
 
 
Catatonic Type: currently the clinical 
picture is dominated by at least two of the 
following: 
 
1) Motoric immobility as evidenced 
by catalepsy (including waxy 
flexibility ) or stupor. 
2) Excessive motor activity (that is 
apparently purposeless and not 
influenced by external stimuli) 
3) Extreme negativism (an apparently 
motiveless resistance to all 
instructions or maintenance of a 
rigid posture against attempts to be 
moved ) or mutism. 
4) Peculiarities of voluntary 
movement as evidenced by 
posturing (voluntary assumption of 
inappropriate or bizarre postures), 
stereotyped movements, prominent 
mannerisms, or prominent 
grimacing. 
5) Echolalia or echopraxia. 
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*CATATONIC TYPE* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*DISORGANIZED TYPE*   
  
IF UNKNOWN, DETERMINE WETHER  
FLAT OR IN APPROPRIATE AFFECT HAS  
BEEN PRESENT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Disorganized Type: currently the 
following criteria are met: 
 
A. All of the following are 
prominent: 
 
1) Disorganized speech 
2) Disorganized behavior  
3) Flat or inappropriate affect  
B. Does not meet criteria for 
Catatonic type. 
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*UNDIFFERENTIATED TYPE*   
   
 
 
 
 
 
 
 
*RESIDUAL TYPE*      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*SCHIZOPHRENIFORM DISORDER* SCHIZOPHRENIFORM DISORDER 
CRITERIA 
 
SCHIZOPHRENIA HAS BEEN RULED OUT BECAUSE THE DURATION IS LESS 
THAN SIX MONTHS 
 
IF NOT KNOWN:How long did (PSYCHOTIC SXS) LAST? 
 
IF NOT KNOWN:  
NJE EN LOGUN KANKAN NIGBA NAA 
 
IF NOT KNOWN: 
Nje aisan Kankan ti a le toju ri nseYin Ni gba naa? 
 
 B.An episode of the disorder  (including prodromal, active and residual phases) lasts at 
least one month but less than six months 
(se o sele fun osu kan Sugbon ko to mefa) 
 
GO TO*BRIEF PSYCHOTIC DISORDER C.14 
 
 
Undifferentiated Type: currently 
symptoms meeting criterion A for 
Schizophrenia are present, but the 
Criteria are not met for the Paranoid, 
Catatonic, or Disorganized Types. 
 
Residual Type: currently, the following 
criteria are met: 
 
A. Absence of prominent 
delusions, hallucinations, 
disorganized speech, and 
grossly disorganized or 
catatonic behavior. 
B. There is continuing evidence of 
the disturbance, as indicated by 
the presence of negative 
symptoms or two or more 
symptoms listed in criterion A 
for Schizophrenia, Present in an 
attenuated form (e.g., odd 
beliefs,  unusual perceptual 
experiences).  
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C. The disturbance is not due to direct physiological effects of substance (eg a drug Of 
abuse,medication)or to a General medical condition 
 
GO TO *PSYCHOTIC DISORDER NOS C.20 
 
SCHIZOPHRENIFORM DISORDER 
 
IF THERE IS ANY INDICATION THAT THE PSYCOTIC SXS MAY BE 
SECONDARY(I.E A DIRECTION PHYSIOLOGICAL CONSEQUENCE OF A GMC 
OR SUBSTANCE,GO TO GMC*/SUBST*C.16 AND RETURN HERE TO MAKE A 
RATING OF “ 1” OR “ 3”  
 
IF OTHER PERIODS OF PSYCHOTIC SXS NOT DUE TO A SUBSTANCE OR GMC 
RETURN TO C.1 OTHERWISE GO TO NEXT MODULE  
 
REFER TO LIST OF GENERAL MEDICAL CONDITIONS AND SUBSTANCES C.5 
 
When diagnoses is made without waiting For recovery, it should be qualified 
as“ Provisional”  
 
N OTE: CODE” 2”  IF THE EXPECTEDRECOVERY HAS NOT YET OCCURRED 
CODE” 3” IF THERE HAS BEEN A FULL RECOVERY 
 
PROVISIONAL DX  
 
DEFINITE DX  
 
CONTINUE ON NEXT PAGE 
 
 
NOW DETERMINE IF GOOD PROGNOSTIC FEATURES ARE PRESENT 
 
At least two of the following features that is generally associated with good prognosis 
 
(1) Onset of prominent psychotic symptoms Within 4 weeks of first noticeable chang In 
usual behaviour or functioning 
 
(2) Confusion or perplexity at the height Of the psychotic episode 
 
(3) Good premorbid social and occupational functioning 
 
(4) Absence of blunted or flat affect 
 
AT LEAST TWO GOOD PROGNOSTICS FEATURES CODED “ 3”   
 
 
*SCHIZOAFFECTIVE DISORDER*  
 
SCHIZOPHRENIA AND SCHIZOPHRENIFORM A DISORDER HAVE BEEN 
RULED OUT BECAUSE OF PROMINENT MOOD SYMPTOMS. CONSIDER. A 
DIAGNOSIS OF SCHIZOAFFECTIVE DISORDER  
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SCHIZOAFFECTIVE DISORDER CRITERIA 
 
A.  An uninterrupted period of illness during which, at some time, there is either a Major 
Depressive Episode (which must include (1) depressed mood), a Manic or a Mixed 
episode concurrent with symptoms that Meet Criterion A for Schizophrenia 
 
Note: The Major Depressive Episode must Include criterion A1: depressed mood  
 
B. Nigba ti ara yin ko ya yi, se o ti sele ri wipe e ma n gbo ohun ajeji tabi ri iranti awon 
eniyan miran fun bi ose meji lai si awon aperemiran. 
 
GO TO CHRONOLOGICAL *C.21 
GO TO PSYCOTIC DISORDER NOS*C2 
 
C. Awon apere to le so fun wa wipe gan n waye Ni gbogbo igba ti ailera yi fi wa. 
 
IF NOT KNOWN: Nje e n lo oogun kankan nigba na  
 
IF NOT KNOWN: Nje e se aisan kankan ti a le foru ri 
 
D. The disturbance is not due to the direct Physiological effects of a substance (e.g. a 
Drug of abuse, medication) or to a general 
 
GO TOPSYCOTIC DISORDER NOS*C.20 
 
 
SCHIZOAFFECTIVE DISORDER.SELECT SUBTYPE 
 
DUE TO SUBSTANCE OR GMC;IF OTHER PERIODS OF PSYCHOTIC SXS NOT 
DUE TO A SUBSTANCE OR GMC 
 
REFER TO LIST OF GENERAL MEDICAL CONDITIONS AND SUBSTANCES ON 
PAGE C5 
 
SCHIZOAFFECTIVE DISORDER SUBTYPES 
 
Manic Episode or Mixed Episode (or a Manic Or Mixed Episode and Major Depressive 
Episodes) during the course of the disturbance 
 
DEPRESSIVE TYPE.  BIPOLAR TYPE 
 
 
GO TO CHRONOLOGICAL *C.21 
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ADDENDUM D 
Neurological Evaluation Scale 
(Buchanan, Heinrichs – 1989) 
 
1. Tandem Walk 
Instructions:  Subject to walk, in a straight line, 12 feet, heel to toe. 
Assessment:  0 = no missteps after subject has completed first full step;  1 
= one or two missteps after completion of first full step;  2 = 3 or more 
missteps, grabbing or falling. 
2. Romberg Test 
Instructions:  Subject to stand with his/her feet together, eyes closed, 
his/her arms held parallel to the floor, and fingers spread apart.  The 
subject is to maintain this position for 1 min. 
Assessment:  0 = relatively stable, minimal swaying; 
1 = marked swaying;  2 = subject steps to maintain balance or falls. 
3. Adventitious Overflow 
Instructions:  Same as Romberg Test. 
Assessment:  0 = absence of movement of fingers, hands, or arms;  1 = 
irregular fluttering movement of fingers only; 
2 = irregular fluttering movement extended to hands and/or arms. 
4. Tremor 
Instructions:  Same as Romberg Test. 
Assessment:  0 = no tremor;  1 = mild, find tremor; 
2 = marked, find or coarse tremor. 
5. Cerebral Dominance 
a. Handedness 
Instructions:  Ask subject to demonstrate how he/she would write, throw a 
ball, use a tennis racket, strike a match, use scissors, thread a needle, use a 
broom, use a shovel, deal cards, use a hammer, brush teeth, and unscrew 
the lid of a jar. 
Assessment:  R – Subject write with right hand and performs at least seven 
other activities with right hand;  M – Subject write with right hand but 
performs less than seven other activities with right/left hand;  L – Subject 
writes with left hand and performs at least seven other activities with left 
hand. 
 
b. Footedness 
Instructions:  Ask subject to demonstrate how he/she would kick a ball. 
Assessment:  R – Subject kicks ball with right foot; 
L – Subject kicks ball with left foot. 
 
c. Eyedness 
Instructions:  Ask subject, with both eye open, to look at a distant object 
through a hole in the center of a 3-inch x 5-inch index card that is held 
with both hands 18 inches in front of the subject.  The subject is to close 
one eye at a time and tell the examiner with which eye closed did he/she 
lose sight of the object. 
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Assessment:  R – Subject loses sight of object with right eye closed;  L – 
Subject loses sight of object with left eye closed. 
6. Audio-Visual Integration 
Instructions:  The subject is asked to match a set of tapping sounds with 
one of three sets of dots presented on a 5-inch x 7-inch index card.  The 
subject is instructed to close his/her eyes during the tapping.  Three 
practice trials are performed first to ensure that the subject understands the 
directions. 
Assessment:  0 = no error;  1 = one error;  2 = two or more errors. 
7. *Stereognosis 
Instructions:  Subject, with eyes closed, is asked to identify an object 
placed in his/her hand.  Subject is instructed to feel the object with one 
hand and to take as much time as needed.  If subject cannot name the 
object, he/she is asked to describe for what purpose the object is used.  The 
subject starts with the dominant hand, based on the prior evaluation of 
handedness, or the hand with which he/she writes, if there is mixed hand 
dominance.  The instructions are repeated at the beginning of the second 
trial. 
Assessment:  0 = no errors;  1 = one error;  2 = more than one error. 
8. *Graphesthesia 
Instructions:  Subject with eyes closed, is asked to identify the number 
written on the tip of his/her forefinger.  The order of hands is determined 
as with stereogenosis. 
Assessment:  0 = no errors;  1 = one error;  2 = more than one error. 
9. *Fist-Ring Test 
Instructions:  The subject is asked to alternate placing his/her hand on the 
table, in the position of a first, with the thumb placed either over the 
knuckles or over the middle phalanges and placing his/her hand, on the 
table, in the position of a ring, with the tips of the thumb and forefinger 
touching and the remaining three fingers extended.  The subject is to bring 
his/her arm into the upright position between each change in hand position.  
If the subject does not perform the movement accurately or in a manner 
that can be appropriately assessed, he/she is to be stopped to be 
reinstructed, and to start the test again.  The subject is to repeat each set of 
hand position changes 15 times. 
Assessment:  0 – no major disruption of motion after first repetition;  
errors limited to incomplete extension of fingers in ring position and no 
more than two hesitancies in the transition from fist to ring or vice versa 
and no more than one fist/ring confusion;  1 = no major disruption of 
motion after first repetition or complete breakdown of motion;  more than 
two hesitancies in the transition from fist to ring, difficulty in developing 
and maintaining a smooth, steady flow of movement, three to four fist/ring 
confusions, or any total of three but not more than four errors;  2 = major 
disruption of movement or complete breakdown of motion, or more than 
four fist/ring hesitations or confusions. 
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10. *Fist-Edge-Palm Test 
Instructions:  Ask the subject, using a smooth and steady rhythmic 
pattern, to touch the table with the side of his/her fist, the edge of his/her 
hand, and the palm of his/her hand.  The subject is to break contact with 
the surface of the table between each change in hand position, but not to 
bring the arm back in full flexion.  The subject is to repeat this sequence of 
position changes 15 times. 
Assessment:  0 = no major disruption of motion after first repetition;  
errors limited to no more than two hesitancies in the transition from one 
position to the next and no more than one mistake in hand position;  1 = no 
major disruption of motion after first repetition of complete breakdown of 
motion; more than two hesitancies in the transition from one position to 
another, difficulty in developing and maintaining a smooth, steady flow of 
movement, three to four position confusions, or any total of three or four 
errors;  2 = major disruption of movement or complete breakdown of 
motion or more than four hesitations or position confusions. 
11. Ozeretski Test 
Instructions:  The subject is to place both hands on the table, one hand 
palm down and the other hand in the shape of a fist.  The subject is then 
asked simultaneously to alternate the position of his/her hand sin a smooth 
and steady motion.  The subject is asked to repeat this motion 15 times. 
Assessment:   0 = no major disruption of motion after first repetition;  
errors limited to no more than two hesitancies in the transition from one 
position to the next and no more than one mistake in hand position;  1 = no 
major disruption of motion after first repetition or complete breakdown of 
motion; more than two hesitancies in the transition from one position to 
another, difficulty in developing and maintaining a smooth, steady flow of 
movement, three to four position confusions, or any total of three, but no 
more than four errors;  2 = major disruption of movement or complete 
breakdown of motion; more than four hesitations or position confusions. 
12. Memory 
Instructions:  Subject is told four words and is asked to repeat them 
immediately after they are all presented.  If the subject is unable to repeat 
the four words correctly, they are represented.  If the subject still cannot 
repeat the four words after a total of three presentations of the words, the 
test is terminated and the subject is given a score of 2 for both parts of the 
item.  If the subject is able to repeat the four words after the initial or two 
subsequent presentations, he/she is then asked to remember the words as 
well as possible and told that he/she will be asked to repeat the words 
twice later on during the interview.  The subject is then asked to recall the 
four words at 5 and 10 min. 
Assessment:  0 = Subject remembers all words; 
1 = Subject remembers three words;  2 = Subject remembers fewer than 
three words. 
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13. Rhythm Tapping Test 
Part A 
Instructions:  Ask the subject to reproduce exactly the series of taps heard 
while the subject has eyes closed.  The subject may have eyes open while 
reproducing series of taps. 
Assessment:  0 = no errors;  1 = one error of either nondiscrimination 
between soft and hard sounds, rhythm, or error in number of taps; 2 = 
more than one error. 
 
Part B 
Instructions:  Ask the subject to produce a series of taps as instructed. 
Assessment:  0 = no errors;  1 = one error;  2 = more than one error. 
14. *Rapid Alternating Movements 
Instructions:  Ask the subject to place his/her hand palms down on legs.  
The subject is to start with his/her dominant hand and is to slap his/her leg 
distinctly with the palm and the back of his/her hand in an alternating 
motion.  The determination of dominance is as described above (see item 
8).  The subject is to perform the task 20 times, with both hands, one hand 
at a time. 
Assessment:  1 – no major disruption of motion, hesitation, or mistake in 
hand placement;  1 = no major disruption of motion or one to two 
hesitations or mistakes in hand placement; 
2 = major disruption of motion or three or more hesitations or mistakes in 
hand placement. 
15. *Finger-Thumb Opposition 
Instructions:  Ask the subject to place both hand palms up with fingers 
fully extended on his/her legs.  The subject is to start with his/her 
dominant hand and is to touch the tip of his/her fingers with the tip of 
his/her thumb, from forefinger to pinky, returning to forefinger, for a total 
of 10 repetitions. 
Assessment:  0 = no major disruption of motion and no more than one 
mistake;  1 = no major disruption of motion or two to three mistakes;  2 = 
major disruption of motion or four or more mistakes. 
16. *Mirror Movements 
Instructions:  The subject’s hand, which is not performing the Finger-
Thumb Opposition Test, is observed for parallel movements of the fingers 
and thumb. 
 
Assessment:  0 = no observable movements of the fingers; 
1 = minor, inconsistent, or repetitive movements of the fingers;  2 = 
consistent, distinctive movements of the fingers. 
17. Extinction (Face-Hand Test)               
Instructions:  The subject is seated, with hands resting palm down, on 
his/her knees and with eyes closed.  The subject is told that he/she will be 
touched on either the cheek, hand, or both, and is to say where he/she is 
asked – the first time this occurs only – if he/she felt a touch anywhere 
else.  The simultaneous touching is done in the following order:  right 
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cheek-left hand, left cheek-right hand, right cheek-right hand, left cheek-
left hand, both hands, and both cheeks. 
Assessment:  0 = no errors;  1 = one error;  2 = more than one error. 
18. Right/Left Confusion 
Instructions:  Subject is asked to point to his/her right foot, left hand;  
place his/her right hand to left shoulder, left hand to right ear; point to 
examiner’s left knee, right elbow; with examiner’s arms crossed, point to 
examiner’s left hand with his/her right hand, and with examiner re-
crossing arms, point to examiner’s right hand with his/her left hand. 
Assessment:   0 = no errors;  1 = one error;  2 = two or more errors. 
19. Synkinesis 
Instructions:  Subject is instructed to follow the cap of a pen with his/her 
eyes only as it is moved between extremes of horizontal gaze.  If the 
subject moves his/her head, the subject is asked to keep his/her head still 
and follow the cape of a pen with the eyes only. 
Assessment:  0 = no movement of the head; 
1 = movement of the head on first trial but not when specifically told to 
keep head still;  2 = movement of the head even when told to keep head 
still. 
20. Convergence 
Instructions:  Subject is instructed to follow the cap of a pen with his/her 
eyes as it is moved toward the subject’s nose. 
Assessment:  0 = both eyes converge on object;  1 = one or both eyes are 
unable to converge completely, but can converge more than halfway;  2 = 
one or both eyes fail to converge more than halfway. 
21. Gaze Impersistence 
Instructions:  Subject is instructed to fix his/her gaze on the cape of a pen 
at a 45o angle in the horizontal place of the right and left visual fields for 
30 sec. 
Assessment:  0 = no deviation from fixation;  1 = deviation from fixation 
after 20 sec;  2 = deviation from fixation before 20 sec. 
 
22. Finger to Nose Test 
Instructions:  The subject is instructed to close eyes and touch the tip of 
his/her nose with the tip of his/her index finger. 
Assessment:  0 = no intention tremor or pass- pointing; 
1 = mild intention tremor or pass-pointing;  2 = marked intention tremor or 
pass-pointing. 
23. Glabellar Reflex 
Instructions:  Subject is instructed to fix his/her gaze on a point across the 
room.  The subject is approached from above the forehead outside of the 
visual field, and the examiner taps the glabellar region 10 times with the 
index finger. 
Assessment:  0 = three or fewer blinks;  1 = four or five full blinks, or 
more than six partial or full blinks;  2 – six or more full blinks. 
24. Snout Reflex 
Instructions:  Subject is instructed to relax, and the examiner presses his 
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finger against the subject’s philtrum. 
Assessment:  0 = no contraction of the orbicularis orris (or puckering of 
the lips);  2 = any contraction of the orbicularis orris (or puckering of the 
lips). 
25. Grasp Reflex 
Instructions:  The subject is instructed not to grab, and the examiner 
strokes the inside of the subject’s palm between the index finger and 
thumb.  This procedure is repeated a second time with the subject being 
asked to spell the word “ help”  backwards. 
Assessment:  0 = no flexion of the subject’s fingers;  1 = mild flexion of 
the subject’s fingers on first trial or flexion of any kind on second trial;  2 
= marked flexion of the subject’s fingers on first trial. 
26. Suck Reflex 
Instructions:  The examiner places the knuckle of a flexed index finger or 
tongue depressor between the subject’s lips. 
Assessment:  0 = no movement;  2 = any pursing or sucking motion by the 
subject’s lips. 
27. Palmomental Reflex     
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Neurological Evaluation Scale (NES) 
 
Name:  ______________________________________________________  Date: 
__________________ 
 
Visit Nr:  ___________________________________ 
 
 
 
 
 
  Absent Present Marked 
1 Tandem Walk 0 1 2 
2 Romberg Test 0 1 2 
3 Adventitious Flow 0 1 2 
4 Tremor 0 1 2 
5 Cerebral Dominance    
 (a) Handedness L M R 
 (b) Footedness L  R 
 (c) Eyedness L  R 
6 Audio-visual Integration 0 1 2 
7 Stereognosis 0 1 2 
8 Graphesthesia 0 1 2 
9 Fist-Ring Test 0 1 2 
10  Fist-Edge-Palm Test 0 1 2 
11 Ozeretski Test 0 1 2 
12 Memory 0 1 2 
13 Rhyth Tapping Test    
 Part A 0 1 2 
 Part B 0 1 2 
14 Rapid Alternating Movements 0 1 2 
15 Finger Thumb Opposition 0 1 2 
16 Mirror Movements 0 1 2 
17  Extinction (Face-Hand Test) 0 1 2 
18 Right/Left Confusion 0 1 2 
19 Synkinesis 0 1 2 
20 Convergence 0 1 2 
21 Gaze Impersistence 0 1 2 
22 Finger to Nose Test 0 1 2 
23 Glabellar Reflex 0 1 2 
24 Snout Reflex 0  2 
25 Grasp Reflex 0 1 2 
26 Suck Reflex 0  2 
27 Palmomental Reflex 0  2 
     
TOTAL SCORE  
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ADDENDUM E 
 
 
 
CLINICAL AND OUTCOME 
ASSESSMENT INSTRUMENTS 
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Pt Initials:………………… Visit:…………………… CRF No:……………… 
Date:……………. 
 
CLINICAL GLOBAL IMPRESSION OF ILLNESS (CGI) 
 D – 7 D – 6  D – 5 D – 4  D – 3  D – 2  D – 1  D – 0 
Date          
Rating          
 
CLINICAL GLOBAL IMPRESSION OF IMPROVEMENT OF ILLNESS (CGI-I) 
NB: Compare to visit D – 7  
 D – 7 D – 6  D – 5 D – 4  D – 3  D – 2  D – 1  D – 0 
Date          
Rating          
 
 
 
CLINICAL GLOBAL IMPRESSION OF ILLNESS (CGI-I) 
 W2 W4 W6 M3 M6 M9 M12 M15 
Date           
Rating         
 
CLINICAL GLOBAL IMPRESSION OF IMPROVEMENT OF ILLNESS (CGI-1) 
NB: Compare to visit D-7 
 W2 W4 W6 M3 M6 M9 M12 M15 
Date           
Rating         
 
 
 
CLINICAL GLOBAL IMPRESSION OF ILLNESS (CGI) 
 M18  M21 M24      
Date          
Rating          
 
CLINICAL GLOBAL IMPRESSION OF IMPROVEMENT OF ILLNESS (CGI-I) 
 M18  M21 M24      
Date          
Rating          
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CALGARY DEPRESSION SCALE FOR SCHIZOPHRENIA 
 
Interviewer: Ask the first question as written. Use follow up probes or qualifiers at 
your discretion. Time framerefers to last two weeks unless stipulated. N.B. The last 
item, #9, is based on observations of the entire interview. 
 
1. DEPRESSION: How would you describe your mood over the last two 
weeks? Do you keep reasonably cheerful or have you been very 
depressed or low spirited recently? In the last two weeks how often 
have you (own words) every day? All day? 
0. Absent 
1. Mild Expresses some sadness or discouragement on questioning. 
2. Moderate Distinct depressed mood persisting up to half the time over last 
2 weeks: present daily. 
3. Severe Markedly depressed mood persisting daily over half the time 
interfering with normal motor and social functioning. 
 
2. HOPELESSNESS: How do you see the future for yourself? Can you 
see any future? - or has life seemed quite hopeless? Have you given 
up or does there still seem some reason for trying? 
0. Absent 
1. Mild Has at times felt hopeless over the last two weeks but still has 
some degree of hope for the future. 
2. Moderate Persistent, moderate sense of hopelessness over last week. Can 
be persuaded to acknowledge possibility of things being better. 
3. Severe Persisting and distressing sense of hopelessness. 
 
3. SELF DEPRECIATION: What is your opinion of your self compared 
to other people? Do you feel better, not as good, or about the same 
as others? Do you feel inferior or even worthless? 
0. Absent 
1. Mild Some inferiority; not amounting to feeling of worthlessness. 
2. Moderate Subject feels worthless, but less than 50% of the time. 
3. Severe Subject feels worthless more than 50% of the time. May be 
challenged to acknowledge otherwise. 
 
4. GUILTY IDEAS OF REFERENCE: Do you have the feeling that you 
are being blamed for something or even wrongly accused? What 
about? (Do not include justifiable blame or accusation. Exclude 
delusions of guilt.) 
0. Absent 
1. Mild Subject feels blamed but not accused less than 50% of the time. 
2. Moderate Persisting sense of being blamed, and/or occasional sense of 
being accused. 
3. Severe Persistent sense of being accused. When challenged, 
acknowledges that it is not so. 
5. PATHOLOGICAL GUILT: Do you tend to blame yourself for little 
things you may have done in the past? Do you think that you deserve 
to be so concerned about this? 
0. Absent 
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1. Mild Subject sometimes feels over guilty about some minor 
peccadillo, but less than 50% of time. 
2. Moderate Subject usually (over 50% of time) feels guilty about past 
actions the significance of which he exaggerates. 
3. Severe Subject usually feels s/he is to blame for everything that has 
gone wrong, even when not his/her fault. 
 
6. MORNING DEPRESSION: When you have felt depressed over the last 
2 weeks have you noticed the depression being worse at any 
particular time of day? 
0. Absent No depression. 
1. Mild Depression present but no diurnal variation. 
2. Moderate Depression spontaneously mentioned to be worse in a.m. 
3. Severe Depression markedly worse in a.m., with impaired functioning 
which improves in p.m. 
 
7. EARLY WAKENING: Do you wake earlier in the morning than is 
normal for you? How many times a week does this happen? 
0. Absent No early wakening. 
1. Mild Occasionally wakes (up to twice weekly) 1 hour or more before 
normal time to wake or alarm time. 
2. Moderate Often wakes early (up to 5 times weekly) 1 hour or more before 
normal time to wake or alarm. 
3. Severe Daily wakes 1 hour or more before normal time. 
 
8. SUICIDE: Have you felt that life wasn’t worth living? Did you ever 
feel like ending it all? What did you think you might do? Did you 
actually try? 
0. Absent 
1. Mild Frequent thoughts of being better off dead, or occasional 
thoughts of suicide. 
2. Moderate Deliberately considered suicide with a plan, but made no 
attempt. 
3. Severe Suicidal attempt apparently designed to end in death (i.e.: 
accidental discovery or inefficient means). 
 
9. OBSERVED DEPRESSION: Based on interviewer’s observations 
during the entire interview. The question “Do you feel like crying?” 
used at appropriate points in the interview, may elicit information 
useful to this observation. 
0. Absent 
1. Mild Subject appears sad and mournful even during parts of the 
interview, involving affectively neutral discussion. 
2. Moderate Subject appears sad and mournful throughout the interview, with 
gloomy monotonous voice and is tearful or close to tears at times. 
3. Severe Subject chokes on distressing topics, frequently sighs deeply 
and cries openly, or is persistently in a state of frozen misery if 
examiner is sure that this is present. 
© Dr. Donald Addington and Dr. Jean Addington 
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Birchwood Insight Scale  
 
Each item is scored: 
0 – no insight (yes to 2, 3, 6, and 8; no to the others) 
1 – unsure (all items) 
2 – insight (no to 2, 3, 6 and 8; yes to the others) 
 
1. Some of my symptoms are made by my mind. 
2. I am mentally well. 
3. I do not need medication. 
4. My stay in hospital is necessary. 
5. The doctor is right in prescribing medication for me. 
6. I do not need to be seen by a doctor or psychiatrist. 
7. If someone said I have a nervous or a mental illness then they would be right. 
8. None of the usual things I experience are due to an illness.  
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Social and Occupational Functioning Assessment Scale  (SOFAS) 
Consider social and occupational functioning on a continuum from excellent 
functioning to grossly impaired functioning. Include impairment due to physical 
limitations, as well as those due to mental impairments. To be counted, impairment 
must be a direct consequence of mental and physical health problems; the effects of 
lack of opportunity and other environmental limitations are not to be considered. 
Code (Note: Use intermediate codes when appropriate, e.g., 45, 68, 72)      Score:  
 
100  
   I 
  91 
 Superior functioning in a wide range of activities  
  90 
   I 
 81 
Good functioning in all areas, occupationally and socially effective. 
 80 
  I 
 71 
No more than a slight impairment in social, occupational, or school 
functioning (e.g., infrequent interpersonal conflict, temporary failing behind 
in schoolwork). 
 70 
  I 
 61 
Some difficulty in social, occupational, or school functioning, but generally 
functioning well, has some meaningful interpersonal relationships. 
 
               
60 
I 
51 
Moderate difficulty in social, Occupational, or school functioning (e.g., few 
friends, conflicts with peers or co-workers). 
 
50 
I 
41 
Serious impairment in social, occupational, or school functioning (e.g, no 
friends, unable to keep a job). 
 
40 
I 
31 
Major impairment in several areas, such as work or school, family relations 
(e.g depressed man avoids friends, neglects family, and is unable to work; 
child frequently beats up younger children, is defiant at home, and is failing at 
school). 
30 
I 
21 
Inability to function in almost all areas (e.g., stays in bed all day; no job, 
home, or friends). 
 
20 
I 
11 
Occasionally fails to maintain personal hygiene; unable to function 
independently. 
10 
I 
1 
Persistent inability to maintain minimal personal hygiene. Unable to function 
without harming self or others or without considerable external support (e.g 
nursing care and supervision). 
0 Inadequate information. 
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WHOQOL-BREF 
The following questions ask how you feel about your quality of life, health, or other 
areas of your life. I will read out each question to you, along with the response 
options. Please choose the answer that appears most appropriate. If you are unsure 
about which response to give to a question, the first response you think of is often the 
best one. 
 
Please keep in mind you standards, hopes, pleasures and concerns. We ask that you 
think about your life in the last four weeks. 
  Very 
poor  
Poor  Neither poor  nor 
good  
Good  Very 
good  
1. How would you rate 
your quality of life? 
1 2 3 4 5 
 
  Very 
dissatisfied  
Dissatisfied  Neither 
satisfied not 
dissatisfied  
Satisfied  Very satisfied  
2. How satisfied are you 
with your health?  
        1    2            3   4     5 
 
The following questions ask about how much you have experienced certain things in 
the last four weeks. 
  Not at 
all  
A little  A moderate 
amount  
Very 
much  
An 
extreme 
amount  
3. To what extent do 
you feel that 
physical pain 
prevents you from 
doing what you need 
to do? 
5 4 3 2 1 
4.  How much do you 
need any medical 
treatment to function 
in your daily life? 
5 4 3 2 1 
5. How much do you 
enjoy life? 
1 2 3 4 5 
6. To what extent do 
you feel your life to 
be meaningful? 
1 2 3 4 5 
 
  Not at all  A little  A moderate 
amount  
Very much  Extremely  
7 How well are you able to  
concentrate? 
1 2 3 4 5 
8. How safe do you feel in 
your daily life? 
1 2 3 4 5 
9.  How healthy is your 
physical environment?  `
1 2 3 4 5  
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The following questions ask about how completely you experience or were able to do 
certain things in the last four weeks. 
  Not at all  A little  Moderately  Mostly  Completely  
10 Do you have enough energy for 
everyday life? 
1 2 3 4 5 
11 Are you able to accept your 
bodily appearance? 
1 2 3 4 5 
12 I have you enough money to 
meet your needs? 
1 2 3 4 5 
13 How available to you is the 
information that you need in 
your day-to-day life? 
1 2 3 4 5 
14 To what extent do you have the 
opportunity for leisure 
activities? 
1 2 3 4 5 
 
  Very 
poor  
Poor  Neither poor  
nor good  
Good  Very 
good  
15 How well are you 
able to get around? 
        1    2            3   4     5 
 
  Very 
dissatisfied  
Dissatisfied  Neither 
satisfied nor 
dissatisfied  
Satisfied  Very satisfied   
16. How satisfied are you 
with your sleep?  
1 2 3 4 5 
17. How satisfied are you 
with your ability to 
perform your daily 
living activities? 
1 2 3 4 5 
18.  How satisfied are you 
with your capacity for 
work? 
1 2 3 4 5 
19. How satisfied are you 
with yourself? 
1 2 3 4 5 
20. How satisfied are you 
with your personal 
relationships? 
1 2 3 4 5 
21 How satisfied are you 
with your sex life? 
1 2 3 4 5 
22. How satisfied are you 
with the support you 
get  from your 
friends? 
1 2 3 4 5 
23 How satisfied are you 
with the conditions of 
your living place? 
1 2 3 4 5 
Stellenbosch University  http://scholar.sun.ac.za
 284 
 
24. How satisfied are you 
with your access to 
health services? 
1 2 3 4 5 
25 How satisfied are you 
with your transport? 
     
 
The following question refers to how often you have felt or experienced certain things 
in the last four weeks. 
  Never  Seldom Quite often  Very often  Always  
26 How often do you have 
negative feelings such as 
blue mood, despair, anxiety, 
depression? 
5 4 3 2 1 
 
 
Do you have any comments about the assessment? 
 
 
 
[the following table should be completed after the interview is finished] 
 
 
 
 
Equations for computing domain scores 
 
Raw 
score  
Transformed 
scores* 
4-20 0-100 
27 Domain 1 (6-Q3) + (6-Q4) + Q10+Q15 + Q16+Q17+Q18 
 
  +   +   +   +    +   +   
 
 
a.= 
 
b: 
 
c: 
28 Domain 2  Q5 + Q6 + Q7 + Q11 + Q19 + (16 – Q26 ) 
 
  +   +   +   +    +   
 
a.= 
 
b: 
 
c: 
29 Domain 3 Q20 + Q21 + Q22 
 
  +   +   
 
a.= 
 
b: 
 
c: 
30 Domain 4 Q8 + Q9+Q12+Q13 + Q14 + Q23+Q24 + Q25 
 
  +   +   +   +  +  + +  
 
 
a.= 
 
b: 
 
c: 
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